<!DOCTYPE html>
<html lang="en" data-bs-theme="light">
  <head>
    <meta charset="utf-8">
    <title>Is my research used in clinical trials?</title>
    <link rel="apple-touch-icon" sizes="180x180" href="https://cdn.holoviz.org/panel/1.2.1/dist/images/apple-touch-icon.png">
    <link rel="icon" href="https://cdn.holoviz.org/panel/1.2.1/dist/images/favicon.ico" type="">
    <link rel="manifest" href="site.webmanifest">
    <meta name="name" content="Is my research used in clinical trials?">
    <link rel="manifest" href="">
    <style>
      html, body {
	display: flow-root;
        box-sizing: border-box;
        height: 100%;
        margin: 0;
        padding: 0;
      }
    </style>
    <link rel="stylesheet" href="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/datatabulator/tabulator-tables@5.5.0/dist/css/tabulator_bootstrap5.min.css" type="text/css" />
    <style>
        .tabulator{position:relative;border:1px solid #dee2e6;font-size:16px;text-align:left;overflow:hidden;-webkit-transform:translateZ(0);-moz-transform:translateZ(0);-ms-transform:translateZ(0);-o-transform:translateZ(0);transform:translateZ(0)}.tabulator[tabulator-layout=fitDataFill] .tabulator-tableholder .tabulator-table{min-width:100%}.tabulator[tabulator-layout=fitDataTable]{display:inline-block}.tabulator.tabulator-block-select{user-select:none}.tabulator .tabulator-header{position:relative;box-sizing:border-box;width:100%;border-bottom:1px solid #dee2e6;background-color:#fff;color:#555;font-weight:700;white-space:nowrap;overflow:hidden;-moz-user-select:none;-khtml-user-select:none;-webkit-user-select:none;-o-user-select:none}.tabulator .tabulator-header.tabulator-header-hidden{display:none}.tabulator .tabulator-header .tabulator-header-contents{position:relative;overflow:hidden}.tabulator .tabulator-header .tabulator-header-contents .tabulator-headers{display:inline-block}.tabulator .tabulator-header .tabulator-col{display:inline-flex;position:relative;box-sizing:border-box;flex-direction:column;justify-content:flex-start;border-right:1px solid #aaa;background:#fff;text-align:left;vertical-align:bottom;overflow:hidden}.tabulator .tabulator-header .tabulator-col.tabulator-moving{position:absolute;border:1px solid #dee2e6;background:#e6e6e6;pointer-events:none}.tabulator .tabulator-header .tabulator-col .tabulator-col-content{box-sizing:border-box;position:relative;padding:4px}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-header-popup-button{padding:0 8px}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-header-popup-button:hover{cursor:pointer;opacity:.6}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-title-holder{position:relative}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-title{box-sizing:border-box;width:100%;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;vertical-align:bottom}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-title.tabulator-col-title-wrap{white-space:normal;text-overflow:clip}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-title .tabulator-title-editor{box-sizing:border-box;width:100%;border:1px solid #999;padding:1px;background:#fff}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-title .tabulator-header-popup-button+.tabulator-title-editor{width:calc(100% - 22px)}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-sorter{display:flex;align-items:center;position:absolute;top:0;bottom:0;right:4px}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-sorter .tabulator-arrow{width:0;height:0;border-left:6px solid transparent;border-right:6px solid transparent;border-bottom:6px solid #bbb}.tabulator .tabulator-header .tabulator-col.tabulator-col-group .tabulator-col-group-cols{position:relative;display:flex;border-top:1px solid #aaa;overflow:hidden;margin-right:-1px}.tabulator .tabulator-header .tabulator-col .tabulator-header-filter{position:relative;box-sizing:border-box;margin-top:2px;width:100%;text-align:center}.tabulator .tabulator-header .tabulator-col .tabulator-header-filter textarea{height:auto!important}.tabulator .tabulator-header .tabulator-col .tabulator-header-filter svg{margin-top:3px}.tabulator .tabulator-header .tabulator-col .tabulator-header-filter input::-ms-clear{width:0;height:0}.tabulator .tabulator-header .tabulator-col.tabulator-sortable .tabulator-col-title{padding-right:25px}@media (hover:hover) and (pointer:fine){.tabulator .tabulator-header .tabulator-col.tabulator-sortable.tabulator-col-sorter-element:hover{cursor:pointer;background-color:#e6e6e6}}.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=none] .tabulator-col-content .tabulator-col-sorter{color:#bbb}@media (hover:hover) and (pointer:fine){.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=none] .tabulator-col-content .tabulator-col-sorter.tabulator-col-sorter-element .tabulator-arrow:hover{cursor:pointer;border-bottom:6px solid #555}}.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=none] .tabulator-col-content .tabulator-col-sorter .tabulator-arrow{border-top:none;border-bottom:6px solid #bbb}.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=ascending] .tabulator-col-content .tabulator-col-sorter{color:#666}@media (hover:hover) and (pointer:fine){.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=ascending] .tabulator-col-content .tabulator-col-sorter.tabulator-col-sorter-element .tabulator-arrow:hover{cursor:pointer;border-bottom:6px solid #555}}.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=ascending] .tabulator-col-content .tabulator-col-sorter .tabulator-arrow{border-top:none;border-bottom:6px solid #666}.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=descending] .tabulator-col-content .tabulator-col-sorter{color:#666}@media (hover:hover) and (pointer:fine){.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=descending] .tabulator-col-content .tabulator-col-sorter.tabulator-col-sorter-element .tabulator-arrow:hover{cursor:pointer;border-top:6px solid #555}}.tabulator .tabulator-header .tabulator-col.tabulator-sortable[aria-sort=descending] .tabulator-col-content .tabulator-col-sorter .tabulator-arrow{border-bottom:none;border-top:6px solid #666;color:#666}.tabulator .tabulator-header .tabulator-col.tabulator-col-vertical .tabulator-col-content .tabulator-col-title{writing-mode:vertical-rl;text-orientation:mixed;display:flex;align-items:center;justify-content:center}.tabulator .tabulator-header .tabulator-col.tabulator-col-vertical.tabulator-col-vertical-flip .tabulator-col-title{transform:rotate(180deg)}.tabulator .tabulator-header .tabulator-col.tabulator-col-vertical.tabulator-sortable .tabulator-col-title{padding-right:0;padding-top:20px}.tabulator .tabulator-header .tabulator-col.tabulator-col-vertical.tabulator-sortable.tabulator-col-vertical-flip .tabulator-col-title{padding-right:0;padding-bottom:20px}.tabulator .tabulator-header .tabulator-col.tabulator-col-vertical.tabulator-sortable .tabulator-col-sorter{justify-content:center;left:0;right:0;top:4px;bottom:auto}.tabulator .tabulator-header .tabulator-frozen{position:sticky;left:0;z-index:10}.tabulator .tabulator-header .tabulator-frozen.tabulator-frozen-left{border-right:2px solid #dee2e6}.tabulator .tabulator-header .tabulator-frozen.tabulator-frozen-right{border-left:2px solid #dee2e6}.tabulator .tabulator-header .tabulator-calcs-holder{box-sizing:border-box;background:#fff!important;border-top:1px solid #dee2e6;border-bottom:1px solid #aaa}.tabulator .tabulator-header .tabulator-calcs-holder .tabulator-row{background:#fff!important}.tabulator .tabulator-header .tabulator-calcs-holder .tabulator-row .tabulator-col-resize-handle,.tabulator .tabulator-header .tabulator-frozen-rows-holder:empty{display:none}.tabulator .tabulator-tableholder{position:relative;width:100%;white-space:nowrap;overflow:auto;-webkit-overflow-scrolling:touch}.tabulator .tabulator-tableholder:focus{outline:none}.tabulator .tabulator-tableholder .tabulator-placeholder{box-sizing:border-box;display:flex;align-items:center;justify-content:center;width:100%}.tabulator .tabulator-tableholder .tabulator-placeholder[tabulator-render-mode=virtual]{min-height:100%;min-width:100%}.tabulator .tabulator-tableholder .tabulator-placeholder .tabulator-placeholder-contents{display:inline-block;text-align:center;padding:10px;color:#ccc;font-weight:700;font-size:20px;white-space:normal}.tabulator .tabulator-tableholder .tabulator-table{position:relative;display:inline-block;background-color:#fff;white-space:nowrap;overflow:visible;color:#333}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.tabulator-calcs{font-weight:700;background:#dadfe4!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.tabulator-calcs.tabulator-calcs-top{border-bottom:2px solid #dee2e6}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.tabulator-calcs.tabulator-calcs-bottom{border-top:2px solid #dee2e6}.tabulator .tabulator-footer{border-top:1px solid #dee2e6;background-color:#e6e6e6;color:#555;font-weight:700;white-space:nowrap;user-select:none;-moz-user-select:none;-khtml-user-select:none;-webkit-user-select:none;-o-user-select:none}.tabulator .tabulator-footer .tabulator-footer-contents{display:flex;flex-direction:row;align-items:center;justify-content:space-between;padding:5px 10px}.tabulator .tabulator-footer .tabulator-footer-contents:empty{display:none}.tabulator .tabulator-footer .tabulator-calcs-holder{box-sizing:border-box;width:100%;text-align:left;background:#f3f3f3!important;border-bottom:1px solid #dee2e6;border-top:1px solid #dee2e6;overflow:hidden}.tabulator .tabulator-footer .tabulator-calcs-holder .tabulator-row{display:inline-block;background:#f3f3f3!important}.tabulator .tabulator-footer .tabulator-calcs-holder .tabulator-row .tabulator-col-resize-handle{display:none}.tabulator .tabulator-footer .tabulator-calcs-holder:only-child{margin-bottom:-5px;border-bottom:none}.tabulator .tabulator-footer>*+.tabulator-page-counter{margin-left:10px}.tabulator .tabulator-footer .tabulator-page-counter{font-weight:400}.tabulator .tabulator-footer .tabulator-paginator{flex:1;text-align:right;color:#555;font-family:inherit;font-weight:inherit;font-size:inherit}.tabulator .tabulator-footer .tabulator-page-size{display:inline-block;margin:0 5px;padding:2px 5px;border:1px solid #dee2e6;border-radius:3px}.tabulator .tabulator-footer .tabulator-pages{margin:0 7px}.tabulator .tabulator-footer .tabulator-page{display:inline-block;margin:0 2px;padding:2px 5px;border:1px solid #dee2e6;border-radius:3px;background:hsla(0,0%,100%,.2)}.tabulator .tabulator-footer .tabulator-page:disabled{opacity:.5}@media (hover:hover) and (pointer:fine){.tabulator .tabulator-footer .tabulator-page:not(.disabled):hover{cursor:pointer;background:rgba(0,0,0,.2);color:#fff}}.tabulator .tabulator-col-resize-handle{position:relative;display:inline-block;width:6px;margin-left:-3px;margin-right:-3px;z-index:10;vertical-align:middle}@media (hover:hover) and (pointer:fine){.tabulator .tabulator-col-resize-handle:hover{cursor:ew-resize}}.tabulator .tabulator-col-resize-handle:last-of-type{width:3px;margin-right:0}.tabulator .tabulator-alert{position:absolute;display:flex;align-items:center;top:0;left:0;z-index:100;height:100%;width:100%;background:rgba(0,0,0,.4);text-align:center}.tabulator .tabulator-alert .tabulator-alert-msg{display:inline-block;margin:0 auto;padding:10px 20px;border-radius:10px;background:#fff;font-weight:700;font-size:16px}.tabulator .tabulator-alert .tabulator-alert-msg.tabulator-alert-state-msg{border:4px solid #333;color:#000}.tabulator .tabulator-alert .tabulator-alert-msg.tabulator-alert-state-error{border:4px solid #d00;color:#590000}.tabulator-row{position:relative;box-sizing:border-box;min-height:24px;background-color:#fff}.tabulator-row.tabulator-row-even{background-color:#e9ecef}@media (hover:hover) and (pointer:fine){.tabulator-row.tabulator-selectable:hover{background-color:#ced4da;cursor:pointer}}.tabulator-row.tabulator-selected{background-color:#9abcea}@media (hover:hover) and (pointer:fine){.tabulator-row.tabulator-selected:hover{background-color:#769bcc;cursor:pointer}}.tabulator-row.tabulator-row-moving{border:1px solid #000;background:#fff}.tabulator-row.tabulator-moving{position:absolute;border-top:1px solid #dee2e6;border-bottom:1px solid #dee2e6;pointer-events:none;z-index:15}.tabulator-row .tabulator-row-resize-handle{position:absolute;right:0;bottom:0;left:0;height:5px}.tabulator-row .tabulator-row-resize-handle.prev{top:0;bottom:auto}@media (hover:hover) and (pointer:fine){.tabulator-row .tabulator-row-resize-handle:hover{cursor:ns-resize}}.tabulator-row .tabulator-responsive-collapse{box-sizing:border-box;padding:5px;border-top:1px solid #dee2e6;border-bottom:1px solid #dee2e6}.tabulator-row .tabulator-responsive-collapse:empty{display:none}.tabulator-row .tabulator-responsive-collapse table{font-size:16px}.tabulator-row .tabulator-responsive-collapse table tr td{position:relative}.tabulator-row .tabulator-responsive-collapse table tr td:first-of-type{padding-right:10px}.tabulator-row .tabulator-cell{display:inline-block;position:relative;box-sizing:border-box;padding:4px;border-right:1px solid #dee2e6;vertical-align:middle;white-space:nowrap;overflow:hidden;text-overflow:ellipsis}.tabulator-row .tabulator-cell.tabulator-frozen{display:inline-block;position:sticky;left:0;background-color:inherit;z-index:10}.tabulator-row .tabulator-cell.tabulator-frozen.tabulator-frozen-left{border-right:2px solid #dee2e6}.tabulator-row .tabulator-cell.tabulator-frozen.tabulator-frozen-right{border-left:2px solid #dee2e6}.tabulator-row .tabulator-cell.tabulator-editing{border:1px solid #1d68cd;outline:none;padding:0}.tabulator-row .tabulator-cell.tabulator-editing input,.tabulator-row .tabulator-cell.tabulator-editing select{border:1px;background:transparent;outline:none}.tabulator-row .tabulator-cell.tabulator-validation-fail{border:1px solid #d00}.tabulator-row .tabulator-cell.tabulator-validation-fail input,.tabulator-row .tabulator-cell.tabulator-validation-fail select{border:1px;background:transparent;color:#d00}.tabulator-row .tabulator-cell.tabulator-row-handle{display:inline-flex;align-items:center;justify-content:center;-moz-user-select:none;-khtml-user-select:none;-webkit-user-select:none;-o-user-select:none}.tabulator-row .tabulator-cell.tabulator-row-handle .tabulator-row-handle-box{width:80%}.tabulator-row .tabulator-cell.tabulator-row-handle .tabulator-row-handle-box .tabulator-row-handle-bar{width:100%;height:3px;margin-top:2px;background:#666}.tabulator-row .tabulator-cell .tabulator-data-tree-branch{display:inline-block;vertical-align:middle;height:9px;width:7px;margin-top:-9px;margin-right:5px;border-bottom-left-radius:1px;border-left:2px solid #dee2e6;border-bottom:2px solid #dee2e6}.tabulator-row .tabulator-cell .tabulator-data-tree-control{display:inline-flex;justify-content:center;align-items:center;vertical-align:middle;height:11px;width:11px;margin-right:5px;border:1px solid #333;border-radius:2px;background:rgba(0,0,0,.1);overflow:hidden}@media (hover:hover) and (pointer:fine){.tabulator-row .tabulator-cell .tabulator-data-tree-control:hover{cursor:pointer;background:rgba(0,0,0,.2)}}.tabulator-row .tabulator-cell .tabulator-data-tree-control .tabulator-data-tree-control-collapse{display:inline-block;position:relative;height:7px;width:1px;background:transparent}.tabulator-row .tabulator-cell .tabulator-data-tree-control .tabulator-data-tree-control-collapse:after{position:absolute;content:"";left:-3px;top:3px;height:1px;width:7px;background:#333}.tabulator-row .tabulator-cell .tabulator-data-tree-control .tabulator-data-tree-control-expand{display:inline-block;position:relative;height:7px;width:1px;background:#333}.tabulator-row .tabulator-cell .tabulator-data-tree-control .tabulator-data-tree-control-expand:after{position:absolute;content:"";left:-3px;top:3px;height:1px;width:7px;background:#333}.tabulator-row .tabulator-cell .tabulator-responsive-collapse-toggle{display:inline-flex;align-items:center;justify-content:center;-moz-user-select:none;-khtml-user-select:none;-webkit-user-select:none;-o-user-select:none;height:15px;width:15px;border-radius:20px;background:#666;color:#fff;font-weight:700;font-size:1.1em}@media (hover:hover) and (pointer:fine){.tabulator-row .tabulator-cell .tabulator-responsive-collapse-toggle:hover{opacity:.7;cursor:pointer}}.tabulator-row .tabulator-cell .tabulator-responsive-collapse-toggle.open .tabulator-responsive-collapse-toggle-close{display:initial}.tabulator-row .tabulator-cell .tabulator-responsive-collapse-toggle.open .tabulator-responsive-collapse-toggle-open{display:none}.tabulator-row .tabulator-cell .tabulator-responsive-collapse-toggle svg{stroke:#fff}.tabulator-row .tabulator-cell .tabulator-responsive-collapse-toggle .tabulator-responsive-collapse-toggle-close{display:none}.tabulator-row .tabulator-cell .tabulator-traffic-light{display:inline-block;height:14px;width:14px;border-radius:14px}.tabulator-row.tabulator-group{box-sizing:border-box;border-bottom:1px solid #999;border-right:1px solid #dee2e6;border-top:1px solid #999;padding:5px 5px 5px 10px;background:#ccc;font-weight:700;min-width:100%}@media (hover:hover) and (pointer:fine){.tabulator-row.tabulator-group:hover{cursor:pointer;background-color:rgba(0,0,0,.1)}}.tabulator-row.tabulator-group.tabulator-group-visible .tabulator-arrow{margin-right:10px;border-left:6px solid transparent;border-right:6px solid transparent;border-top:6px solid #666;border-bottom:0}.tabulator-row.tabulator-group.tabulator-group-level-1{padding-left:30px}.tabulator-row.tabulator-group.tabulator-group-level-2{padding-left:50px}.tabulator-row.tabulator-group.tabulator-group-level-3{padding-left:70px}.tabulator-row.tabulator-group.tabulator-group-level-4{padding-left:90px}.tabulator-row.tabulator-group.tabulator-group-level-5{padding-left:110px}.tabulator-row.tabulator-group .tabulator-group-toggle{display:inline-block}.tabulator-row.tabulator-group .tabulator-arrow{display:inline-block;width:0;height:0;margin-right:16px;border-top:6px solid transparent;border-bottom:6px solid transparent;border-right:0;border-left:6px solid #666;vertical-align:middle}.tabulator-row.tabulator-group span{margin-left:10px;color:#d00}.tabulator-popup-container{position:absolute;display:inline-block;box-sizing:border-box;border:1px solid #dee2e6;box-shadow:0 0 5px 0 rgba(0,0,0,.2);font-size:16px;overflow-y:auto;-webkit-overflow-scrolling:touch;z-index:10000}.tabulator-popup{padding:5px;border-radius:3px}.tabulator-tooltip{max-width:Min(500px,100%);padding:3px 5px;border-radius:2px;box-shadow:none;font-size:12px;pointer-events:none}.tabulator-menu .tabulator-menu-item{position:relative;box-sizing:border-box;padding:5px 10px;user-select:none}.tabulator-menu .tabulator-menu-item.tabulator-menu-item-disabled{opacity:.5}@media (hover:hover) and (pointer:fine){.tabulator-menu .tabulator-menu-item:not(.tabulator-menu-item-disabled):hover{cursor:pointer;background:#e9ecef}}.tabulator-menu .tabulator-menu-item.tabulator-menu-item-submenu{padding-right:25px}.tabulator-menu .tabulator-menu-item.tabulator-menu-item-submenu:after{display:inline-block;position:absolute;top:calc(5px + .4em);right:10px;height:7px;width:7px;content:"";border-color:#dee2e6;border-style:solid;border-width:1px 1px 0 0;vertical-align:top;transform:rotate(45deg)}.tabulator-menu .tabulator-menu-separator{border-top:1px solid #dee2e6}.tabulator-edit-list{max-height:200px;font-size:16px;overflow-y:auto;-webkit-overflow-scrolling:touch}.tabulator-edit-list .tabulator-edit-list-item{padding:4px;color:#333;outline:none}.tabulator-edit-list .tabulator-edit-list-item.active{background:#1d68cd}.tabulator-edit-list .tabulator-edit-list-item.focused{outline:1px solid #1d68cd}@media (hover:hover) and (pointer:fine){.tabulator-edit-list .tabulator-edit-list-item:hover{cursor:pointer;color:#fff;background:#1d68cd}}.tabulator-edit-list .tabulator-edit-list-placeholder{padding:4px;color:#333;text-align:center}.tabulator-edit-list .tabulator-edit-list-group{border-bottom:1px solid #dee2e6;padding:6px 4px 4px;color:#333;font-weight:700}.tabulator-edit-list .tabulator-edit-list-group.tabulator-edit-list-group-level-2,.tabulator-edit-list .tabulator-edit-list-item.tabulator-edit-list-group-level-2{padding-left:12px}.tabulator-edit-list .tabulator-edit-list-group.tabulator-edit-list-group-level-3,.tabulator-edit-list .tabulator-edit-list-item.tabulator-edit-list-group-level-3{padding-left:20px}.tabulator-edit-list .tabulator-edit-list-group.tabulator-edit-list-group-level-4,.tabulator-edit-list .tabulator-edit-list-item.tabulator-edit-list-group-level-4{padding-left:28px}.tabulator-edit-list .tabulator-edit-list-group.tabulator-edit-list-group-level-5,.tabulator-edit-list .tabulator-edit-list-item.tabulator-edit-list-group-level-5{padding-left:36px}.tabulator.tabulator-ltr{direction:ltr}.tabulator.tabulator-rtl{text-align:initial;direction:rtl}.tabulator.tabulator-rtl .tabulator-header .tabulator-col{border-left:1px solid #aaa;border-right:initial}.tabulator.tabulator-rtl .tabulator-header .tabulator-col.tabulator-col-group .tabulator-col-group-cols{margin-right:0;margin-left:-1px}.tabulator.tabulator-rtl .tabulator-header .tabulator-col.tabulator-sortable .tabulator-col-title{padding-right:0;padding-left:25px}.tabulator.tabulator-rtl .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-sorter{left:8px;right:auto}.tabulator.tabulator-rtl .tabulator-row .tabulator-cell{border-right:initial;border-left:1px solid #dee2e6}.tabulator.tabulator-rtl .tabulator-row .tabulator-cell .tabulator-data-tree-branch{margin-right:0;margin-left:5px;border-bottom-left-radius:0;border-bottom-right-radius:1px;border-left:initial;border-right:2px solid #dee2e6}.tabulator.tabulator-rtl .tabulator-row .tabulator-cell .tabulator-data-tree-control{margin-right:0;margin-left:5px}.tabulator.tabulator-rtl .tabulator-row .tabulator-cell.tabulator-frozen.tabulator-frozen-left{border-left:2px solid #dee2e6}.tabulator.tabulator-rtl .tabulator-row .tabulator-cell.tabulator-frozen.tabulator-frozen-right{border-right:2px solid #dee2e6}.tabulator.tabulator-rtl .tabulator-row .tabulator-col-resize-handle:last-of-type{width:3px;margin-left:0;margin-right:-3px}.tabulator.tabulator-rtl .tabulator-footer .tabulator-calcs-holder{text-align:initial}.tabulator-print-fullscreen{position:absolute;top:0;bottom:0;left:0;right:0;z-index:10000}body.tabulator-print-fullscreen-hide>:not(.tabulator-print-fullscreen){display:none!important}.tabulator-print-table{border-collapse:collapse}.tabulator-print-table .tabulator-data-tree-branch{display:inline-block;vertical-align:middle;height:9px;width:7px;margin-top:-9px;margin-right:5px;border-bottom-left-radius:1px;border-left:2px solid #dee2e6;border-bottom:2px solid #dee2e6}.tabulator-print-table .tabulator-print-table-group{box-sizing:border-box;border-bottom:1px solid #999;border-right:1px solid #dee2e6;border-top:1px solid #999;padding:5px 5px 5px 10px;background:#ccc;font-weight:700;min-width:100%}@media (hover:hover) and (pointer:fine){.tabulator-print-table .tabulator-print-table-group:hover{cursor:pointer;background-color:rgba(0,0,0,.1)}}.tabulator-print-table .tabulator-print-table-group.tabulator-group-visible .tabulator-arrow{margin-right:10px;border-left:6px solid transparent;border-right:6px solid transparent;border-top:6px solid #666;border-bottom:0}.tabulator-print-table .tabulator-print-table-group.tabulator-group-level-1 td{padding-left:30px!important}.tabulator-print-table .tabulator-print-table-group.tabulator-group-level-2 td{padding-left:50px!important}.tabulator-print-table .tabulator-print-table-group.tabulator-group-level-3 td{padding-left:70px!important}.tabulator-print-table .tabulator-print-table-group.tabulator-group-level-4 td{padding-left:90px!important}.tabulator-print-table .tabulator-print-table-group.tabulator-group-level-5 td{padding-left:110px!important}.tabulator-print-table .tabulator-print-table-group .tabulator-group-toggle{display:inline-block}.tabulator-print-table .tabulator-print-table-group .tabulator-arrow{display:inline-block;width:0;height:0;margin-right:16px;border-top:6px solid transparent;border-bottom:6px solid transparent;border-right:0;border-left:6px solid #666;vertical-align:middle}.tabulator-print-table .tabulator-print-table-group span{margin-left:10px;color:#d00}.tabulator-print-table .tabulator-data-tree-control{display:inline-flex;justify-content:center;align-items:center;vertical-align:middle;height:11px;width:11px;margin-right:5px;border:1px solid #333;border-radius:2px;background:rgba(0,0,0,.1);overflow:hidden}@media (hover:hover) and (pointer:fine){.tabulator-print-table .tabulator-data-tree-control:hover{cursor:pointer;background:rgba(0,0,0,.2)}}.tabulator-print-table .tabulator-data-tree-control .tabulator-data-tree-control-collapse{display:inline-block;position:relative;height:7px;width:1px;background:transparent}.tabulator-print-table .tabulator-data-tree-control .tabulator-data-tree-control-collapse:after{position:absolute;content:"";left:-3px;top:3px;height:1px;width:7px;background:#333}.tabulator-print-table .tabulator-data-tree-control .tabulator-data-tree-control-expand{display:inline-block;position:relative;height:7px;width:1px;background:#333}.tabulator-print-table .tabulator-data-tree-control .tabulator-data-tree-control-expand:after{position:absolute;content:"";left:-3px;top:3px;height:1px;width:7px;background:#333}.tabulator{background-color:#fff;border:none}.tabulator .tabulator-header{border-top:1px solid #dee2e6;border-bottom:2px solid #dee2e6;color:inherit}.tabulator .tabulator-header .tabulator-col{border-right:none;background-color:#fff}.tabulator .tabulator-header .tabulator-col .tabulator-col-content{padding:12px}.tabulator .tabulator-header .tabulator-col .tabulator-col-content .tabulator-col-sorter{right:0}.tabulator .tabulator-header .tabulator-col.tabulator-col-group .tabulator-col-group-cols{border-top:1px solid #dee2e6}.tabulator .tabulator-header .tabulator-col .tabulator-header-filter input{padding:.375rem .75rem;background-color:#fff;background-clip:padding-box;border:1px solid #ced4da;border-radius:.25rem;transition:border-color .15s ease-in-out,box-shadow .15s ease-in-out;font-size:1rem;line-height:1.5;color:#495057}.tabulator .tabulator-header .tabulator-col .tabulator-header-filter input:focus{color:#495057;background-color:#fff;border:1px solid #1d68cd;outline:0}.tabulator .tabulator-header .tabulator-calcs-holder{width:100%;border-bottom:1px solid #dee2e6}.tabulator .tabulator-tableholder .tabulator-placeholder span{color:#000}.tabulator .tabulator-footer,.tabulator .tabulator-footer .tabulator-paginator,.tabulator .tabulator-tableholder .tabulator-table{color:inherit}.tabulator .tabulator-footer .tabulator-pages{margin:0}.tabulator .tabulator-footer .tabulator-page{margin:5px 0 0;padding:8px 12px}.tabulator .tabulator-footer .tabulator-page[data-page=first]{border-top-left-radius:4px;border-bottom-left-radius:4px}.tabulator .tabulator-footer .tabulator-page[data-page=last]{border:1px solid #dee2e6;border-top-right-radius:4px;border-bottom-right-radius:4px}.tabulator .tabulator-footer .tabulator-page.active{border-color:#0d6efd;background-color:#0d6efd;color:#fff}.tabulator .tabulator-footer .tabulator-page:disabled{border-color:#dee2e6;background:#fff;color:#6c757d}@media (hover:hover) and (pointer:fine){.tabulator .tabulator-footer .tabulator-page:not(.disabled):hover{border-color:#dee2e6;background:#e9ecef;color:#0a58ca}}.tabulator.thead-dark .tabulator-header,.tabulator.thead-dark .tabulator-header .tabulator-col{border-color:#dee2e6;background-color:#fff;color:#212529}.tabulator.table{background-color:#fff}.tabulator.table:not(.thead-light) .tabulator-header,.tabulator.table:not(.thead-light) .tabulator-header .tabulator-col{border-color:#dee2e6;background-color:#fff;color:#212529}.tabulator.table .tabulator-tableholder{color:#212529}.tabulator.table .tabulator-row{border-color:#dee2e6;background-color:#fff;color:#212529}@media (hover:hover) and (pointer:fine){.tabulator.table .tabulator-row:hover{background-color:#dee2e6}.tabulator.table .tabulator-row:hover .tabulator-cell{background-color:#ced4da}}.tabulator.table .tabulator-row.tabulator-selected{background-color:#9abcea}.tabulator.table .tabulator-footer{border-color:#dee2e6!important}.tabulator.table .tabulator-footer .tabulator-calcs-holder{border-color:#dee2e6!important;background:#fff!important}.tabulator.table .tabulator-footer .tabulator-calcs-holder .tabulator-row{border-color:#dee2e6!important;background-color:#fff!important;color:#212529!important}.tabulator.table-striped:not(.table) .tabulator-row.tabulator-row-even{background-color:#e9ecef}.tabulator.table-striped:not(.table) .tabulator-row.tabulator-row-even.tabulator-selected{background-color:#9abcea}@media (hover:hover) and (pointer:fine){.tabulator.table-striped:not(.table) .tabulator-row.tabulator-row-even.tabulator-selectable:hover{background-color:#ced4da;cursor:pointer}.tabulator.table-striped:not(.table) .tabulator-row.tabulator-row-even.tabulator-selected:hover{background-color:#769bcc;cursor:pointer}}.tabulator.table-striped.table .tabulator-row:nth-child(2n) .tabulator-cell{background-color:transparent}.tabulator.table-bordered{border:1px solid #dee2e6}.tabulator.table-bordered .tabulator-header .tabulator-col,.tabulator.table-bordered .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell{border-right:1px solid #dee2e6}.tabulator.table-borderless .tabulator-header,.tabulator.table-borderless .tabulator-row{border:none}.tabulator.table-sm .tabulator-header .tabulator-col .tabulator-col-content{padding:5px!important}.tabulator.table-sm .tabulator-tableholder .tabulator-table .tabulator-row{min-height:26px}.tabulator.table-sm .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell{padding:5px!important}.tabulator.table-sm .tabulator-row{padding-top:0;padding-bottom:0}.tabulator.table-sm .tabulator-col-resize-handle{padding:0}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-primary{background:#cfe2ff!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-secondary{background:#e2e3e5!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-success{background:#d1e7dd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-info{background:#cff4fc!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-warning{background:#fff3cd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-danger{background:#f8d7da!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-light{background:#f8f9fa!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table{background:#212529!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.table-active{background:#6c757d!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-primary{background:#cfe2ff!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-secondary{background:#e2e3e5!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-success{background:#d1e7dd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-info{background:#cff4fc!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-warning{background:#fff3cd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-danger{background:#f8d7da!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-light{background:#f8f9fa!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-dark{background:#212529!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row.bg-active{background:#6c757d!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-primary{background:#cfe2ff!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-secondary{background:#e2e3e5!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-success{background:#d1e7dd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-info{background:#cff4fc!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-warning{background:#fff3cd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-danger{background:#f8d7da!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-light{background:#f8f9fa!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table{background:#212529!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.table-active{background:#6c757d!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-primary{background:#cfe2ff!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-secondary{background:#e2e3e5!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-success{background:#d1e7dd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-info{background:#cff4fc!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-warning{background:#fff3cd!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-danger{background:#f8d7da!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-light{background:#f8f9fa!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-dark{background:#212529!important}.tabulator .tabulator-tableholder .tabulator-table .tabulator-row .tabulator-cell.bg-active{background:#6c757d!important}.tabulator-row{min-height:40px;border-bottom:1px solid #dee2e6}.tabulator-row .tabulator-cell{padding:12px;border-right:none}.tabulator-row .tabulator-cell:last-of-type{border-right:none}.tabulator-row .tabulator-cell .tabulator-data-tree-control{border:1px solid #ccc}.tabulator-row .tabulator-cell .tabulator-data-tree-control .tabulator-data-tree-control-collapse:after,.tabulator-row .tabulator-cell .tabulator-data-tree-control .tabulator-data-tree-control-expand,.tabulator-row .tabulator-cell .tabulator-data-tree-control .tabulator-data-tree-control-expand:after{background:#ccc}.tabulator-row.tabulator-group{background:#fafafa}.tabulator-row.tabulator-group span{color:#666}.tabulator-edit-select-list{background:#fff}.tabulator-edit-select-list .tabulator-edit-select-list-item.active{color:#fff}.tabulator-edit-select-list .tabulator-edit-select-list-item.active.focused{outline:1px solid hsla(0,0%,100%,.5)}@media (hover:hover) and (pointer:fine){.tabulator-edit-select-list .tabulator-edit-select-list-item:hover{color:#fff}}.tabulator-edit-select-list .tabulator-edit-select-list-group,.tabulator-edit-select-list .tabulator-edit-select-list-notice{color:inherit}.tabulator.tabulator-rtl .tabulator-header .tabulator-col{text-align:initial;border-left:initial}.tabulator-print-table .tabulator-print-table-group{background:#fafafa}.tabulator-print-table .tabulator-print-table-group span{color:#666}.tabulator-print-table .tabulator-data-tree-control{color:inherit}.tabulator-print-table .tabulator-data-tree-control .tabulator-data-tree-control-collapse:after,.tabulator-print-table .tabulator-data-tree-control .tabulator-data-tree-control-expand,.tabulator-print-table .tabulator-data-tree-control .tabulator-data-tree-control-expand:after{background:#ccc}.tabulator-popup-container{background:#fff}.tabulator-edit-list .tabulator-edit-list-item.active{color:#fff}.tabulator-edit-list .tabulator-edit-list-item.active.focused{outline:1px solid hsla(0,0%,100%,.5)}@media (hover:hover) and (pointer:fine){.tabulator-edit-list .tabulator-edit-list-item:hover{color:#fff}}
/*# sourceMappingURL=tabulator_bootstrap5.min.css.map */
    </style>

<style type="text/css">
:host(.pn-loading),
.pn-loading {
  overflow: hidden;
}

:host(.pn-loading):before,
.pn-loading:before {
  position: absolute;
  height: 100%;
  width: 100%;
  content: '';
  z-index: 1000;
  background-color: rgb(255, 255, 255, 0.5);
  border-color: lightgray;
  background-repeat: no-repeat;
  background-position: center;
  background-size: auto 50%;
  border-width: 1px;
  cursor: progress;
}

:host(.pn-loading) .pn-loading-msg,
.pn-loading .pn-loading-msg {
  position: absolute;
  top: 72%;
  font-size: 2em;
  color: black;
  width: 100%;
  text-align: center;
}


:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {
  background-image: url("data:image/svg+xml;base64,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");
  background-size: auto calc(min(50%, 400px));
}
</style>
<script type="text/javascript">
if ('serviceWorker' in navigator) {
  navigator.serviceWorker.register('./serviceWorker.js').then(reg => {
    reg.onupdatefound = () => {
      const installingWorker = reg.installing;
      installingWorker.onstatechange = () => {
        if (installingWorker.state === 'installed' &&
            navigator.serviceWorker.controller) {
          // Reload page if service worker is replaced
          location.reload();
        }
      }
    }
  })
}
</script>

<script type="text/javascript" src="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/jquery/jquery.slim.min.js"></script>
<script type="text/javascript" src="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/plotlyplot/plotly-2.18.0.min.js"></script>
<script type="text/javascript" src="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/datatabulator/tabulator-tables@5.5.0/dist/js/tabulator.js"></script>
<script type="text/javascript" src="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/datatabulator/luxon/build/global/luxon.min.js"></script>
<script type="text/javascript" src="https://cdn.bokeh.org/bokeh/release/bokeh-3.2.1.min.js"></script>
<script type="text/javascript" src="https://cdn.bokeh.org/bokeh/release/bokeh-gl-3.2.1.min.js"></script>
<script type="text/javascript" src="https://cdn.bokeh.org/bokeh/release/bokeh-widgets-3.2.1.min.js"></script>
<script type="text/javascript" src="https://cdn.bokeh.org/bokeh/release/bokeh-tables-3.2.1.min.js"></script>
<script type="text/javascript" src="https://cdn.holoviz.org/panel/1.2.1/dist/panel.min.js"></script>

<script type="text/javascript">
  Bokeh.set_log_level("info");
</script>
    <!-- Template CSS -->
    <link rel="stylesheet" href="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/bootstrap5/css/bootstrap.min.css">
    <link rel="stylesheet" href="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/theme/default.css">
    <link rel="stylesheet" href="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/theme/bootstrap_default.css">
    <link rel="stylesheet" href="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/bootstraptemplate/bootstrap.css">
    <style type="text/css">
    
:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {
  background-image: url("data:image/svg+xml;base64,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");
  background-size: auto calc(min(50%, 400px));
}
    </style>

    <style>
      :root {
	--header-background: var(--design-primary-color, var(--panel-primary-color));
	--header-color: var(--design-primary-text-color, var(--panel-on-primary-color));
	--sidebar-width: 350px;
      }
      #header {
	--bs-body-bg: var(--header-background);
	--bs-body-color: var(--header-color);
	background-color: var(--header-background);
	color: var(--header-color);
      }
      #sidebar {
        max-width: var(--sidebar-width) !important;
        width: var(--sidebar-width);
      }
    </style>

    <!-- Template JS -->
    <script src="https://cdn.holoviz.org/panel/1.2.1/dist/bundled/bootstrap5/js/bootstrap.bundle.min.js"></script>
  </head>
  <body class="pn-loading pn-arc">
<div class="container-fluid d-flex flex-column vh-100 overflow-hidden" id="container">
  <nav class="navbar navbar-expand-md sticky-top shadow" id="header">
    <div class="app-header">
<a class="title" href="" >&nbsp;Is my research used in clinical trials?</a>    </div>
    <div id="header-items">
    </div>
    <div class="pn-busy-container">
      <div id="be336cf6-2e6f-4419-a775-f281022e6947" data-root-id="p1016" style="display: contents;"></div>
    </div>
  </nav>

  <div class="row overflow-hidden" id="content">

    <div class="col mh-100 float-left" id="main">
          <div id="e3b3b04b-40e1-4765-97a4-d13e7e23f472" data-root-id="p1017" style="display: contents;"></div>
    </div>
  </div>

  <div id="pn-Modal" class="modal fade pn-modal" role="dialog" tabindex="-1" aria-hidden="true">
    <div class="modal-dialog">
      <div class="modal-content pn-modal-content">
	<button type="button" id="pn-closeModal" class="btn-close pn-modal-close" data-bs-dismiss="modal" aria-label="Close"></button>
	<div class="modal-body">
	</div>
      </div>
    </div>
  </div>
</div>

<div id="ae9ac02f-829b-46f5-b297-a9a2f69216ac" data-root-id="p1009" style="display: contents;"></div>
<div id="ad97d1a7-5ce5-42e5-a72e-410f525ce77c" data-root-id="p1012" style="display: contents;"></div>
<div id="bc0230a8-c341-4a63-822a-b9b80bcf8293" data-root-id="p1002" style="display: contents;"></div>
<div id="e4cedbbf-56e6-4fee-ad91-ee5d4ee3e1d1" data-root-id="p1013" style="display: contents;"></div>

  
    <script type="text/javascript">
      const pyodideWorker = new Worker("./clinical_trials.js");
      pyodideWorker.busy = false
      pyodideWorker.queue = []
      
      function send_change(jsdoc, event) {
        if (event.setter_id != null && event.setter_id == 'py') {
          return
        } else if (pyodideWorker.busy && event.model && event.attr) {
          let events = []
          for (const old_event of pyodideWorker.queue) {
            if (!(old_event.model === event.model && old_event.attr === event.attr)) {
              events.push(old_event)
            }
          }
          events.push(event)
          pyodideWorker.queue = events
          return
        }
        const patch = jsdoc.create_json_patch([event])
        pyodideWorker.busy = true
        pyodideWorker.postMessage({type: 'patch', patch: patch})
      }
      
      pyodideWorker.onmessage = async (event) => {
        const msg = event.data
      
        const body = document.getElementsByTagName('body')[0]
        const loading_msgs = document.getElementsByClassName('pn-loading-msg')
        if (msg.type === 'idle') {
          if (pyodideWorker.queue.length) {
            const patch = pyodideWorker.jsdoc.create_json_patch(pyodideWorker.queue)
            pyodideWorker.busy = true
            pyodideWorker.queue = []
            pyodideWorker.postMessage({type: 'patch', patch: patch})
          } else {
            pyodideWorker.busy = false
          }
        } else if (msg.type === 'status') {
          let loading_msg
          if (loading_msgs.length) {
            loading_msg = loading_msgs[0]
          } else if (body.classList.contains('pn-loading')) {
            loading_msg = document.createElement('div')
            loading_msg.classList.add('pn-loading-msg')
            body.appendChild(loading_msg)
          }
          if (loading_msg != null) {
            loading_msg.innerHTML = msg.msg
          }
        } else if (msg.type === 'render') {
          const docs_json = JSON.parse(msg.docs_json)
          const render_items = JSON.parse(msg.render_items)
          const root_ids = JSON.parse(msg.root_ids)
      
          // Remap roots in message to element IDs
          const root_els = document.querySelectorAll('[data-root-id]')
          const data_roots = []
          for (const el of root_els) {
             el.innerHTML = ''
             data_roots.push([el.getAttribute('data-root-id'), el.id])
          }
          data_roots.sort((a, b) => a[0]<b[0] ? -1: 1)
          const roots = {}
          for (let i=0; i<data_roots.length; i++) {
            roots[root_ids[i]] = data_roots[i][1]
          }
          render_items[0]['roots'] = roots
          render_items[0]['root_ids'] = root_ids
      
          // Embed content
          const [views] = await Bokeh.embed.embed_items(docs_json, render_items)
      
          // Remove loading spinner and message
          body.classList.remove("pn-loading", "arc")
          for (const loading_msg of loading_msgs) {
            loading_msg.remove()
          }
      
          // Setup bi-directional syncing
          pyodideWorker.jsdoc = jsdoc = [...views.roots.values()][0].model.document
          jsdoc.on_change(send_change.bind(null, jsdoc), false)
          pyodideWorker.postMessage({'type': 'rendered'})
          pyodideWorker.postMessage({'type': 'location', location: JSON.stringify(window.location)})
        } else if (msg.type === 'patch') {
          pyodideWorker.jsdoc.apply_json_patch(msg.patch, msg.buffers, setter_id='py')
        }
      };
    </script>
    <script type="application/json" id="p1140">
      {"9930c1ed-40c2-480b-9332-9bc6908ca5e2":{"version":"3.2.1","title":"Is my research used in clinical trials?","roots":[{"type":"object","name":"panel.models.location.Location","id":"p1002","attributes":{"name":"location","reload":false}},{"type":"object","name":"panel.models.markup.HTML","id":"p1009","attributes":{"name":"js_area","stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1088","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1085","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/bundled/theme/bootstrap.css"}}],"width":0,"height":0,"margin":0,"sizing_mode":"fixed","align":"start","disable_math":true}},{"type":"object","name":"panel.models.reactive_html.ReactiveHTML","id":"p1012","attributes":{"name":"actions","subscribed_events":{"type":"set","entries":["dom_event"]},"stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1089","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"id":"p1085"}],"margin":0,"align":"start","data":{"type":"object","name":"BootstrapTemplateActions1","id":"p1010","attributes":{"name":"BootstrapTemplateActions00137"}},"scripts":{"type":"map","entries":[["render",["state.modal = new bootstrap.Modal(document.getElementById(&amp;#x27;pn-Modal&amp;#x27;))"]],["open_modal",["state.modal.show()"]],["close_modal",["state.modal.hide()"]]]}}},{"type":"object","name":"panel.models.browser.BrowserInfo","id":"p1013","attributes":{"name":"browser_info"}},{"type":"object","name":"panel.models.markup.HTML","id":"p1016","attributes":{"name":"busy_indicator","css_classes":["loader","light"],"stylesheets":[":host { --loading-spinner-size: 20px; }","\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1090","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1091","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loadingspinner.css"}},{"id":"p1085"}],"min_width":20,"min_height":20,"margin":[5,10],"align":"start"}},{"type":"object","name":"Row","id":"p1017","attributes":{"name":"140513137533728","tags":["main"],"stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1092","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1093","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/listpanel.css"}},{"id":"p1085"}],"margin":0,"sizing_mode":"stretch_both","align":"start","children":[{"type":"object","name":"Column","id":"p1018","attributes":{"name":"Column00186","stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1094","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1095","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/listpanel.css"}},{"id":"p1085"}],"margin":0,"align":"start","children":[{"type":"object","name":"TextInput","id":"p1020","attributes":{"stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1096","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"id":"p1085"}],"width":300,"min_width":300,"margin":[5,10],"align":"start","placeholder":"Enter DOI here...","max_length":5000}},{"type":"object","name":"Column","id":"p1021","attributes":{"name":"Column00177","stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1125","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1126","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/listpanel.css"}},{"id":"p1085"}],"margin":0,"align":"start","children":[{"type":"object","name":"panel.models.markup.HTML","id":"p1024","attributes":{"css_classes":["markdown"],"stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1100","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1101","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/markdown.css"}},{"id":"p1085"}],"margin":[5,10],"align":"start"}}]}},{"type":"object","name":"panel.models.plotly.PlotlyPlot","id":"p1035","attributes":{"name":"Plotly00115","stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1102","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1103","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/plotly.css"}},{"id":"p1085"},":host { --plotly-icon-color: gray; --plotly-active-icon-color: rgb(36,36,36); }"],"margin":[5,10],"align":"start","data":[{"type":"map","entries":[["alignmentgroup","True"],["hovertemplate","is_trial=False&lt;br&gt;Year=%{x}&lt;br&gt;Citations=%{y}&lt;extra&gt;&lt;/extra&gt;"],["legendgroup","False"],["marker",{"type":"map","entries":[["color","#1F77B4"],["pattern",{"type":"map","entries":[["shape",""]]}]]}],["name","False"],["offsetgroup","False"],["orientation","v"],["showlegend",true],["textposition","auto"],["xaxis","x"],["yaxis","y"],["type","bar"]]},{"type":"map","entries":[["alignmentgroup","True"],["hovertemplate","is_trial=True&lt;br&gt;Year=%{x}&lt;br&gt;Citations=%{y}&lt;extra&gt;&lt;/extra&gt;"],["legendgroup","True"],["marker",{"type":"map","entries":[["color","#FF7F0E"],["pattern",{"type":"map","entries":[["shape",""]]}]]}],["name","True"],["offsetgroup","True"],["orientation","v"],["showlegend",true],["textposition","auto"],["xaxis","x"],["yaxis","y"],["type","bar"]]}],"layout":{"type":"map","entries":[["template",{"type":"map","entries":[["data",{"type":"map","entries":[["barpolar",[{"type":"map","entries":[["marker",{"type":"map","entries":[["line",{"type":"map","entries":[["color","white"],["width",0.5]]}],["pattern",{"type":"map","entries":[["fillmode","overlay"],["size",10],["solidity",0.2]]}]]}],["type","barpolar"]]}]],["bar",[{"type":"map","entries":[["error_x",{"type":"map","entries":[["color","rgb(36,36,36)"]]}],["error_y",{"type":"map","entries":[["color","rgb(36,36,36)"]]}],["marker",{"type":"map","entries":[["line",{"type":"map","entries":[["color","white"],["width",0.5]]}],["pattern",{"type":"map","entries":[["fillmode","overlay"],["size",10],["solidity",0.2]]}]]}],["type","bar"]]}]],["carpet",[{"type":"map","entries":[["aaxis",{"type":"map","entries":[["endlinecolor","rgb(36,36,36)"],["gridcolor","white"],["linecolor","white"],["minorgridcolor","white"],["startlinecolor","rgb(36,36,36)"]]}],["baxis",{"type":"map","entries":[["endlinecolor","rgb(36,36,36)"],["gridcolor","white"],["linecolor","white"],["minorgridcolor","white"],["startlinecolor","rgb(36,36,36)"]]}],["type","carpet"]]}]],["choropleth",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["type","choropleth"]]}]],["contourcarpet",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["type","contourcarpet"]]}]],["contour",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["colorscale",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]],["type","contour"]]}]],["heatmapgl",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["colorscale",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]],["type","heatmapgl"]]}]],["heatmap",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["colorscale",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]],["type","heatmap"]]}]],["histogram2dcontour",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["colorscale",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]],["type","histogram2dcontour"]]}]],["histogram2d",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["colorscale",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]],["type","histogram2d"]]}]],["histogram",[{"type":"map","entries":[["marker",{"type":"map","entries":[["line",{"type":"map","entries":[["color","white"],["width",0.6]]}]]}],["type","histogram"]]}]],["mesh3d",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["type","mesh3d"]]}]],["parcoords",[{"type":"map","entries":[["line",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","parcoords"]]}]],["pie",[{"type":"map","entries":[["automargin",true],["type","pie"]]}]],["scatter3d",[{"type":"map","entries":[["line",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scatter3d"]]}]],["scattercarpet",[{"type":"map","entries":[["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scattercarpet"]]}]],["scattergeo",[{"type":"map","entries":[["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scattergeo"]]}]],["scattergl",[{"type":"map","entries":[["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scattergl"]]}]],["scattermapbox",[{"type":"map","entries":[["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scattermapbox"]]}]],["scatterpolargl",[{"type":"map","entries":[["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scatterpolargl"]]}]],["scatterpolar",[{"type":"map","entries":[["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scatterpolar"]]}]],["scatter",[{"type":"map","entries":[["fillpattern",{"type":"map","entries":[["fillmode","overlay"],["size",10],["solidity",0.2]]}],["type","scatter"]]}]],["scatterternary",[{"type":"map","entries":[["marker",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["type","scatterternary"]]}]],["surface",[{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}],["colorscale",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]],["type","surface"]]}]],["table",[{"type":"map","entries":[["cells",{"type":"map","entries":[["fill",{"type":"map","entries":[["color","rgb(237,237,237)"]]}],["line",{"type":"map","entries":[["color","white"]]}]]}],["header",{"type":"map","entries":[["fill",{"type":"map","entries":[["color","rgb(217,217,217)"]]}],["line",{"type":"map","entries":[["color","white"]]}]]}],["type","table"]]}]]]}],["layout",{"type":"map","entries":[["annotationdefaults",{"type":"map","entries":[["arrowhead",0],["arrowwidth",1]]}],["autotypenumbers","strict"],["coloraxis",{"type":"map","entries":[["colorbar",{"type":"map","entries":[["outlinewidth",1],["tickcolor","rgb(36,36,36)"],["ticks","outside"]]}]]}],["colorscale",{"type":"map","entries":[["diverging",[[0.0,"rgb(103,0,31)"],[0.1,"rgb(178,24,43)"],[0.2,"rgb(214,96,77)"],[0.3,"rgb(244,165,130)"],[0.4,"rgb(253,219,199)"],[0.5,"rgb(247,247,247)"],[0.6,"rgb(209,229,240)"],[0.7,"rgb(146,197,222)"],[0.8,"rgb(67,147,195)"],[0.9,"rgb(33,102,172)"],[1.0,"rgb(5,48,97)"]]],["sequential",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]],["sequentialminus",[[0.0,"#440154"],[0.1111111111111111,"#482878"],[0.2222222222222222,"#3e4989"],[0.3333333333333333,"#31688e"],[0.4444444444444444,"#26828e"],[0.5555555555555556,"#1f9e89"],[0.6666666666666666,"#35b779"],[0.7777777777777778,"#6ece58"],[0.8888888888888888,"#b5de2b"],[1.0,"#fde725"]]]]}],["colorway",["#1F77B4","#FF7F0E","#2CA02C","#D62728","#9467BD","#8C564B","#E377C2","#7F7F7F","#BCBD22","#17BECF"]],["font",{"type":"map","entries":[["color","rgb(36,36,36)"]]}],["geo",{"type":"map","entries":[["bgcolor","white"],["lakecolor","white"],["landcolor","white"],["showlakes",true],["showland",true],["subunitcolor","white"]]}],["hoverlabel",{"type":"map","entries":[["align","left"]]}],["hovermode","closest"],["mapbox",{"type":"map","entries":[["style","light"]]}],["paper_bgcolor","white"],["plot_bgcolor","white"],["polar",{"type":"map","entries":[["angularaxis",{"type":"map","entries":[["gridcolor","rgb(232,232,232)"],["linecolor","rgb(36,36,36)"],["showgrid",false],["showline",true],["ticks","outside"]]}],["bgcolor","white"],["radialaxis",{"type":"map","entries":[["gridcolor","rgb(232,232,232)"],["linecolor","rgb(36,36,36)"],["showgrid",false],["showline",true],["ticks","outside"]]}]]}],["scene",{"type":"map","entries":[["xaxis",{"type":"map","entries":[["backgroundcolor","white"],["gridcolor","rgb(232,232,232)"],["gridwidth",2],["linecolor","rgb(36,36,36)"],["showbackground",true],["showgrid",false],["showline",true],["ticks","outside"],["zeroline",false],["zerolinecolor","rgb(36,36,36)"]]}],["yaxis",{"type":"map","entries":[["backgroundcolor","white"],["gridcolor","rgb(232,232,232)"],["gridwidth",2],["linecolor","rgb(36,36,36)"],["showbackground",true],["showgrid",false],["showline",true],["ticks","outside"],["zeroline",false],["zerolinecolor","rgb(36,36,36)"]]}],["zaxis",{"type":"map","entries":[["backgroundcolor","white"],["gridcolor","rgb(232,232,232)"],["gridwidth",2],["linecolor","rgb(36,36,36)"],["showbackground",true],["showgrid",false],["showline",true],["ticks","outside"],["zeroline",false],["zerolinecolor","rgb(36,36,36)"]]}]]}],["shapedefaults",{"type":"map","entries":[["fillcolor","black"],["line",{"type":"map","entries":[["width",0]]}],["opacity",0.3]]}],["ternary",{"type":"map","entries":[["aaxis",{"type":"map","entries":[["gridcolor","rgb(232,232,232)"],["linecolor","rgb(36,36,36)"],["showgrid",false],["showline",true],["ticks","outside"]]}],["baxis",{"type":"map","entries":[["gridcolor","rgb(232,232,232)"],["linecolor","rgb(36,36,36)"],["showgrid",false],["showline",true],["ticks","outside"]]}],["bgcolor","white"],["caxis",{"type":"map","entries":[["gridcolor","rgb(232,232,232)"],["linecolor","rgb(36,36,36)"],["showgrid",false],["showline",true],["ticks","outside"]]}]]}],["title",{"type":"map","entries":[["x",0.05]]}],["xaxis",{"type":"map","entries":[["automargin",true],["gridcolor","rgb(232,232,232)"],["linecolor","rgb(36,36,36)"],["showgrid",false],["showline",true],["ticks","outside"],["title",{"type":"map","entries":[["standoff",15]]}],["zeroline",false],["zerolinecolor","rgb(36,36,36)"]]}],["yaxis",{"type":"map","entries":[["automargin",true],["gridcolor","rgb(232,232,232)"],["linecolor","rgb(36,36,36)"],["showgrid",false],["showline",true],["ticks","outside"],["title",{"type":"map","entries":[["standoff",15]]}],["zeroline",false],["zerolinecolor","rgb(36,36,36)"]]}]]}]]}],["xaxis",{"type":"map","entries":[["anchor","y"],["domain",[0.0,1.0]],["title",{"type":"map","entries":[["text","Year"]]}],["type","category"]]}],["yaxis",{"type":"map","entries":[["anchor","x"],["domain",[0.0,1.0]],["title",{"type":"map","entries":[["text","Citations"]]}]]}],["legend",{"type":"map","entries":[["title",{"type":"map","entries":[["text","is_trial"]]}],["tracegroupgap",0]]}],["margin",{"type":"map","entries":[["t",60]]}],["barmode","relative"]]},"config":{"type":"map","entries":[["responsive",false]]},"data_sources":[{"type":"object","name":"ColumnDataSource","id":"p1027","attributes":{"selected":{"type":"object","name":"Selection","id":"p1028","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1029"},"data":{"type":"map","entries":[["x",[{"type":"ndarray","array":{"type":"bytes","data":"4QcAAOMHAADkBwAA5QcAAOYHAADnBwAA"},"shape":[6],"dtype":"int32","order":"little"}]],["y",[{"type":"ndarray","array":{"type":"bytes","data":"AQAAAAIAAACuAAAAxAEAADsCAADgAAAA"},"shape":[6],"dtype":"int32","order":"little"}]]]}}},{"type":"object","name":"ColumnDataSource","id":"p1030","attributes":{"selected":{"type":"object","name":"Selection","id":"p1031","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1032"},"data":{"type":"map","entries":[["x",[{"type":"ndarray","array":{"type":"bytes","data":"5AcAAOUHAADmBwAA5wcAAA=="},"shape":[4],"dtype":"int32","order":"little"}]],["y",[{"type":"ndarray","array":{"type":"bytes","data":"CQAAACYAAAAhAAAACgAAAA=="},"shape":[4],"dtype":"int32","order":"little"}]]]}}}],"relayout":null,"restyle":null,"viewport_update_throttle":200}}]}},{"type":"object","name":"Column","id":"p1038","attributes":{"name":"Column00192","stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJtYXJnaW46IGF1dG87IGJhY2tncm91bmQ6IG5vbmU7IGRpc3BsYXk6IGJsb2NrOyBzaGFwZS1yZW5kZXJpbmc6IGF1dG87IiB2aWV3Qm94PSIwIDAgMTAwIDEwMCIgcHJlc2VydmVBc3BlY3RSYXRpbz0ieE1pZFlNaWQiPiAgPGNpcmNsZSBjeD0iNTAiIGN5PSI1MCIgZmlsbD0ibm9uZSIgc3Ryb2tlPSIjYzNjM2MzIiBzdHJva2Utd2lkdGg9IjEwIiByPSIzNSIgc3Ryb2tlLWRhc2hhcnJheT0iMTY0LjkzMzYxNDMxMzQ2NDE1IDU2Ljk3Nzg3MTQzNzgyMTM4Ij4gICAgPGFuaW1hdGVUcmFuc2Zvcm0gYXR0cmlidXRlTmFtZT0idHJhbnNmb3JtIiB0eXBlPSJyb3RhdGUiIHJlcGVhdENvdW50PSJpbmRlZmluaXRlIiBkdXI9IjFzIiB2YWx1ZXM9IjAgNTAgNTA7MzYwIDUwIDUwIiBrZXlUaW1lcz0iMDsxIj48L2FuaW1hdGVUcmFuc2Zvcm0+ICA8L2NpcmNsZT48L3N2Zz4=\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1104","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1105","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/listpanel.css"}},{"id":"p1085"}],"margin":0,"sizing_mode":"stretch_both","align":"start","children":[{"type":"object","name":"Row","id":"p1039","attributes":{"name":"Row00189","stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1106","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1107","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/listpanel.css"}},{"id":"p1085"}],"margin":0,"align":"start","children":[{"type":"object","name":"Checkbox","id":"p1041","attributes":{"stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1108","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"id":"p1085"}],"margin":[5,10],"align":"start","label":"show clinical trials"}},{"type":"object","name":"RangeSlider","id":"p1043","attributes":{"stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1109","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"id":"p1085"}],"margin":[5,10],"align":"start","value":[2017,2023],"start":2017,"end":2023}}]}},{"type":"object","name":"panel.models.tabulator.DataTabulator","id":"p1078","attributes":{"subscribed_events":{"type":"set","entries":["table-edit","cell-click"]},"stylesheets":["\n:host(.pn-loading.pn-arc):before, .pn-loading.pn-arc:before {\n  background-image: url(\"data:image/svg+xml;base64,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\");\n  background-size: auto calc(min(50%, 400px));\n}",{"type":"object","name":"ImportedStyleSheet","id":"p1111","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/css/loading.css"}},{"type":"object","name":"ImportedStyleSheet","id":"p1112","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/bundled/font-awesome/css/all.min.css"}},{"id":"p1085"},{"type":"object","name":"ImportedStyleSheet","id":"p1110","attributes":{"url":"https://cdn.holoviz.org/panel/1.2.1/dist/bundled/datatabulator/tabulator-tables@5.5.0/dist/css/tabulator_bootstrap5.min.css"}}],"margin":[5,10],"sizing_mode":"stretch_both","align":"start","configuration":{"type":"map","entries":[["selectable",true],["columns",[{"type":"map","entries":[["field","title"],["width","40.0%"]]},{"type":"map","entries":[["field","year"],["formatter","int"],["formatterParams",{"type":"map"}],["sorter","number"],["width","15.0%"]]},{"type":"map","entries":[["field","doi"],["formatter","link"],["formatterParams",{"type":"map","entries":[["label","\u21d7"],["target","_blank"]]}],["width","15.0%"]]},{"type":"map","entries":[["field","pmid"],["formatter","link"],["formatterParams",{"type":"map","entries":[["urlPrefix","https://pubmed.ncbi.nlm.nih.gov/"],["label","\u21d7"],["target","_blank"]]}],["sorter","number"],["width","15.0%"]]},{"type":"map","entries":[["field","is_trial"],["formatter","tickCross"],["formatterParams",{"type":"map"}],["sorter","boolean"],["width","15.0%"]]}]],["dataTree",false],["maxHeight","100%"]]},"columns":[{"type":"object","name":"TableColumn","id":"p1051","attributes":{"field":"title","title":"title","width":0,"formatter":{"type":"object","name":"StringFormatter","id":"p1049"},"editor":{"type":"object","name":"StringEditor","id":"p1050"}}},{"type":"object","name":"TableColumn","id":"p1056","attributes":{"field":"year","title":"year","width":0,"formatter":{"type":"object","name":"NumberFormatter","id":"p1054","attributes":{"text_align":"right"}},"editor":{"type":"object","name":"IntEditor","id":"p1055"}}},{"type":"object","name":"TableColumn","id":"p1061","attributes":{"field":"doi","title":"doi","width":0,"formatter":{"type":"object","name":"StringFormatter","id":"p1059"},"editor":{"type":"object","name":"StringEditor","id":"p1060"}}},{"type":"object","name":"TableColumn","id":"p1066","attributes":{"field":"pmid","title":"pmid","width":0,"formatter":{"type":"object","name":"NumberFormatter","id":"p1064","attributes":{"text_align":"right","format":"0,0.0[00000]"}},"editor":{"type":"object","name":"NumberEditor","id":"p1065"}}},{"type":"object","name":"TableColumn","id":"p1071","attributes":{"field":"is_trial","title":"is_trial","width":0,"formatter":{"type":"object","name":"StringFormatter","id":"p1069","attributes":{"text_align":"center"}},"editor":{"type":"object","name":"CheckboxEditor","id":"p1070"}}}],"editable":false,"hidden_columns":["index"],"layout":"fit_data_table","source":{"type":"object","name":"ColumnDataSource","id":"p1075","attributes":{"selected":{"type":"object","name":"Selection","id":"p1074","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1077"},"data":{"type":"map","entries":[["index",{"type":"ndarray","array":{"type":"bytes","data":"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"},"shape":[1424],"dtype":"int32","order":"little"}],["title",{"type":"ndarray","array":["Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies","COVID-19 infection and rheumatoid arthritis: Faraway, so close!","Translating IL-6 biology into effective treatments","SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity","EULAR definition of difficult-to-treat rheumatoid arthritis","Management of Rheumatoid Arthritis: An Overview","Macrophages: The Good, the Bad, and the Gluttony","Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement","The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19","Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","&amp;lt;p&amp;gt;JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data&amp;lt;/p&amp;gt;","COVID\u201019 pneumonia treated with Sarilumab: A clinical series of eight patients","JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future","Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy","&lt;scp&gt;SARS&lt;/scp&gt;\u2013&lt;scp&gt;CoV&lt;/scp&gt;\u20102 Infection and&lt;scp&gt;COVID&lt;/scp&gt;\u201019 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta\u2010Analysis","EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?","The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New\u2010Onset Rheumatoid Arthritis","Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response","EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons","EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis","Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease","Novel insights into macrophage diversity in rheumatoid arthritis synovium","Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries","Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease","Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy","The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review","The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions","Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis","Transforming clinical trials in rheumatology: towards patient-centric precision medicine","Cardiovascular effects of approved drugs for rheumatoid arthritis","Rheumatoid arthritis","Cellular Signaling Pathways in Medium and Large Vessel Vasculitis","Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention","Managing rheumatoid arthritis during COVID-19","Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases","The JAK\u2013STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies","The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis","Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis","From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis","The role of IL-6 and IL-6 blockade in COVID-19","Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland","Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data","Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?","Prevalence of patients with rheumatoid arthritis and age\u2010stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan","Frailty in Rheumatic Diseases","Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis","Systemic diseases and the cornea","EULAR recommendations for intra-articular therapies","Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients","Autoantibodies in Rheumatoid Arthritis \u2013 Laboratory and Clinical Perspectives","Topical nanocarriers for management of Rheumatoid Arthritis: A review","DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability","Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response","Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache?","Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic","A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review","Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series","Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study","JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis","Critical Role of Synovial Tissue\u2013Resident Macrophage and Fibroblast Subsets in the Persistence of Joint Inflammation","A review of upadacitinib in rheumatoid arthritis","Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study","Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission","In-depth bibliometric analysis and current scientific mapping research in the context of rheumatoid arthritis pharmacotherapy","Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients","Upadacitinib in Rheumatoid Arthritis: A Benefit\u2013Risk Assessment Across a Phase III Program","Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice","Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?","Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations","The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review","Response to: \u2018Comment on: \u2018EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update\u2019 by Gossec&lt;i&gt;et al&lt;/i&gt;\u2019 by Wei&lt;i&gt;et al&lt;/i&gt;","Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting","Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis","Greetings from the editor","Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction","Biotherapies in Uveitis","Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis","Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","Insights into the treatment of rheumatoid arthritis: A paradigm in medicine","Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial","Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study","Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis","Modeling Rheumatoid Arthritis In Vitro: From Experimental Feasibility to Physiological Proximity","The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review","Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis","Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments","Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors","Changing Patterns of Medical Visits and Factors Associated with No-show in Patients with Rheumatoid Arthritis during COVID-19 Pandemic","Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study","Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study","Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation","Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview","The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis","Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies","TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol","The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases","Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review","Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends","The PICASO cloud platform for improved holistic care in rheumatoid arthritis treatment\u2014experiences of patients and clinicians","Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis\u2014secondary publication","Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study","Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis","Body composition in patients with rheumatoid arthritis: a narrative literature review","Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic","Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis","Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis","Prevalence of Sarcopenia and its Association with Antirheumatic Drugs in Middle-Aged and Older Adults with Rheumatoid Arthritis: A Systematic Review and Meta-analysis","Treatment of rheumatoid arthritis by phototherapy: advances and perspectives","Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib","Treating Autoimmune Inflammatory Diseases with an siERN1-Nanoprodrug That Mediates Macrophage Polarization and Blocks Toll-like Receptor Signaling","Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response","Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease","Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study","Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study","Rheumatoid arthritis Primer \u2014 behind the scenes","Selection and perception of methotrexate treatment information in people with rheumatoid arthritis","Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis","Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020?","Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT","Current treatment options and safety considerations when treating adult-onset Still\u2019s disease","Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study","Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms","Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial","Liposomal Nanosystems in Rheumatoid Arthritis","A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-\u03b1 Inhibitors: The NETWORK-004 Prospective Observational Study","Biomimetic and Bioinspired Intervention Strategies for the Treatment of Rheumatoid Arthritis","The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups","Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study","DMARDs\u2013Gut Microbiota Feedback: Implications in the Response to Therapy","Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis","Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review","Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis","Current insights and future prospects for the pathogenesis and treatment for rheumatoid arthritis","Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy","Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis","Inclusion of Synovial Tissue\u2013Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment\u2010Naive Rheumatoid Arthritis Patients","Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis","Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis","Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics","Disease-modifying anti-asthmatic drugs","Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis","Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study","The advances of methotrexate resistance in rheumatoid arthritis","Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID\u201019 Epidemic","State of the art: approved and emerging JAK inhibitors for rheumatoid arthritis","Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics","Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking","Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?","A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents","Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials","Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort","Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease","High patient global assessment scores in patients with rheumatoid arthritis otherwise in remission do not reflect subclinical inflammation","Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles: In vivo results","Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis","CTLA4-Ig treatment induces M1\u2013M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients","CaP-based anti-inflammatory HIF-1\u03b1 siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy","A broad look into the future of rheumatoid arthritis","Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis","Treatment of early rheumatoid arthritis: Methotrexate and beyond","Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain","Tofacitinib and Baricitinib Are Taken up by Different Uptake Mechanisms Determining the Efficacy of Both Drugs in RA","Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic","Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis","Activity Prediction of Small Molecule Inhibitors for Antirheumatoid Arthritis Targets Based on Artificial Intelligence","Identifying Compound Effect of Drugs on Rheumatoid Arthritis Treatment Based on the Association Rule and a Random Walking-Based Model","&amp;lt;p&amp;gt;Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases&amp;lt;/p&amp;gt;","Changes in the pharmacological management of rheumatoid arthritis over two decades","Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment","Serum levels of the soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis and reflects joint damage over time","Clinical evidence of an interferon\u2013glucocorticoid therapeutic synergy in COVID-19","Change in dietary inflammatory index score is associated with control of long-term rheumatoid arthritis disease activity in a Japanese cohort: the TOMORROW study","Bioflavonoid Robinin from Astragalus falcatus Lam. Mildly Improves the Effect of Metothrexate in Rats with Adjuvant Arthritis","Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis","Shield and sword nano-soldiers ameliorate rheumatoid arthritis by multi-stage manipulation of neutrophils","Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon","Switching between reference adalimumab and biosimilars in chronic immune\u2010mediated inflammatory diseases: A systematic literature review","Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs","Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis","Perspectives of JAK Inhibitors for Large Vessel Vasculitis","Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis","The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era","Rheumatoid arthritis: advances in treatment strategies","Ozoralizumab: First Approval","Patient global assessment to define remission in rheumatoid arthritis:quo vadis?","OUP accepted manuscript","Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study","Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis","The role of extracellular vesicles in rheumatoid arthritis: a systematic review","Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthritis","Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives","Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study","Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche","Abatacept in monotherapy &lt;i&gt;vs&lt;/i&gt; combined in interstitial lung disease of rheumatoid arthritis\u2014multicentre study of 263 Caucasian patients","Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry","Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects","Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis","Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry","Multi-omics approach to precision medicine for immune-mediated diseases","Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis","Evaluation of Ruthenium-Based Assemblies as Carriers of Photosensitizers to Treat Rheumatoid Arthritis by Photodynamic Therapy","Glycerophospholipid metabolism is involved in rheumatoid arthritis pathogenesis by regulating the IL-6/JAK signaling pathway","Challenges in the management of older patients with inflammatory rheumatic diseases","APLAR recommendations on the practice of telemedicine in rheumatology","JAK inhibitors in difficult-to-treat adult-onset Still\u2019s disease and systemic-onset juvenile idiopathic arthritis","2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment","Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?","Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis","Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients","Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio","The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis","The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis","Glucocorticoid and opioid use in rheumatoid arthritis management","Systematic Review of Outcomes and Patient Experience With Virtual Care in Rheumatoid Arthritis","Role of Janus Kinase inhibitors in rheumatoid arthritis treatment","Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission","Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission","Cycling of tumor necrosis factor inhibitors &lt;i&gt;versus&lt;/i&gt; switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis","Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis\u2014the ANSWER cohort study","MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients","COVID\u201019 in DMARD\u2010treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database","Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan","Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan","Association between inflammatory cytokines and immune\u2013checkpoint molecule in rheumatoid arthritis","Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years","Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study","Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician","Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1","Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis","Treatment strategies for elderly-onset rheumatoid arthritis in the new era","Off\u2010Label Use of Hydroxychloroquine in COVID\u201019: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance","Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A &lt;scp&gt;Pharmacogenomics\u2010Driven&lt;/scp&gt; Machine Learning Approach","Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of &lt;scp&gt;Well\u2010Being&lt;/scp&gt; and Disease Activity","Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis\u2014going beyond treat to target","Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data","Cellular and molecular diversity in Rheumatoid Arthritis","Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events","Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria","Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNF\u03b1 therapy: a placebo-controlled phase II study","Patient\u2010centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis","'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps","American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision","Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic","Traditional Chinese medicine on treating active rheumatoid arthritis","Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis","Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review","A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis","Revisiting the cardiovascular risk of hydroxychloroquine in RA","The patient perspective of nurse\u2010led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis","Glucocorticoids: surprising new findings on their mechanisms of actions","Identification of Common Differentially Expressed Genes and Potential Therapeutic Targets in Ulcerative Colitis and Rheumatoid Arthritis","An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy","Conventional disease-modifying agents in rheumatoid arthritis \u2013 a review of their current use and role in treatment algorithms","Effect of significant weight loss on disease activity: reason to implement this non-pharmaceutical intervention in daily clinical practice","Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients","Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry","Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020","Primary and secondary non-response: in need of operational definitions in observational studies","An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis","Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients na\u00efve to DMARDs","Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis","Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink","Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis","Filgotinib in Rheumatoid Arthritis: A Profile of Its Use","Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment","Network Pharmacology and Molecular Docking-Based Prediction of the Mechanism of Qianghuo Shengshi Decoction against Rheumatoid Arthritis","Shikonin induces programmed death of fibroblast synovial cells in rheumatoid arthritis by inhibiting energy pathways","Influence of anti\u2010rheumatic agents on the periodontal condition of patients with rheumatoid arthritis and periodontitis: A systematic review and meta\u2010analysis","Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial","Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study","Pain Management Strategies in Rheumatoid Arthritis: A Narrative Review","Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study","Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials","Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal Models","TELERA\u2014Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial","Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases","Nanoengineered therapy aiming at the etiology of rheumatoid arthritis","EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology","Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients","The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience","Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010\u20132019 \u2013 a country with a national tender system for prescription of costly drugs","New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations","N-Acetyl-L-cysteine in human rheumatoid arthritis and its effects on nitric oxide (NO) and malondialdehyde (MDA): analytical and clinical considerations","Epidemiology of rheumatoid arthritis: genetic and environmental influences","Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study","The development of COVID-19 treatment","Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three\u2010Year Results From the ESPOIR Cohort","Psoriatic arthritis: still room for improvement","Prevalence of Elbow Joint Arthritis and Enthesitis in Rheumatoid Arthritis","Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?","The Influence of Different Disease States on Rituximab Pharmacokinetics","Does healthcare regime affiliation influence the clinical outcomes of patients with rheumatoid arthritis?","Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity","Prevalence, Predictors, and Prognostic Benefits of Remission Achievement in Patients With Systemic Lupus Erythematosus: A Systematic Review","Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients","The progress of rheumatology in the 21st century potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases","The impact of different (rheumatoid) arthritis phenotypes on patients\u2019 lives","Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage","Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands","Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis","Mesenchymal Stem Cells Enhance Therapeutic Effect and Prevent Adverse Gastrointestinal Reaction of Methotrexate Treatment in Collagen-Induced Arthritis","Treat-to-Target Strategies in Rheumatoid Arthritis: a Systematic Review and Cost-Effectiveness Analysis","Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study)","Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study","In vitro and ex vivo functional characterization of human HLA-DRB1\u221704 restricted T cell receptors","COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies","Soufeng sanjie formula alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation","The Role of Natural Products in Rheumatoid Arthritis: Current Knowledge of Basic In Vitro and In Vivo Research","Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort","Safety of the Methotrexate\u2013leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil)","Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study","Association of first, second, and third-line bDMARDs and tsDMARD with drug survival among seropositive rheumatoid arthritis patients: Cohort study in A real world setting","The Assessment of Muscle Mass and Function in Patients with Long-Standing Rheumatoid Arthritis","Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway","Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis","Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers","In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes","Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study","Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review","Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk","Toward Overcoming Treatment Failure in Rheumatoid Arthritis","Methotrexate in early rheumatoid arthritis: Is the anchor drug still holding?","Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future?","Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution","COVID-19\u2014A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis","Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy","Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search","Comparison of Efficacy of Acupuncture-Related Therapy in the Treatment of Rheumatoid Arthritis: A Network Meta-Analysis of Randomized Controlled Trials","Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review","Rheumatoid arthritis and osteoimmunology: The adverse impact of a deregulated immune system on bone metabolism","Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review","Treatment Guidelines in Rheumatoid Arthritis","The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis","Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities","Microbes, helminths, and rheumatic diseases","Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis","Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study","Anti-TNF biosimilars in rheumatology: the end of an era?","Multidisciplinary Approach to Prevent &amp;lt;i&amp;gt;de novo&amp;lt;/i&amp;gt; Hepatitis B in Patients with Rheumatoid Arthritis","Patient\u2010Reported Outcomes in Rheumatology Patients With Limited English Proficiency and Limited Health Literacy","Tailoring biologic therapy for real-world rheumatoid arthritis patients","Protein array-based companion diagnostics in precision medicine","How to Define Boolean Low Disease Activity in Rheumatoid Arthritis: Experience from a Large Real-world Cohort","Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry","Low-dose rituximab protocol in rheumatoid arthritis\u2014outcome and economic impact","Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis","Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case\u2013control study","Long\u2010term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)\u2010\u03b1 antagonists versus TNF\u2010\u03b1 antagonists alone in psoriatic patients","Technological Advancements in Monoclonal Antibodies","Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database","Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study","Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients","Rheumatoid arthritis in Colombia: a clinical profile and prevalence from a national registry","Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis","Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic","Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese Population","Signalling and putative therapeutic molecules on the regulation of synoviocyte signalling in rheumatoid arthritis","The sonographic identification of cortical bone interruptions in rheumatoid arthritis: a morphological approach","Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study","Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study","Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA","Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial","Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom","Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target","In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope","Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis","Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study","Biomaterial-based immunotherapeutic strategies for rheumatoid arthritis","Factors Associated with &amp;lt;i&amp;gt;Pneumocystis jirovecii&amp;lt;/i&amp;gt; Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study","How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis","Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis","Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA","Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions","Treating-to-target in rheumatology: Theory and practice","Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study","Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data","Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis","Dietary polyphenols for management of rheumatoid arthritis: Pharmacotherapy and novel delivery systems","New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis","Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis","Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy","Caffeine and rheumatoid arthritis: A complicated relationship","Total-Body &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations","Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies","Association between Endodontic Infection, Its Treatment and Systemic Health: A Narrative Review","Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis","2019 update: EULAR RA management recommendations, efficacy and safety systematic literature reviews","Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network","Indicators of rheumatoid arthritis disease activity. An association with a patient\u2019s psychological status","What value do JAK inhibitors have in treating rheumatoid arthritis?","Methotrexate: what are the true risks of treatment?","Predictors of long\u2010term clinical remission in rheumatoid arthritis","Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations","Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis","Investigating the safety and compliance of using csDMARDs in rheumatoid arthritis treatment through face-to-face interviews: a cross-sectional study in China","Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials","&amp;lt;p&amp;gt;Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World&amp;lt;/p&amp;gt;","Marine-Derived Biologically Active Compounds for the Potential Treatment of Rheumatoid Arthritis","DiR-labeled tolerogenic dendritic cells for targeted imaging in collagen- induced arthritis rats","Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis","Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review","Should we use glucocorticoids in early rheumatoid arthritis? Results at 5 years from the early RA UCLouvain Brussels cohort","Similarity of Response to Biologics Between Elderly-onset Rheumatoid Arthritis (EORA) and Non-EORA Elderly Patients: From the FIRST Registry","Effectiveness of a Second Biologic After Failure of a Non\u2013tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis","Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study","Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis","Elderly patients with comorbidities in the definition of difficult-to-treat rheumatoid arthritis","Current and innovative therapeutic strategies for the treatment of giant cell arteritis","A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritis","Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies","Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis","Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder","Adrenocortical dysfunction in rheumatoid arthritis: \u0391 narrative review and future directions","Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis","What dose of folic acid to use with methotrexate in rheumatoid arthritis?","Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis","Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region","Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study","Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales","Risk of Heart Failure in Rheumatoid Arthritis Patients Treated with Tumor Necrosis Factor\u2010\u03b1 Inhibitors","Possibilities for personalised medicine in rheumatoid arthritis: hype or hope","Methotrexate Alters the Expression of microRNA in Fibroblast-like Synovial Cells in Rheumatoid Arthritis","A Bridge Too Far? Real\u2010World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort","The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis","The Relationship between Platelet Indices and Ultrasound, Clinical, Laboratory Parameters of Disease Activity in Patients with Rheumatoid Arthritis","Advances in Use of Nanomaterials for Musculoskeletal Regeneration","Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study","Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis","Pre-RA: Can early diagnosis lead to prevention?","Drug levels, anti-drug antibodies and B-cell counts were not predictive of response in rheumatoid arthritis patients on (ultra-)low-dose rituximab","Biologikatherapie von rheumatoider Arthritis und Spondyloarthritiden","Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report","Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective","Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study","A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus","Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions","Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry","Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation","Effects of Biological/Targeted Therapies on Bone Mineral Density in Inflammatory Arthritis","Perspectives of at-Risk Individuals on Preventive Intervention for Rheumatoid Arthritis: A Mini Review","Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis","Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis","Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission","Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis","Synchronous Investigation of the Mechanism and Substance Basis of Tripterygium Glycosides Tablets on Anti-rheumatoid Arthritis and Hepatotoxicity","Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases","Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update","Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis","Association Between Low-Dose Methotrexate Exposure and Melanoma","After JAK inhibitor failure: to cycle or to switch, that is the question \u2013 data from the JAK-pot collaboration of registries","The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings","Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis","The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis","Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals","A meta\u2010analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis","The Effect of Meditation, Mindfulness, and Yoga in Patients with Rheumatoid Arthritis","Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain","Autoantibodies to disease\u2010related proteins in joints as novel biomarkers for the diagnosis of rheumatoid arthritis","Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?","Beyond Methotrexate and Biologics in RA \u2013 Efficacy of JAK Inhibitors and their Place in the Current Treatment Armamentarium","Validation of the Italian Version of the Educational Needs Assessment Tool in Rheumatoid Arthritis Patients and Factors Associated with Educational Needs","Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow\u2010ups and predictors of achieving treatment target","Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study","The role of rehabilitation and apparatus physiotherapy in rheumatic disease treatment strategies","Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life","Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis","Neglected extra-articular manifestations in rheumatoid arthritis patients with normal body mass index: reduced skeletal muscle overlapping overfat","Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE","Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis","Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis","The role of ixekizumab in non-radiographic axial spondyloarthritis","To apply the recent EULAR recommendations, more knowledge on adherence patterns to medication and to physical activity is needed","Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study","Association between Health Literacy, Patient Activation, and Functional Capacity in Individuals with Rheumatoid Arthritis","Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases","Operationalizing Treat-to-Target for Osteoporosis","Estado, control, impacto y manejo actual de la artritis reumatoide seg\u00fan los pacientes: encuesta nacional AR 2020","Geographic variations in rheumatoid arthritis treatment in Japan: A nationwide retrospective study using the national database of health insurance claims and specific health checkups of Japan","Effectiveness and tolerability of oral &lt;i&gt;vs&lt;/i&gt; subcutaneous methotrexate in patients with rheumatoid arthritis","Evaluation Method of Rheumatoid Arthritis by the X-ray Photograph using Deep Learning","Rheumatoid Arthritis Relapse and Remission \u2013 Advancing Our Predictive Capability Using Modern Imaging","Abrupt change to telephone follow\u2010up clinics in a regional rheumatology service during &lt;scp&gt;COVID&lt;/scp&gt; \u201019: analysis of treatment decisions","A comparison of Janus kinase inhibitor safety in rheumatoid arthritis","Delayed diagnosis in axial spondyloarthritis\u2014how can we do better?","Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients","Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia","The susceptibility of attaining and maintaining DMARD-free remission in different (rheumatoid) arthritis phenotypes","Evaluating filgotinib for the treatment of rheumatoid arthritis","Cryptococcal pneumonia in a patient with rheumatoid arthritis treated with baricitinib","A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis","Multiple time-point assessment of lncRNA &lt;i&gt;MEG3&lt;/i&gt; shows potential to monitor treatment efficacy in rheumatoid arthritis patients","The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients","Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study","\u2018More than just chitchat\u2019: a qualitative study concerning the need and potential format of a peer mentor programme for patients with early rheumatoid arthritis","Back to Basics: Prioritizing Communication as a Key Instrument in Managing Rheumatoid Arthritis","Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status","Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review)","Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE)","The perception of stakeholders on the applicability of nurse-led clinics in the management of rheumatoid arthritis","Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis","MicroRNA-106b overexpression suppresses synovial inflammation and alleviates synovial damage in patients with rheumatoid arthritis","The effectiveness of e-learning in patient education delivered to patients with rheumatoid arthritis: The WebRA study\u2014protocol for a pragmatic randomised controlled trial","Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis","Geranium wilfordii maxim.: A review of its traditional uses, phytochemistry, pharmacology, quality control and toxicology","Current evidence on the use of the adalimumab biosimilar SB5 (Imraldi&lt;sup&gt;TM&lt;/sup&gt;): a multidisciplinary perspective","Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis","Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)","Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review","Effectiveness and safety of aerobic exercise for rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials","Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study","Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study","Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany","Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs","The role of antifibrotics in the treatment of rheumatoid arthritis\u2013associated interstitial lung disease","Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis","Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study","Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis","Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan","Treatment of Giant Cell Arteritis (GCA)","Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study","Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts","Metabolic reprogramming of synovial fibroblasts in osteoarthritis by inhibition of pathologically overexpressed pyruvate dehydrogenase kinases","Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial","Sensory testing and topical capsaicin can characterize patients with rheumatoid arthritis","Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea","Risk of Serious Infection With Low-dose Glucocorticoids in Patients With Rheumatoid Arthritis","Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard care","Biochanin A as a modulator of the inflammatory response: An updated overview and therapeutic potential","Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology","Australian recommendations on tapering of biologic and targeted synthetic disease\u2010modifying anti\u2010rheumatic drugs in inflammatory arthritis","Treatment strategies of COVID-19: A rheumatology perspective","Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium","Unincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study","Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies","Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis","Vasculitogenic T Cells in Large Vessel Vasculitis","Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response","Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis","Gut Microbiota Structure and Metabolites, Before and After Treatment in Early Rheumatoid Arthritis Patients: A Pilot Study","Hit-hard and early versus step-up treatment in severe sarcoidosis","Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort","Outcomes of coronavirus disease 19 patients with a history of rheumatoid arthritis: A retrospective registry\u2010based study in Iran","Comparative safety of Janus kinase inhibitors and tumor necrosis factor inhibitors in patients undergoing treatment for rheumatoid arthritis","Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis","Disease mechanisms in preclinical rheumatoid arthritis: A narrative review","-Omic Approaches and Treatment Response in Rheumatoid Arthritis","The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls\u2014a prospective cohort study","American College of Rheumatology/ &lt;scp&gt;EULAR&lt;/scp&gt; Remission Criteria for Rheumatoid Arthritis: 2022 Revision","Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications","Articular Tissue-Mimicking Organoids Derived from Mesenchymal Stem Cells and Induced Pluripotent Stem Cells","Applications and prospects of intra-articular drug delivery system in arthritis therapeutics","Discovery and Optimization of &lt;i&gt;N&lt;/i&gt;-Acyl-6-sulfonamide-tetrahydroquinoline Derivatives as Novel Non-Steroidal Selective Glucocorticoid Receptor Modulators","IgD enhances the release of neutrophil extracellular traps (NETs) via Fc\u03b4R in rheumatoid arthritis patients","Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases\u2014RA as a role model","Anti-Arthritic and Anti-Cancer Activities of Polyphenols: A Review of the Most Recent In Vitro Assays","A guide to managing reproductive health in rheumatology","An updated review of infliximab biosimilar, CT-P13, in the treatment of immune-mediated inflammatory diseases","Adoptive Treg cell-based immunotherapy: Frontier therapeutic aspects in rheumatoid arthritis","Recognition System of Positions of Joints of Hands in an X-ray photograph to Develop an Automatic Evaluation System for Rheumatoid Arthritis Using Machine Learning","The perennial search for alternatives to corticosteroids in rheumatology: is there light at the end of the tunnel?","Clinical markers combined with HMGB1 polymorphisms to predict efficacy of conventional DMARDs in rheumatoid arthritis patients","Rethinking the Balance of Risks and Rewards of Chronic Low-Dose Glucocorticoids in Rheumatoid Arthritis","Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases","Predictors of Flares in Patients with Rheumatoid Arthritis Who Exhibit Low Disease Activity: A Nationwide Cohort Study","Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience","What Next after Biologic Therapy Fails in Rheumatoid Arthritis?","High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study","Introductory Chapter: Rheumatoid Arthritis - Overview of Current Facts and Strategies","Biomechanical Particularities in the Therapy of the Rheumatic Knee","Topical issues of perioperative management of patients with rheumatoid arthritis during arthroplasty of large joints in conditions of orthopedic department (literature review)","Consideration of differences in drug usage between young-onset and elderly-onset rheumatoid arthritis with target of low disease activity","Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study","Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study","Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study","The unsustainable bubble of disease-modifying antirheumatic drugs in rheumatology","Janus kinase inhibitors for the treatment of rheumatoid arthritis","Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review","Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine","Is There a Symmetry in Disease Control and Quality of Life of Patients with Rheumatoid Arthritis Treated with Biological Therapy?","The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies","Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients","MTX optimization or adding bDMARD equally improve disease activity in rheumatoid arthritis: results from the prospective study STRATEGE","Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients","The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume","Factors affecting persistence with biologic treatments in patients with rheumatoid arthritis: a systematic literature review","Tofacitinib versus tocilizumab in the treatment of biological-na\u00efve or previous biological-failure patients with methotrexate-refractory active rheumatoid arthritis","Positive rate and prognostic significance of the superb microvascular imaging signal in joints of rheumatoid arthritis patients in remission with normal C-reactive protein levels and erythrocyte sedimentation rates","Joint tenderness and ultrasound inflammation in DMARD-na\u00efve patients with early rheumatoid arthritis","Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings","Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature","Sonographic assessment of cartilage damage at the metacarpal head in rheumatoid arthritis: qualitative versus quantitative methods","Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis","Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis","Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature","Real-world data on MTX tolerance with regimens used in children versus adults","Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs","Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA)","2021 ACR guideline reflects changes in RA treatment","Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis","Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis","Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis","Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness Registry","Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis","Sarilumab monotherapy &lt;i&gt;vs&lt;/i&gt; sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis","Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis","\u201cWays in which the neonatal Fc-receptor is involved in autoimmunity\u201d","Subclinical synovitis detected by magnetic resonance imaging and ultrasonography following clinical remission in patients with rheumatoid arthritis: A retrospective study","Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission","Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis","Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis","Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs","Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis","Nxhl Controls Angiogenesis by Targeting VE-PTP Through Interaction With Nucleolin","Decentralizing healthcare in Norway to improve patient-centered outpatient clinic management of rheumatoid arthritis \u2013 a conceptual model","Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs)","A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping","Hematological parameters as a predictor of disease remission in patients with rheumatoid arthritis","Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study","Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients","Long-term glucocorticoids for rheumatoid arthritis","Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea","Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis","Implications of a diagnosis of rheumatoid arthritis in resource-poor countries","Real-world effectiveness and safety of golimumab in rheumatoid arthritis treatment: A two-center study in Taiwan","Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review","Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements","Short-term induction glucocorticoids and disease-modifying anti-rheumatic drugs (DMARD) therapy for rheumatoid arthritis","Role of Suppressor of cytokine signaling 2 during the development and resolution of an experimental arthritis","Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)","Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis","Risk of adrenal insufficiency in patients with polymyalgia rheumatica versus patients with rheumatoid arthritis: A cross-sectional study","Clinical-Like Cryotherapy in Acute Knee Arthritis Protects Neuromuscular Junctions of Quadriceps and Reduces Joint Inflammation in Mice","Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration","Nucleic Acids for Potential Treatment of Rheumatoid Arthritis","Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study","Increased remission with fewer corticosteroids and more biologics in rheumatoid arthritis at 7-year follow-up in real-life conditions","Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies","The Role of Autoantibody Testing in Modern Personalized Medicine","Herpes zoster meningitis in a rheumatoid arthritis patient treated with tofacitinib","Interleukin-17 as a predictor of subclinical synovitis in the remission state of rheumatoid arthritis","The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry","Using patient-reported data from a smartphone app to capture and characterize real-time patient-reported flares in rheumatoid arthritis","Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years","Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-\u0251 inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis","Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents","The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study","Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases","SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine","Mucosa\u2010associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors","Musculoskeletal ultrasound for treating rheumatoid arthritis to target\u2014a systematic literature review","Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study","The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence","Targets Exploration of Hydroxychloroquine for Pigmentation and Cell Protection Effect in Melanocytes: The Clue for Vitiligo Treatment","Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis","How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studies","Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study","Real-world evidence of the effectiveness and safety of generic tofacitinib in rheumatoid arthritis patients: a retrospective, single-centre analysis from Western India","Risk of Severe Infection among Rheumatoid Arthritis Patients on Biological DMARDs: A Population-Based Cohort Study","Increasing trend of radiographic features of knee osteoarthritis in rheumatoid arthritis patients before total knee arthroplasty","The Effect of Anti-rheumatic Drugs on the Skeleton","Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients\u2019 offspring","Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking","Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs","Assessment of inflammation in patients with rheumatoid arthritis using thermography and machine learning: a fast and automated technique","Optimal Biologic Drugs for the Treatment of Ankylosing Spondylitis: Results from a Network Meta-Analysis and Network Metaregression","Upadacitinib for the Treatment of Rheumatoid Arthritis: An Extensive Review","Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance","Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis","Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts","Therapeutic drug monitoring of teriflunomide: do plasma concentrations predict response to leflunomide in patients with rheumatoid arthritis?","Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis","The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States","Secondary Failure of Tocilizumab in Treating Elderly-Onset Rheumatoid Arthritis With Systemic Symptoms Complicated by Diverticulum Perforation","High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort","Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis","Dynamics of patient reported outcomes during the use various biological disease-modifying antirheumatic drugs for rheumatoid arthritis","Rheumatoid arthritis and mitochondrial homeostasis: The crossroads of metabolism and immunity","The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis","Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis","Tapering biologic DMARDs in rheumatoid arthritis","Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems","Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial","A novel anti-TNF-\u03b1 drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritis","Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis","Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis","The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6)","Who stop telemonitoring disease activity and who adhere: a prospective cohort study of patients with inflammatory arthritis","The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective","Kinins and their B1 and B2 receptors as potential therapeutic targets for pain relief","Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies","Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine","Erosion-free rheumatoid arthritis: clinical and conceptional implications\u2014a BARFOT study","A Case of Capillary Leak Syndrome and Intestinal Ischemia Caused by Rheumatoid Vasculitis","A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases","A multidisciplinary lifestyle program for rheumatoid arthritis: the \u2018Plants for Joints\u2019 randomized controlled trial","Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis","Treatment in Patients with Psoriatic Disease and Rheumatoid Arthritis: Seven Case Reports","&lt;scp&gt;COVID&lt;/scp&gt; \u201019 Vaccination and the Incidence of &lt;i&gt;De Novo&lt;/i&gt; or Recurrent Rheumatoid Arthritis: A French and International ( &lt;scp&gt;VigiBase&lt;/scp&gt; ) Signal Detection Study","Expected impact of immunomodulatory agents during pregnancy: A newborn's perspective","Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis","Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study","EULAR updates its RA management recommendations","A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate","Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational study","Effectiveness of duloxetine for remnant pain relief in patients with rheumatoid arthritis despite remission","Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study","Evaluating upadacitinib for the treatment of rheumatoid arthritis.","Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides)","Twenty years\u2019 follow-up of radiocarpal arthrodesis for rheumatoid wrists","Problems of pain and quality of life in rheumatoid arthritis: focus on baricitinib","Elderly-onset rheumatoid arthritis: an outlook from a practicing rheumatologist","Recommendations for the Management of Patients With Systemic Rheumatic Diseases During the Coronavirus Disease Pandemic","A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis","Clinical conditions needed to acquire sustained functional remission in rheumatoid arthritis patients","Current state, control, impact and management of rheumatoid arthritis according to patient: AR 2020 national survey","Perspectives of Methotrexate-Based Radioagents for Application in Nuclear Medicine","Response to interleukin-6 receptor antagonists in patients with rheumatoid arthritis is independent of the number of prior used TNF inhibitors: A systematic review and metaanalysis","Effectiveness of initial methotrexate-based treatment approaches in early rheumatoid arthritis: an elicitation of rheumatologists\u2019 beliefs","The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study)","Correspondence on \u2018Cardiovascular effects of biological versus csDMARD therapy in treatment naive, early rheumatoid arthritis\u2019","Monitoring of Peripheral Blood Leukocytes and Plasma Samples: A Pilot Study to Examine Treatment Response to Leflunomide in Rheumatoid Arthritis","Insulin resistance in patients with rheumatoid arthritis","Musculoskeletal ultrasound using superb microvascular imaging documents treatment response to biosimilar infliximab in rheumatoid arthritis","Effect of total glucosides of paeony and Tripterygium wilfordii polyglycosides on erythrocyte methotrexate polyglutamates in rats, analysed using ultra-high-performance liquid chromatography-tandem mass spectrometry","Quality evaluation of the underlying evidence in the updated treatment recommendations for systemic lupus erythematosus","Use of Janus kinase inhibitors in the treatment of immunoinflammatory rheumatic diseases: safety issues","Artritis reumatoide: Tratamiento","Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?","Diagnosing and managing patients with rheumatoid arthritis","Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights","Frecuencia de positividad de la prueba de intradermorreacci\u00f3n a tuberculina en una cohorte de pacientes con artritis reumatoide","The role of imaging in predicting the development of rheumatoid arthritis","Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization","Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies","Minicircles for Investigating and Treating Arthritic Diseases","A Critical Look at Race\u2010Based Practices in Rheumatology Guidelines","Correspondence on \u2018Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study\u2019","Therapeutic education improves rheumatoid arthritis patients\u2019 knowledge about methotrexate: a single center retrospective study","Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression","Does opioid-based pharmacotherapy have a place in rheumatoid arthritis therapy?","Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis","Targeted and biological drugs in the treatment of inflammatory rheumatic diseases","Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis","Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study","Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy","Corticosteroid injections in the temporomandibular joint temporarily alleviate pain and improve function in rheumatoid arthritis","Artritis reumatoide: manifestaciones extraarticulares y comorbilidades","Application of Automated Hand Ultrasound Scanning and a Simplified Three-Joint Scoring System for Assessment of Rheumatoid Arthritis Activity","Treatment of moderate rheumatoid arthritis","The impact of T2T therapy on the treatment of the patients with the early rheumatoid arthritis (data from OREL registry)","Tapering of disease-modifying antirheumatic drugs: an overview for daily practice","The effect of nurse\u2010led care on fatigue in patients with rheumatoid arthritis: A systematic review and meta\u2010analysis of randomised controlled studies","Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South\u2010Western Saudi Arabia: A Retrospective Study","Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors","Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis","Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib","Methotrexat-Versorgung vor dem Einsatz von Biologika bei rheumatoider Arthritis","New Insights into Bone Loss in RA","Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab","Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device","Retention of golimumab treatment following discontinuation of non\u2010TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry","Effect of TNF inhibitors with bisphosphonates vs bisphosphonates alone on bone mineral density and bone and cartilage biomarkers at 1 year in patients with rheumatoid arthritis: A prospective study","Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients","Correlation and agreement between physical and ultrasound examination after a training session dedicated to the standardization of synovitis assessment in rheumatoid arthritis patients","Clinical utility of therapy selection informed by predicted non-response to tumor necrosis factor-\u0251 inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in Rheumatoid Arthritis","Paradoxical Reactions to Biologicals in Chronic Inflammatory Systemic Diseases.","Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ)","European bio-na\u00efve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response","Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib","Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis","Predictive factors for achievement of treatment goals in patients with postmenopausal osteoporosis treated with denosumab","Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options","Predictive factors for retention of golimumab over a median 4\u2010year duration in Japanese patients with rheumatoid arthritis in a real\u2010world setting: A retrospective study and literature review","Implementing a &lt;scp&gt;Treat\u2010to\u2010Target&lt;/scp&gt; Approach for Rheumatoid Arthritis During the &lt;scp&gt;COVID&lt;/scp&gt; \u201019 Pandemic: Results of a Virtual Learning Collaborative Program","Disease modification in gout: a qualitative study of gout expert rheumatologists","Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis","Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases","Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology","High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study","Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients","A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis","Conversion of the MDHAQ to the HAQ score: a simple algorithm developed and validated in a cohort of 13 391 real-world patients","Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes","Impact of lifestyle and comorbidities on seropositive rheumatoid arthritis risk from Korean health insurance data","Pathogenesis of follicular thymic hyperplasia associated with rheumatoid arthritis","The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity","Factors influencing the Sharp score of 1057 patients with rheumatoid arthritis and anemia: a retrospective study","Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patients","Ultrasound scoring systems for evaluation of synovitis and tenosynovitis in patients with rheumatoid arthritis","Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland","Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases","Unmet Needs in Rheumatoid Arthritis: A Subgroup of Patients With High Levels of Pain, Fatigue, and Psychosocial Distress 3 Years After Diagnosis","Gut microbial dysbiosis in rheumatoid arthritis: a systematic review protocol of case-control studies","Real-World Evidence of the Effectiveness and Safety of Generic Tofacitinib in Rheumatoid Arthritis Patients: A Retrospective, Single-Centre Analysis from Western India","Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study","Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis","Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases\u2014Reply","Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2","Male Sex Predicts a Favorable Outcome in Early ACPA-Negative Rheumatoid Arthritis: Data From an Observational Study","Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain","Comparison of Teleconsultations and In-Person Consultations from Outpatients with Rheumatoid Arthritis, During the COVID-19 Pandemic: An Internal Audit of Medical Notes","Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis","The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study","Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system","Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort","Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in Rheumatoid Arthritis Patients in Greece: Analysis of the Greek Cohort of SENSE study","When topical therapy of atopic dermatitis fails: a guide for the clinician","Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look","Implementation of the treat-to-target approach and treatment satisfaction in patients with rheumatoid arthritis: perspectives of Chinese rheumatologists","Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic","Surgical intervention for patients with rheumatoid arthritis is declining except for foot and ankle surgery: A single-centre, 20-year observational cohort study","Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection","Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study","Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual","Oral methotrexate at doses 15\u201325 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis","Making space for patients\u2019 preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis","Immune\u2010related conditions and cancer\u2010specific mortality among older adults with cancer in the United States","Assessing acceptability and identifying barriers and facilitators to implementation of the EULAR recommendations for patient education in inflammatory arthritis: a mixed-methods study with rheumatology professionals in 23 European and Asian countries","Three Months of Glucocorticoids in Rheumatoid Arthritis: A Bridge Too Short?","Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results","Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry","Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time\u2010series analysis","Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?","Serum Amyloid A Protein\u2013Associated Kidney Disease: Presentation, Diagnosis, and Management","Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis","Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study","Effectiveness of Golimumab as Second Anti-TNF\u03b1 Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study","Subcutaneous panniculitis\u2010like &lt;scp&gt;T\u2010cell&lt;/scp&gt; lymphoma associated with methotrexate treatment","Clinical prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: A systematic review and meta-analysis","Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes","Dantrolene, a stabilizer of the ryanodine receptor, prevents collagen-induced arthritis","Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis","Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes","Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study","Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study","Validity and Reliability of the Thai Version of the 19-Item Compliance-Questionnaire-Rheumatology","The long\u2010term persistence of &lt;scp&gt;tumor necrosis factor&lt;/scp&gt; inhibitors in patients with moderate to severe immune\u2010mediated rheumatic diseases: A nation\u2010wide, population\u2010based real\u2010world study","Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis","Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial","Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis","PHARAO-Studie: Arzneimittelversorgung entz\u00fcndlich rheumatischer Erkrankungen","Basic Methods of Physical Rehabilitation of Patients with Rheumatoid Arthritis","Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study","Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritis","Nano-Based Co-Delivery System for Treatment of Rheumatoid Arthritis","Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach","An intersectional analysis of LncRNAs and mRNAs reveals the potential therapeutic targets of Bi Zhong Xiao Decoction in collagen-induced arthritis rats","Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors","Remission or Not Remission, That\u2019s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis","Management of chronic rheumatic diseases in women 18\u201345 years of age in Asia Pacific: insights from patient and clinician surveys","Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth","Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study","Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study","Egyptian guidelines for the treatment of Rheumatoid Arthritis \u2014 2022 update","Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic Disorders in Rheumatoid Arthritis Patients","Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis","Management of Axial Spondyloarthritis \u2013 Insights into Upadacitinib","Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas","Diet and the risk of rheumatoid arthritis \u2013 A systematic literature review","Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region","The Stat3 inhibitor F0648-0027 is a potential therapeutic against rheumatoid arthritis","Sarcopenia in Immune-Mediated Rheumatic Diseases\u2014Review","The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients","Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach","Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis","Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis","Better Clinical Results in Rheumatoid Arthritis Patients Treated Under a Multidisciplinary Care Model When Compared with a National Rheumatoid Arthritis Registry","Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis","The Effect of Upadacitinib on Lipid Profile and Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials","An update on thermal imaging in rheumatoid arthritis","Serum proteomics analysis of biomarkers for evaluating clinical response to MTX/IGU therapy in early rheumatoid arthritis","Early intervention in psoriasis: Where do we go from here?","Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country","Olokizumab's Effectiveness and Safety in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment","Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13","Regulatory Fibroblast\u2010Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis","Case report: JAKi and TNFi dual therapy is a potential treatment strategy for difficult-to-treat rheumatoid arthritis","Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis","Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study","Controversies in rheumatology: telemedicine\u2014friend or foe?","A common missense variant rs874881 of PADI4 gene and rheumatoid arthritis: Genetic association study and in-silico analysis","The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study","Association between Rheumatic Disease Comorbidity Index and factors of poor prognosis in a cohort of 280 patients with rheumatoid arthritis","Factors Associated With Quality Care Among Adults With Rheumatoid Arthritis","Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy","Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design","Association between malignancy risk and Janus kinase inhibitors versus tumour necrosis factor inhibitors in Korean patients with rheumatoid arthritis: a nationwide population-based study","Management of autoinflammatory syndromes and periodic fevers","Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacity","Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials","The prevalence of rheumatoid arthritis in Western Australia","Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis","Matrix Metalloproteinase-9 Level in Synovial Fluid\u2014Association with Joint Destruction in Early Rheumatoid Arthritis","Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM","From Bench to Bedside in Rheumatoid Arthritis from the \u201c2022 GISEA International Symposium\u201d","First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept","Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy","Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort","Patient participation in defining best-practice rheumatology service provision in Aotearoa New Zealand: a qualitative study with service consumers","Trends in Hospitalization for Tuberculosis and Other Opportunistic Infections in Australian Patients with Inflammatory Joint Diseases","Prevalence of apical periodontitis in patients with autoimmune diseases: A case\u2010control study","Global trends in research of fibroblasts associated with rheumatoid diseases in the 21st century: A bibliometric analysis","Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis","Olive Oil and Nuts in Rheumatoid Arthritis Disease Activity","Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort study","Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis","Safety and efficacy associated with long-term low dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis","Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review","Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes","Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease","&lt;sup&gt;68&lt;/sup&gt;Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study","Sarcopenia in Rheumatoid arthritis. A narrative review","Nanomedicine is more than a supporting role in rheumatoid arthritis therapy","An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis","Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial","How to self-examine for tender and swollen joints: co-producing a training video for people with rheumatoid arthritis","The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?","Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.","Does methotrexate improve TNF inhibitor drug survival in elderly patients with RA?","Reply","Diagnostic Challenges and Management Update in Rheumatoid Arthritis","Biological disease\u2010modifying drugs for rheumatoid arthritis","Response to: \u2018Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis\u2019 by Bugatti et al","Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis","Onkologie und Versorgung in Fach- und Publikumsmedien","Growing Need for Diagnostic Precision in Rheumatoid Arthritis: Proposal of MR Imaging Criteria for Early Diagnosis","Response to: \u2018Comment on \u2018Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab\u2019\u2019 by Pethoe-Schramm et al","Response to: \u2018Tapering antirheumatic drugs in a resource-poor setting: real-world evidence\u2019 by Haroon&lt;i&gt;et al&lt;/i&gt;","Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI)","Comment on: \u2018It can\u2019t be zero!\u2019 difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study: reply","Whole Genome and Embryo Transcriptome Analysis of Vertebrate Identifies nxhl Controlling Angiogenesis by Targeting VE-PTP","Whole Genome and Embryo Transcriptome Analysis of Vertebrate Identifies nxhl Controlling Angiogenesis by Targeting VE-PTP","Budget impact analysis of an early identification and referral model for diagnosing patients with suspected rheumatoid arthritis in Ireland","Development and Validation of Adherence Score for Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs","Les patients atteints d\u2019arthrite inflammatoire qui adh\u00e8rent le plus au traitement ne font pas plus d\u2019activit\u00e9 physique : une \u00e9tude transversale de 152 patients, l\u2019\u00e9tude ImBAIA","Tapering and discontinuation of oral glucocorticoids without deterioration of disease status in patients with rheumatoid arthritis under a stable treatment","One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry","Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses","Compliance with oral disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Colombian experience","Factors predicting addition of disease-modifying antirheumatic drugs after initial methotrexate monotherapy in patients with rheumatoid arthritis","Rheumatoid arthritis relapse in patients with other iatrogenic immunodeficiency-associated lymphoproliferative disorders and its treatment","Risikostratifizierung f\u00fcr Therapieentscheidungen bei Rheumatoider Arthritis","Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings","Biologic therapies for the treatment of rheumatoid arthritis","Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatients","Advantages and disadvantages of targeted therapy in patients with rheumatoid arthritis","Comment on: Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway","If You Want to Perform a Cost-effectiveness Trial, First Do a Modeling Study","Glukokortikoidfreie und glukokortikoidarme Therapie der rheumatoiden Arthritis","Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey","Arthralgien mit Nachweis von Anti-CCP-Antik\u00f6rpern","Current Treatment Strategies in Rheumatoid Arthritis After Methotrexate Are Not Enough to Maintain Sustained Remission: There Is No Holy Grail!","Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept","Actualit\u00e9s dans la polyarthrite rhumato\u00efde","Performance of a pre\u2010administration infection screening questionnaire in patients with rheumatoid arthritis administered biological disease\u2010modifying antirheumatic drugs","Current advances in the treatment of autoimmune-associated interstitial lung diseases","Behandlungsempfehlungen vs. Real-Life: Therapie der rheumatoiden Arthritis in \u00d6sterreich","Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent","How important is JAK1 selectivity?","Pr\u00e9valence du COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques trait\u00e9s par bioth\u00e9rapies ou inhibiteurs des JAK : une \u00e9tude bas\u00e9e sur la population au cours des deux premiers mois de l\u2019\u00e9pid\u00e9mie de COVID-19 en Italie","Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)","Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritis","Efficacy of Bi Qi Capsules in combination with methotrexate in the treatment of rheumatoid arthritis","Response to: \u2018Correspondence on \u2018Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study\u2019 by Gong and Zhang and Lin&lt;i&gt;et al&lt;/i&gt;","Methotrexate-induced lung damage in a patient with rheumatoid arthritis","Hydroxychloroquine dans les maladies syst\u00e9miques et auto-immunes : o\u00f9 en sommes-nous ?","Musculoskeletal Ultrasound of Rheumatologic Conditions","Novel Immunomodulatory Therapies for Respiratory Pathologies","Editorial: Traditional Medicine and Rheumatology","In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?","Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?","AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients","Effect of subcutaneous high-dose methotrexate treatment on the management of rheumatoid arthritis","ASSOCIATION OF SEROLOGICAL STATUS WITH THE FREQUENCY OF CLINICAL AND RADIOLOGICAL REMISSION IN RHEUMATOID ARTHRITIS","Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts","Investigating the Causes and Incidence of Mortality in Patients Using Biological Disease Modifying Antirheumatic Drug (DMARD) and the Mortality Rates Thereof Compared to the General Population","The use of biosimilars as a new approach to the treatment of rheumatoid arthritis","Synovial fluid cell count of 84 930/mm3 in adult-onset Still\u2019s disease","Leflunomide: modern look at safety problem (literature review)","The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review","Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan","Predictive Role of Ultrasound Remission for Progressive Ultrasonography-Detected Structural Damage in Patients with Rheumatoid Arthritis","Rheumatology: biosimilars are here to stay","A not-to-miss Cause of Severe Cervical Spine Pain in a Patient with Rheumatoid Arthritis: A Case-Based Review","Biologics Targeting Immune Modulation in Inflammatory Disorders","Modern Genetic Engineering Technology Achievements in Rheumatology","Rheumatologic Aspects of the COVID-19 Pandemic: A Practical Resource for Physicians in Kuwait and the Gulf region as Recommended by the Kuwait Association of Rheumatology","Rehabilitation bei rheumatoider Arthritis","Belgian rheumatologists\u2019 preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study","Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis","Diagnosis and management of rheumatoid arthritis","Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility","Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study","JAK-Hemmer bei adulter und juveniler Arthritis","Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum","Pregnancy outcomes in patients with rheumatoid arthritis who discontinue methotrexate treatment to conceive","Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort","Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide","The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort","Rheumatoid Arthritis, Osteoarthritis, and Gout","Intra-articular glucocorticoid injection site: best practice guidelines","Association between ultrasound images and patient-reported outcomes in the treatment of rheumatoid arthritis: a retrospective study","Impact du statut s\u00e9rologique du facteur rhumato\u00efde (FR) et des anticorps anti-prot\u00e9ines citrullin\u00e9es (ACPA) sur le maintien th\u00e9rapeutique de l\u2019abatacept (ABA) \u00e0 2 ans chez des patients (pts) atteints de polyarthrite rhumato\u00efde (PR)","Rheumatoid Arthritis","Advances with pharmacotherapy for the treatment of interstitial lung disease","Dynamics of clinical manifestations and cytokine concentrations in rheumatoid arthritis patients on tofacitinib therapy","Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort","Clinical Advantage of Attaining Index-Based Remission Prior to Composite Remission in Treating Rheumatoid Arthritis","Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis","Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases","Extracorporeal Membrane Oxygenation in Immunocompromised Patients With Acute Respiratory Distress Syndrome\u2014A Retrospective Cohort Study","Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis","Application of IL-6 antagonists in autoimmune disorders","Glukokortikoidfreie und glukokortikoidarme Therapie der rheumatoiden Arthritis","Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations","Rheumatologie 2021","Neues zu Therapiestrategien bei der rheumatoiden Arthritis","So behandle ich \u2013 die Polymyalgia rheumatica mit m\u00f6glichst geringer kumulativer Glukokortikoiddosis","Introduction on therapeutic opportunities for autoimmunity","Rheumatoid arthritis and HIV-associated arthritis: Two sides of the same coin or different coins","Ultrasound remission in patients with rheumatoid arthritis in clinical remission","Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals","Clinical-like cryotherapy in acute knee arthritis of the knee improves inflammation signs, pain, joint swelling, and motor performance in mice","Association of cancer with comorbid inflammatory conditions and treatment in patients with Lynch syndrome","Intraindividual Changes in Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Tests in Korean Patients Visiting Local Clinics and Hospitals","JAK inhibition and the holy grail for pain control in early RA","Effect of different initial rituximab regimens on B cell depletion in children with autoimmune neurological diseases","The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study","Ultrasound-guided lymph node biopsy sampling to study the immunopathogenesis of rheumatoid arthritis: a well-tolerated valuable research tool","Management of rheumatoid arthritis","Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)","Number needed to treat and cost per responder of Janus kinase inhibitors approved for the treatment of moderate-to-severe rheumatoid arthritis in Japan","Rheumatoid Arthritis","Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis","Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era","Exploring Drug Cost and Disease Outcome in Rheumatoid Arthritis Patients Treated With Biologic and Targeted Synthetic DMARDs in Norway from 2010 to 2019 \u2013 A Country With a National Tender System for Prescription of Costly Drugs","Yunpi Qufeng Chushi Formula for Pre-Rheumatoid Arthritis: Study Protocol for a Multiple-Center, Double-Blind, Placebo-Controlled Randomized Controlled Trial","A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping (Preprint)","Management of rheumatoid arthritis in China: a study of the implementation of 2019 EULAR recommendations","Painkillers in the treatment of inflammatory arthritis: past, present and future","Methotrexate Pneumonitis After a Low-Dose Medication Error: A Case Report","Rheumatic side effects of cancer immunotherapy with immune checkpoint inhibitors","Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patients","Early diagnosis and therapy of rheumatoid arthritis","State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis","Antimicrobial agents and torsades de pointes","Current Status and Future Challenges in the Treatment of Rheumatic Diseases","Semi-automated socio-anthropologic analysis of the&lt;i&gt;medical discourse&lt;/i&gt;on rheumatoid arthritis: potential impact in public health","Influence of frailty on patient global assessment in rheumatoid arthritis","Effectiveness of SB4 transition from originator etanercept in rheumatoid arthritis and axial spondyloarthritis: A subgroup analysis from the BENEFIT study","Factors associated with frailty in rheumatoid arthritis patients with decreased renal function","Combination therapies in rheumatoid arthritis\u2014choose your partner carefully","Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity","Patient Experienced Symptom State in rheumatoid arthritis: sensitivity to change in disease activity and impact","&lt;scp&gt;ABCB1&lt;/scp&gt; gene polymorphisms impact the effect of high\u2010dose intravenous methylprednisolone therapy on optic neuritis associated with &lt;scp&gt;AQP4\u2010IgG&lt;/scp&gt; \u2010positive neuromyelitis optica spectrum disorder","The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study","OSG-Prothesen am arthritischen und arthrotischen Fu\u00df","Biologics in Rheumatoid Arthritis","Patient Consent for Biologics","Nachrichten des Verbandes Rheumatologischer Akutkliniken e. V.","Metagenomics from bench to bedside and from bedside to bench","Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study)","Hyperlipidemia and rheumatoid arthritis","Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort","Des scores \u00e9lev\u00e9s d\u2019\u00e9valuation globale par le patient en cas de polyarthrite rhumato\u00efde en r\u00e9mission ne refl\u00e8tent pas une inflammation infraclinique","Rheumatoid Arthritis","To choose or not? The value of discrete-choice experiments in rheumatology","Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit","Rheumatoid arthritis: extra articular manifestations and comorbidities","Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study","Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination","Meta\u2010Analyses on the Effects of Disease\u2010Modifying Antirheumatic Drugs on the Most Relevant Patient\u2010Reported Outcome Domains in Rheumatoid Arthritis","Digitalization and disruptive change in rheumatology","Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study","Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data","Practices among General Practitioners in Rheumatoid Arthritis (GEPRA-I): results of a region-wide online survey","Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence","The Clinical Impact of Seropositivity on Treatment Response in Patients with Rheumatoid Arthritis Treated with Etanercept: A Real-World Iraqi Experience","Pr\u00e9venir les complications cardiovasculaires dans les rhumatismes inflammatoires chroniques","Impact of continuity of care on risk for major osteoporotic fracture in patients with new onset rheumatoid arthritis","Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis","Janus kinase inhibitors in immunoinflammatory rheumatic diseases","IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis","Comparison of the efficacy and safety of the original rituximab and its biosimilar in routine clinical practice","Relationship between laboratory biomarkers and ultrasonographic signs of inflammation in patients with rheumatoid arthritis treated with a rituximab biosimilar","Impact of a pharmaceutical care service for patients with rheumatoid arthritis using a customised mobile device (the PROUD trial): study protocol for a randomised controlled trial","Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study","Development of an interdisciplinary early rheumatoid arthritis care pathway","Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies","Clinical variables, including novel joint index, associated with future patient\u2010physician discordance in global assessment of rheumatoid arthritis ( &lt;scp&gt;RA&lt;/scp&gt; ) disease activity based on a large &lt;scp&gt;RA&lt;/scp&gt; database in Japan","THE PLACE OF LEFLUNOMIDE IN DISEASE-MODIFYING THERAPY OF RHEUMATOID ARTHRITIS: NEW ASPECTS","Analysis of combined deficiency of interleukin-1 and -6 versus single deficiencies in TNF-mediated arthritis and systemic bone loss","Reply","Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden","Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? \u2013 A Cohort Study in a Colombian Population","Real-life experience of tofacitinib in patients with treatment-resistant rheumatoid arthritis: 5 -year follow up: Monocentric experience","Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry","Measuring Disease Activity and Functional Capacity in Telerheumatology","Effectiveness and Safety of Golimumab for Patients \u226575 Years Old with Rheumatoid Arthritis","Optimizing the anti-inflammatory strategies in (osteo)arthritis: local or systemic?","Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research","The Herbal Combination of Radix astragali, Radix angelicae sinensis, and Caulis lonicerae Regulates the Functions of Type 2 Innate Lymphocytes and Macrophages Contributing to the Resolution of Collagen-Induced Arthritis","Anti-Citrullinated Protein Antibody Titers Are Independently Modulated by Both Disease Activity and Conventional or Biologic Anti-Rheumatic Drugs","Differential diagnosis of inflammatory arthritis from musculoskeletal ultrasound view","Overlap syndrome variant: transformation of adults' Still's disease into rheumatoid arthritis (clinical case)","Measuring a grey area in medication deployment reveals delays from invention to clinical use of rheumatoid arthritis medications","Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis","Twenty Years of Targeted and Biologic Immunomodulatory Drugs","Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses","Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis","Investigation of remission with ultrasound in patients with rheumatoid arthritis according to different clinical remission criteria","Anti-Rheumatoid Arthritis Potential of Rhododendron Molle G. Don Leaf Extract in Adjuvant Induced Arthritis Rats","Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?","Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial","Biologic DMARDs and targeted synthetic DMARDs and the risk of all-cause mortality in rheumatoid arthritis: A systematic review and meta-analysis","Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort","ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis","Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study","Abatacept downregulates Fc\u03b3 receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis","Five cases of seronegative persistent inflammatory monoarthritis improved with biological therapy","The serum immunoglobulin G titres against &lt;i&gt;Porphyromonas gingivalis&lt;/i&gt; as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: A retrospective cohort study","Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis","Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy","Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis","Validation of the Korean Leeds satisfaction questionnaire in rheumatoid arthritis with Rasch models","The effective threshold dose of etanercept biosimilars in patients with methotrexate- resistant rheumatoid arthritis","The Assessment of the Quality of Life in Patients with Rheumatoid Foot","Clinical course in patients with chronic undifferentiated arthritis of the elbow after arthroscopic synovectomy","Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study","Comment combler l\u2019\u00e9cart entre les essais cliniques et la pratique m\u00e9dicale courante dans les rhumatismes inflammatoires chroniques?","The Safety and Effectiveness of Infliximab Biosimilar in Managing Rheumatoid Arthritis: A Real-Life Experience from Jordan","Long\u2010term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis","The potential role of community pharmacy staff in reducing patient delay in consulting with symptoms of rheumatoid arthritis: a qualitative study","Assessment of the effect of DMARD use on the mortality of patients with rheumatoid arthritis","National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)","Association between locomotive syndrome and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients: A retrospective observational study","Treatment Sequence After Initiating Biologic Therapy for Patients With Rheumatoid Arthritis in Korea: A Nationwide Retrospective Cohort Study","Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study","Is histopathological synovitis score a predictor of postoperative requirement for additional or alternative drug treatment in the patients with rheumatoid arthritis?","Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis","Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010\u20132019","Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database","Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studies","EULAR 75-year anniversary: commentaries on&lt;i&gt;ARD&lt;/i&gt;papers from 25 years ago","Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients","COVID-19 Pandemisi S\u0131ras\u0131nda Anti Romatizmal \u0130la\u00e7lara Halk\u0131n \u0130lgisi: T\u00fcrkiye\u2019deki Google Trends Analizi, Kesitsel \u00c7al\u0131\u015fma","The role of monitoring the level of matrix metalloproteinase 3 in patients with rheumatoid arthritis on anti-B-cell therapy","lncRNA-mediated synovitis in rheumatoid arthritis: A perspective for biomarker development","Withdrawal of MTX in rheumatoid arthritis patients on bDMARD/tsDMARD plus methotrexate at target: a systematic review and meta-analysis","New insights into the pathogenesis and management of rheumatoid arthritis","Ultrasound response to tofacitinib in patients with rheumatoid arthritis: Data from a multicenter 24 weeks prospective study","Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?","Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience","Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials","Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis","Overtreatment in rheumatoid arthritis: are there reasons for concern?","Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index and sex: a cohort study in SCQM","Action of Tofacitinib in a Rat Model of Synovitis","Latest models for the discovery and development of rheumatoid arthritis drugs","Serum level of IFN\u03b2 distinguishes early from late relapses after biologics withdrawal in rheumatoid arthritis","The effect of long non-coding RNAs in joint destruction of rheumatoid arthritis","Estado actual y retos futuros en el tratamiento de las enfermedades reum\u00e1ticas","Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study","Similar effect of co-administration of methotrexate and folic acid for the treatment of arthritis compared to separate administration","Quelle place pour les inhibiteurs de JAK en 2022 ?","High Throughput Genetic Characterisation of Caucasian Patients Affected by Multi-Drug Resistant Rheumatoid or Psoriatic Arthritis","Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study","Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis","Effect of Er Miao San on rheumatoid arthritis via the NF-\u03baB signaling pathway: Based on network pharmacology and experimental validation","Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis","Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees","Impact de la multimorbidit\u00e9 sur la r\u00e9ponse th\u00e9rapeutique aux traitements de fond antirhumatismaux dans la polyarthrite rhumato\u00efde r\u00e9cente : donn\u00e9es de la cohorte Espoir","Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment","Necesidades, impacto y perspectiva actual de los pacientes con espondiloartritis incluyendo la artritis psori\u00e1sica","Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More","The bone-protective mechanisms of active components from TCM drugs in rheumatoid arthritis treatment","Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: Comparative study with Filgotinib and Tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial","Associations Between microRNA-related Genetic Polymorphisms and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients","Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis","Consistency of recommendations for pharmacotherapy of rheumatoid arthritis","Validating MRI and ultrasound findings to predict bone destruction in rheumatoid arthritis","Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis","Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis","Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study","Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials","Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting","Consensus Statement der \u00d6sterreichischen Gesellschaften f\u00fcr Rheumatologie und Rehabilitation, Pneumologie, Infektiologie, Dermatologie und Gastroenterologie zum Umgang mit latenter Tuberkulose bei Therapien mit biologischen oder \u201etargeted synthetic\u201c DMARDs (\u201edisease modifying antirheumatic drugs\u201c)","\u201cWithout Them, I Would Never Have Been Able to Carry on\u201d Levers for the Sustained Employment of Patients with Chronic Inflammatory Arthritis: A French Qualitative Study","Incidence and factors related to SARS-CoV-2 infection in a cohort of patients with rheumatoid arthritis from a health service provider in Colombia during the COVID-19 pandemic","Which should be first: biologic DMARDs or Janus kinase inhibitors?","Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis","Filgotinib in rheumatoid arthritis","Epimedii Herba: An ancient Chinese herbal medicine in the prevention and treatment of rheumatoid arthritis","Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study","EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis","Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity","Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis","Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines","A Thermographic Disease Activity Index for remote assessment of rheumatoid arthritis","Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: results of 10 years of use","Nationwide, large-scale implementation of an online system for remote entry of patient-reported outcomes in rheumatology: characteristics of users and non-users and time to first entry","Clinical Advantage of Attaining Index-Based Remission Prior to Composite Remission in Treating Rheumatoid Arthritis","High Serum Level of TNF-\u03b1 in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis","Novel Gut microbiota as new biomarkers to evaluate the therapeutic effect of different DMARDs in Rheumatoid Arthritis","Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors","Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review","Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians","Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment","Reumato\u00efde artritis","Reasons for discontinuation of methotrexate in the treatment of rheumatoid arthritis and challenges of methotrexate resumption: a single-center, retrospective study","A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis","Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance","Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Na\u00efve and Switched Patients: After 5 Years of Follow-Up","Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis","Antirheumatic treatment, disease activity and risk of&lt;i&gt;Staphylococcus aureus&lt;/i&gt;bacteraemia in rheumatoid arthritis: a nationwide nested case\u2013control study","Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis (RA): A Retrospective Study From Two Centers in Jeddah, Saudi Arabia","Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care","Key Conditions and Principles of Orthopaedic Management","Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis","Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate","Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study","Impact clinique de l\u2019arr\u00eat de la corticoth\u00e9rapie chez des patients atteints de polyarthrite rhumato\u00efde trait\u00e9s par upadacitinib ou adalimumab","Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study","Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset","Receiver operating characteristic analysis using a novel combined thermal and ultrasound imaging for assessment of disease activity in rheumatoid arthritis","Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors","Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe","Comparison of Efficacy and Safety of Original and Biosimilar Adalimumab in Active Rheumatoid Arthritis in a Real-World National Cohort","Association between disease-modifying antirheumatic drugs and bone turnover biomarkers.","Precautions before starting tofacitinib in persons with rheumatoid arthritis","Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis","Investigation of the Effect of Selected Piperazine-2,5-Diones on Cartilage-Related Cells","Commentary: Janus kinase inhibitors and juvenile idiopathic arthritis associated uveitis","Profile of Patients with Rheumatoid Arthritis: a Descriptive Analysis","Prescription analysis of rheumatology and endocrinology departments of a teaching hospital in Western India","Arthritiden \u2013 Begutachtung","Semi-automated socio-anthropologic analysis of the medical discourse on rheumatoid arthritis: Potential impact on public health","Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis","Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy","Acute Ischemic Stroke in the Patients with Inflammatory Arthritis: An Analysis of Data from National Health Insurance Service","Interleukin 6 receptor inhibitors in the treatment of rheumatoid arthritis during the COVID-19 pandemic, Moscow experience","Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis","The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review","Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings","An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study","Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)","Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy","Healthcare resource utilization and costs in stable patients with rheumatoid arthritis: Comparing nurse-led and rheumatologist-led models of care delivery","Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience","Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies","Factors associated with selection of targeted therapy in patients with rheumatoid arthritis","Outcomes Following Adalimumab Bio-originator to Biosimilar Switch\u2014A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries","Accelerated atherosclerosis in rheumatoid arthritis: a systematic review","Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study","Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies","Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis","JAK Inhibition in Patients with Rheumatoid Arthritis: Haemodynamic Effects and Impact on Micro- and Macrovascular Function. Study Design and Rationale","Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis","Correlation Between Total Bilirubin, Total Bilirubin/Albumin Ratio with Disease Activity in Patients with Rheumatoid Arthritis","The effect of smoking on response to methotrexate in rheumatoid arthritis patients: A systematic review and meta-analysis","Anti-rheumatoid arthritis potential of Rhododendron molle G. Don leaf extract in adjuvant induced arthritis rats","A rare case of scleritis and multiple rheumatoid pulmonary nodules associated with seronegative rheumatoid arthritis","JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis","Barriers to the Diagnosis of Early Inflammatory Arthritis: A Literature Review","Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison","R\u00e9\u00e9ducation dans les formes axiales et p\u00e9riph\u00e9riques de rhumatismes inflammatoires","Cardiovascular Manifestations in Rheumatoid Arthritis","Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy.","Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice","Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial","Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+","Novel Gut microbiota as new biomarkers to evaluate the therapeutic effect of different DMARDs in Rheumatoid Arthritis","Int\u00e9r\u00eat du dosage des anticorps antim\u00e9dicaments dans les rhumatismes inflammatoires","Microwave Radiometry for the Diagnosis and Monitoring of Inflammatory Arthritis","HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study","Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany\u2014a health insurance claims data analysis","Influence of perception of glucocorticoids on compliance of treatment in patients with rheumatoid arthritis and systemic lupus erythematosus","Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine","High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis","Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice","Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease","Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug","Appearance of Ankylosing Spondylitis in a Middle-Aged Female Patient With a Long History of Rheumatoid Arthritis","The efficacy and safety of olokizumab for rheumatoid arthritis: a systematic review, pairwise, and network meta-analysis","Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases","Recent insights into comorbidities in atopic dermatitis","Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study","Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis","Is there a reduction in hip destruction under a treat-to-target strategy in patients with rheumatoid arthritis?","Clinical Visit Frequencies in Rheumatology: A Systematic Literature Review","Targeting Tumor Necrosis Factor Receptor 1 with Selected Aptamers for Anti-Inflammatory Activity","Patients\u2019 perspectives towards biologic dose reduction in psoriasis: a qualitative study","Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application","Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients","Serum matrix metalloproteinase-3 levels monitor the therapeutic efficacy in Syrian patients with rheumatoid arthritis","Patterns in the sequential treatment of rheumatoid arthritis patients starting a b/tsDMARD: 10-year experience from a US-based registry","Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data","Gu\u00eda de pr\u00e1ctica cl\u00ednica para la detecci\u00f3n temprana, el diagn\u00f3stico, el tratamiento y el seguimiento de los pacientes con artritis reumatoide. Asociaci\u00f3n Colombiana de Reumatolog\u00eda, 2022","Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers","Open challenges in the management of autoimmune hepatitis","The link between rheumatic disorders and inborn errors of immunity","Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study","Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review","Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial","Advanced therapies in rheumatoid arthritis","Effect of Saffron Extract, Astaxanthin, and Carnosic Acid on the Levels of Matrix Metalloproteinase-9 and on Body Weight Changes in Arthritis Experiments","The Proportion of Patients With Rheumatoid Arthritis Achieving ACR20/50/70; Consistent Patterns of a 60/40/20 as Demonstrated by a Systematic Review and Meta-analysis","Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab","Geschlechtsspezifische Unterschiede in Diagnostik und Therapie entz\u00fcndlich-rheumatischer Erkrankungen","Changes in Bone Metabolism in Patients with Rheumatoid Arthritis during Tumor Necrosis Factor Inhibitor Therapy","Frequency of Helicobacter pylori in Patients With Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance","Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease","Simultaneous quantitative analysis and in vitro anti-arthritic effects of five polyphenols from Terminalia chebula","Sarcopenia and COVID-19 Outcomes","Aetiologies of Acute Complications in Autoimmune Rheumatologic Diseases: A Hospital-Based Cross-Sectional Study","A scoping review of shared care models for rheumatoid arthritis with patient-initiated follow-up","Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review","Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning","Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis","Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR","Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments","Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study","Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry","An Evidence-Based Update on the Potential Association between Rheumatoid Arthritis and Lymphangioleiomyomatosis","Leishmania infantum infection after visiting southern Spain in patients on biological treatment; an observational, longitudinal, cohort study","Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review","Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study","Rheumatoid Arthritis","Meaningful Improvement and Worsening in Patients Who Do Not Achieve Low Disease Activity and Switch Therapy to a New Biologic or Targeted Disease-Modifying Antirheumatic Drug","Tocilizumab experience in patients with rheumatoid arthritis: A retrospective study","Selective JAK1 inhibitors for the treatment of inflammatory bowel disease","Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis","Naru-3 inhibits inflammation, synovial hyperplasia, and neovascularization in collagen-induced arthritis in rats","Difficult-to-treat rheumatoid arthritis treated with Abatacept combined with Baricitinib: A case report","Egyptian recommendations for the management of systemic lupus erythematosus: a consensus, evidence-based, clinical practice guidelines for treat-to-target management","Six-month follow-up of periodontal condition and oral mucosa lesions in arthritis patients undergoing anti-tumour necrosis factor-\u03b1 therapy","Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review","The Influence of Anti-Citrullinated Polypeptide Antibodies on Bone Mineral Density Decrease and Incident Major Osteoporotic Fractures in Patients with Rheumatoid Arthritis: A Retrospective Case-Control Study","A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma","Clinical characteristics of flares in patients with rheumatoid arthritis after total hip and total knee arthroplasty","Comprehensive analysis of pain syndrome in patients with rheumatoid arthritis","Rheumatoid Arthritis from Easy to Complex Disease: From the \u201c2022 GISEA International Symposium\u201d","A Framework of Faster CRNN and VGG16-Enhanced Region Proposal Network for Detection and Grade Classification of Knee RA","Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study","Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy","Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry","Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)","Administrative Databases and Diagnostic Therapeutic and Assistance Paths -PDTA- in the Monitoring Treatment of Rheumatoid Arthritis: The Experience of ATS Pavia","The Effectiveness of Telemedicine in Patients with Rheumatoid Arthritis: An Overview of Systematic Reviews and Meta-Analysis","The effect of JuanBiQiangGu granules in combination with methotrexate on joint inflammation in rheumatoid arthritis: a randomized controlled trial","Patients with spondyloarthritis including psoriatic arthritis: Current needs, impact, and perspective","Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study","Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment","Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study","Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis","A review on pharmacokinetics of sinomenine and its anti-inflammatory and immunomodulatory effects","What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis","Efficacy and safety of tofacitinib combined with methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis","A Bibliometric and Documentary Analysis of the Concept of Strategic Management: Perspective at Health Administration","The Barriers and Enablers to the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review","Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry","Rheuma und Geriatrie","Effect of body mass index on treatment response of biologic\u2212/targeted synthetic-DMARDs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. A systematic review","FLARE-RA in patients with rheumatoid arthritis: translation and cross-cultural adaptation into Turkish","Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis \u2013 study protocol for a randomised controlled trial","Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort","Fallvorstellung: Geschwollene H\u00e4nde","Prevalence and Predictors of Remission and Sustained Remission in Patients with Rheumatoid Arthritis from the United Arab Emirates: A Two-Year Prospective Study","From misconceptions to reasonable osteoarthritis patients therapy","Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients","Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study","Patient\u2013Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians","New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis","Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial","TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis","Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients","Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry","Changes in knee joint destruction patterns among patients with rheumatoid arthritis undergoing total knee arthroplasty in recent decades","Using Twitter Data Analysis to Understand the Perceptions, Beliefs, and Attitudes about Pharmacotherapy Used in Rheumatology: An Observational Study","Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease","The Methotrexate Story: How did a Cancer Chemotherapeutic Agent Become a Disease-modifying Antirheumatic Drug","Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-na\u00efve patients with rheumatoid arthritis: &lt;i&gt;Post-hoc&lt;/i&gt; analysis of a multicentre, real-world observational study in Japan (ORIGAMI)","Exclusion of older adults from randomized controlled trials in rheumatoid arthritis","Rheumatology specialist care delivered at the Southern &lt;scp&gt;QLD&lt;/scp&gt; Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care","Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs","Intensive treatment for the progression of joint damage in rheumatoid arthritis patients with low disease activity or remission","Hypoxia with or without Treadmill Exercises Affects Slow-Twitch Muscle Atrophy and Joint Destruction in a Rat Model of Rheumatoid Arthritis","Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease\u2010modifying antirheumatic drugs: A multi\u2010centre cohort study","Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis","Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases","The association between CYB5A gene rs1790834 polymorphism and clinical improvement after 6 months of leflunomide treatment in women with rheumatoid arthritis","What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines","EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis","Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets","Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?","Biologics Initiation in Rheumatoid Arthritis by Race and Ethnicity: Results From a Randomized Survey Study","Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus","Influence of chronic pain in osteoarthritis on the risk of cardiovascular diseases and modern methods of drug prevention","Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response","Connecting the use of innovative treatments and glucocorticoids with the multidisciplinary evaluation through rule-based natural-language processing: a real-world study on patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis","Fibromyalgia and mental health in rheumatoid arthritis: a cross-sectional prevalence study from the COVID-19 pandemic","YouTube\u00ae as a source of information for Spanish-speaking patients with rheumatoid arthritis","Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis","Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea","Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis","What is new in the treatment of interstitial lung diseases","The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases","The Mediterranean diet, and not dietary inflammatory index, is associated with rheumatoid arthritis disease activity, the impact of disease and functional disability","Serum &lt;scp&gt;CDC42&lt;/scp&gt; is increased during tumor necrosis factor inhibitor treatment, and its elevation correlates with satisfactory treatment response in rheumatoid arthritis patients","Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab)","Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment","Rhodiola rosea L. Extract, a Known Adaptogen, Evaluated in Experimental Arthritis","Pharmatherapeutic Treatment of Osteoarthrosis\u2014Does the Pill against Already Exist? A Narrative Review","Physical function and severe side effects matter most to patients with RA (&amp;lt; 5 years): a discrete choice experiment assessing preferences for personalized RA treatment"],"shape":[1424],"dtype":"object","order":"little"}],["year",{"type":"ndarray","array":{"type":"bytes","data":"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"},"shape":[1424],"dtype":"int32","order":"little"}],["doi",{"type":"ndarray","array":["https://doi.org/10.3389/fimmu.2020.01708","https://doi.org/10.1016/j.autrev.2020.102523","https://doi.org/10.1038/s41584-020-0419-z","https://doi.org/10.1136/annrheumdis-2021-220781","https://doi.org/10.1136/annrheumdis-2020-217344","https://doi.org/10.3390/cells10112857","https://doi.org/10.3389/fimmu.2021.708186","https://doi.org/10.1136/annrheumdis-2020-218398","https://doi.org/10.1016/j.jaut.2020.102468","https://doi.org/10.1038/s41584-021-00726-8","https://doi.org/10.2147/jir.s219586","https://doi.org/10.1002/jmv.26062","https://doi.org/10.3390/biom10071002","https://doi.org/10.1016/j.jbspin.2020.05.003","https://doi.org/10.1002/art.42030","https://doi.org/10.1136/ard-2022-223356","https://doi.org/10.3390/ijms21145171","https://doi.org/10.1002/art.41622","https://doi.org/10.1038/s41584-020-0395-3","https://doi.org/10.1136/annrheumdis-2021-221733","https://doi.org/10.3389/fmed.2020.601618","https://doi.org/10.1136/annrheumdis-2021-220973","https://doi.org/10.1681/asn.2020040523","https://doi.org/10.1016/j.autrev.2021.102758","https://doi.org/10.1136/annrheumdis-2020-218697","https://doi.org/10.1093/rheumatology/keaa860","https://doi.org/10.1016/j.jconrel.2020.09.016","https://doi.org/10.3390/cells9020475","https://doi.org/10.3389/fphar.2021.680043","https://doi.org/10.3389/fimmu.2021.686155","https://doi.org/10.1038/s41584-020-0491-4","https://doi.org/10.1038/s41584-021-00593-3","https://doi.org/10.1186/s41232-020-00133-8","https://doi.org/10.3389/fimmu.2020.587089","https://doi.org/10.1080/14656566.2020.1787381","https://doi.org/10.1007/s10067-020-05358-z","https://doi.org/10.1016/s2665-9913(21)00175-2","https://doi.org/10.1093/eurheartj/ehab447","https://doi.org/10.3390/cells10113017","https://doi.org/10.1016/j.autrev.2021.102797","https://doi.org/10.3390/ijms21114015","https://doi.org/10.3390/ijms22020686","https://doi.org/10.1080/1744666x.2021.1919086","https://doi.org/10.1136/rmdopen-2020-001174","https://doi.org/10.1136/bmj.m2288","https://doi.org/10.1016/j.autrev.2021.102750","https://doi.org/10.1111/1756-185x.13974","https://doi.org/10.3389/fimmu.2020.576134","https://doi.org/10.1136/rmdopen-2020-001512","https://doi.org/10.1016/j.exer.2021.108455","https://doi.org/10.1136/annrheumdis-2021-220266","https://doi.org/10.3389/fimmu.2020.01439","https://doi.org/10.3389/fimmu.2021.685312","https://doi.org/10.1016/j.biopha.2021.111880","https://doi.org/10.1136/rmdopen-2020-001220","https://doi.org/10.3390/ijms21144911","https://doi.org/10.1007/s40265-020-01349-1","https://doi.org/10.3389/fphar.2020.598308","https://doi.org/10.1007/s10067-021-05700-z","https://doi.org/10.1016/j.ejim.2021.07.016","https://doi.org/10.1136/annrheumdis-2021-221961","https://doi.org/10.3389/fmed.2020.607725","https://doi.org/10.3389/fimmu.2021.715894","https://doi.org/10.1080/14397595.2020.1782049","https://doi.org/10.1136/annrheumdis-2020-217425","https://doi.org/10.1038/s41584-022-00790-8","https://doi.org/10.1016/j.biopha.2022.113614","https://doi.org/10.1136/annrheumdis-2020-217171","https://doi.org/10.1007/s40264-020-01036-w","https://doi.org/10.1093/rheumatology/keab209","https://doi.org/10.3390/ijms22052449","https://doi.org/10.1038/s41409-021-01326-6","https://doi.org/10.1186/s13102-022-00397-2","https://doi.org/10.1136/annrheumdis-2020-218456","https://doi.org/10.3390/nu13010107","https://doi.org/10.1007/s00296-021-04863-x","https://doi.org/10.1136/annrheumdis-2021-220577","https://doi.org/10.1136/annrheumdis-2020-217811","https://doi.org/10.1007/s00296-020-04547-y","https://doi.org/10.3390/jcm9113599","https://doi.org/10.1186/s13075-020-02354-1","https://doi.org/10.1177/1759720x211073001","https://doi.org/10.1016/j.jaut.2020.102425","https://doi.org/10.1007/s40744-020-00199-3","https://doi.org/10.1136/annrheumdis-2020-219547","https://doi.org/10.1007/s00198-021-05871-0","https://doi.org/10.3390/ijms21217916","https://doi.org/10.3390/jcm10030509","https://doi.org/10.1016/j.carbpol.2021.118923","https://doi.org/10.3390/ijms23052871","https://doi.org/10.1016/j.coph.2020.08.002","https://doi.org/10.3346/jkms.2020.35.e423","https://doi.org/10.1016/j.cmi.2020.12.003","https://doi.org/10.2147/ppa.s289692","https://doi.org/10.1016/j.phrs.2021.105445","https://doi.org/10.3390/jcm10061241","https://doi.org/10.1097/rhu.0000000000001749","https://doi.org/10.1016/j.ebiom.2021.103427","https://doi.org/10.1186/s13063-020-04731-2","https://doi.org/10.1177/1759720x20964031","https://doi.org/10.1007/s40265-020-01448-z","https://doi.org/10.1016/j.phrs.2021.105618","https://doi.org/10.1186/s13075-021-02526-7","https://doi.org/10.1093/mr/roac017","https://doi.org/10.1093/rheumatology/keaa922","https://doi.org/10.2147/oarrr.s306378","https://doi.org/10.1177/1759720x211015006","https://doi.org/10.1093/rheumatology/keab632","https://doi.org/10.3390/ijms222111592","https://doi.org/10.1080/1744666x.2020.1858803","https://doi.org/10.1007/s00223-021-00873-w","https://doi.org/10.1039/d1nr03623h","https://doi.org/10.1111/1756-185x.14217","https://doi.org/10.1021/acsnano.1c03726","https://doi.org/10.3389/fimmu.2021.789334","https://doi.org/10.3390/jpm12030444","https://doi.org/10.1007/s10067-022-06122-1","https://doi.org/10.1136/ard-2022-223357","https://doi.org/10.3390/jcm9041227","https://doi.org/10.1038/s41572-020-0168-y","https://doi.org/10.1111/1756-185x.13833","https://doi.org/10.1371/journal.pone.0235637","https://doi.org/10.3390/s20174797","https://doi.org/10.1136/rmdopen-2020-001290","https://doi.org/10.1080/14740338.2020.1839411","https://doi.org/10.1093/rheumatology/keab078","https://doi.org/10.3390/ijms22031185","https://doi.org/10.1136/annrheumdis-2020-219825","https://doi.org/10.3390/pharmaceutics13040454","https://doi.org/10.1007/s40744-021-00330-y","https://doi.org/10.1002/adfm.202104640","https://doi.org/10.1186/s12891-021-04624-8","https://doi.org/10.3389/fphar.2021.726490","https://doi.org/10.3390/biom10111479","https://doi.org/10.3390/jpm10040271","https://doi.org/10.3390/nu12123800","https://doi.org/10.3390/jpm11010044","https://doi.org/10.1016/j.clim.2021.108680","https://doi.org/10.1136/rmdopen-2020-001525","https://doi.org/10.1186/s13075-021-02582-z","https://doi.org/10.1002/art.41726","https://doi.org/10.1177/1759720x21999564","https://doi.org/10.1155/2021/6652845","https://doi.org/10.1186/s13075-021-02567-y","https://doi.org/10.1016/s0140-6736(22)00331-2","https://doi.org/10.1016/j.biopha.2022.113126","https://doi.org/10.1093/rap/rkaa020","https://doi.org/10.1007/s10787-020-00741-3","https://doi.org/10.1111/cts.12883","https://doi.org/10.1080/14656566.2020.1822325","https://doi.org/10.3390/biom10121672","https://doi.org/10.1093/rheumatology/keab014","https://doi.org/10.1016/j.jbspin.2021.105143","https://doi.org/10.1097/rhu.0000000000001720","https://doi.org/10.1080/14397595.2021.1902617","https://doi.org/10.1080/25785826.2021.1928383","https://doi.org/10.3390/ijms22116114","https://doi.org/10.1016/j.jbspin.2021.105242","https://doi.org/10.1016/j.colsurfb.2021.111952","https://doi.org/10.1093/ecco-jcc/jjab206","https://doi.org/10.1186/s13075-021-02691-9","https://doi.org/10.1016/j.jconrel.2022.01.029","https://doi.org/10.1177/1759720x221076211","https://doi.org/10.1101/2022.02.25.481990","https://doi.org/10.1016/j.coph.2022.102227","https://doi.org/10.1136/ard-2022-223358","https://doi.org/10.1007/s10067-020-05087-3","https://doi.org/10.3390/ijms21186632","https://doi.org/10.3904/kjim.2020.417","https://doi.org/10.1038/s41598-020-74185-8","https://doi.org/10.1021/acscombsci.0c00169","https://doi.org/10.1155/2020/4031015","https://doi.org/10.2147/itt.s277991","https://doi.org/10.1093/rheumatology/keaa892","https://doi.org/10.3390/cells10020323","https://doi.org/10.1016/j.trsl.2021.02.007","https://doi.org/10.1038/s41392-021-00496-5","https://doi.org/10.1186/s13075-021-02478-y","https://doi.org/10.3390/nu13041268","https://doi.org/10.3389/fphar.2021.644187","https://doi.org/10.1016/j.jconrel.2021.05.008","https://doi.org/10.1186/s13075-021-02560-5","https://doi.org/10.1111/bcp.15101","https://doi.org/10.1093/rheumatology/keab609","https://doi.org/10.1038/s12276-022-00725-z","https://doi.org/10.3389/fimmu.2022.881705","https://doi.org/10.3390/jpm12030499","https://doi.org/10.1007/s00296-022-05136-x","https://doi.org/10.1007/s11010-022-04492-3","https://doi.org/10.1007/s40265-022-01821-0","https://doi.org/10.1136/annrheumdis-2020-218802","https://doi.org/10.1093/rheumatology/keaa834","https://doi.org/10.1007/s10067-021-05609-7","https://doi.org/10.1136/rmdopen-2020-001511","https://doi.org/10.1007/s10067-021-05614-w","https://doi.org/10.1080/14397595.2021.1886653","https://doi.org/10.3389/fimmu.2021.630170","https://doi.org/10.1093/rheumatology/keab204","https://doi.org/10.1186/s12929-021-00714-w","https://doi.org/10.1093/rheumatology/keab317","https://doi.org/10.1371/journal.pone.0250877","https://doi.org/10.1136/rmdopen-2021-001637","https://doi.org/10.1186/s13075-021-02562-3","https://doi.org/10.1093/rheumatology/keab647","https://doi.org/10.1186/s41232-021-00173-8","https://doi.org/10.1186/s13075-021-02651-3","https://doi.org/10.3390/pharmaceutics13122104","https://doi.org/10.1016/j.bbrc.2022.02.003","https://doi.org/10.1038/s41584-022-00768-6","https://doi.org/10.1111/1756-185x.14286","https://doi.org/10.1093/rheumatology/keac440","https://doi.org/10.1136/ard-2022-223335","https://doi.org/10.1136/ard-2022-223365","https://doi.org/10.1007/s11926-020-00921-8","https://doi.org/10.1186/s13075-020-02269-x","https://doi.org/10.1007/s10067-020-05363-2","https://doi.org/10.3389/fimmu.2020.572475","https://doi.org/10.1007/s40744-020-00230-7","https://doi.org/10.1016/j.bcp.2020.114360","https://doi.org/10.1016/j.semarthrit.2020.09.016","https://doi.org/10.1097/bor.0000000000000788","https://doi.org/10.1002/acr.24586","https://doi.org/10.1097/bor.0000000000000792","https://doi.org/10.1038/s41598-021-86335-7","https://doi.org/10.1093/rheumatology/keab276","https://doi.org/10.1177/1759720x211002682","https://doi.org/10.1186/s13075-021-02496-w","https://doi.org/10.3389/fimmu.2021.663736","https://doi.org/10.1111/fcp.12695","https://doi.org/10.1007/s40744-021-00325-9","https://doi.org/10.1186/s12891-021-04392-5","https://doi.org/10.1371/journal.pone.0260254","https://doi.org/10.1038/s41598-021-94504-x","https://doi.org/10.1093/rheumatology/keab643","https://doi.org/10.2147/btt.s252575","https://doi.org/10.1007/s40744-021-00379-9","https://doi.org/10.1097/rhu.0000000000001804","https://doi.org/10.1093/mr/roab087","https://doi.org/10.1002/jcph.2006","https://doi.org/10.1002/acr.24834","https://doi.org/10.1002/acr.24847","https://doi.org/10.1136/rmdopen-2021-001959","https://doi.org/10.1007/s40744-021-00361-5","https://doi.org/10.1016/j.smim.2021.101519","https://doi.org/10.1080/1744666x.2022.2039630","https://doi.org/10.1136/lupus-2021-000634","https://doi.org/10.1136/annrheumdis-2022-222228","https://doi.org/10.1111/all.15439","https://doi.org/10.1136/rmdopen-2022-002387","https://doi.org/10.1136/ard-2022-223413","https://doi.org/10.1007/s40744-020-00201-y","https://doi.org/10.1097/md.0000000000020642","https://doi.org/10.1186/s13075-020-02275-z","https://doi.org/10.1007/s12325-020-01437-4","https://doi.org/10.1016/j.semarthrit.2020.07.003","https://doi.org/10.1038/s41584-020-00521-x","https://doi.org/10.1111/jocn.15531","https://doi.org/10.1136/annrheumdis-2020-218798","https://doi.org/10.3389/fgene.2020.572194","https://doi.org/10.1016/j.ijid.2020.12.018","https://doi.org/10.5114/reum.2020.101400","https://doi.org/10.1136/rmdopen-2020-001498","https://doi.org/10.1136/rmdopen-2020-001539","https://doi.org/10.1007/s10067-021-05613-x","https://doi.org/10.1136/annrheumdis-2021-220112","https://doi.org/10.1136/annrheumdis-2021-220202","https://doi.org/10.1038/s41401-021-00665-w","https://doi.org/10.1097/md.0000000000025481","https://doi.org/10.2147/oarrr.s282627","https://doi.org/10.1093/rheumatology/keab548","https://doi.org/10.2147/oarrr.s322086","https://doi.org/10.1007/s40261-021-01055-0","https://doi.org/10.1136/annrheumdis-2021-220750","https://doi.org/10.1155/2021/6623912","https://doi.org/10.1038/s41598-021-97713-6","https://doi.org/10.1111/jre.12925","https://doi.org/10.1016/s2665-9913(21)00220-4","https://doi.org/10.1136/annrheumdis-2021-221007","https://doi.org/10.1080/15360288.2021.1973647","https://doi.org/10.1016/j.semarthrit.2021.10.001","https://doi.org/10.1136/rmdopen-2021-001882","https://doi.org/10.3390/biomedicines10010044","https://doi.org/10.3389/fmed.2021.791715","https://doi.org/10.1016/j.autrev.2021.103016","https://doi.org/10.1016/j.nantod.2021.101367","https://doi.org/10.1136/annrheumdis-2021-221307","https://doi.org/10.3390/ijms23031246","https://doi.org/10.3389/fped.2022.820586","https://doi.org/10.1186/s12913-021-07425-w","https://doi.org/10.2147/jir.s353539","https://doi.org/10.1007/s00726-022-03185-x","https://doi.org/10.1080/1744666x.2022.2106970","https://doi.org/10.1136/ard-2022-222824","https://doi.org/10.3389/fimmu.2023.1125246","https://doi.org/10.1002/acr.24237","https://doi.org/10.1016/s0140-6736(20)30800-x","https://doi.org/10.3390/jcm9051590","https://doi.org/10.1097/bor.0000000000000727","https://doi.org/10.2174/1389200221666200719004035","https://doi.org/10.1007/s10067-020-05347-2","https://doi.org/10.1016/j.rdc.2020.07.005","https://doi.org/10.1002/acr.24464","https://doi.org/10.7573/dic.2020-7-5","https://doi.org/10.47360/1995-4484-2020-532-543","https://doi.org/10.1093/rheumatology/keaa845","https://doi.org/10.1177/1759720x20959971","https://doi.org/10.1007/s10067-020-05567-6","https://doi.org/10.1186/s13075-021-02612-w","https://doi.org/10.1155/2021/8850820","https://doi.org/10.1007/s42399-021-00727-4","https://doi.org/10.1007/s00296-021-04804-8","https://doi.org/10.1002/art.41720","https://doi.org/10.1016/j.jtauto.2021.100087","https://doi.org/10.1080/03007995.2021.1906637","https://doi.org/10.1186/s13020-021-00448-9","https://doi.org/10.3390/antiox10040599","https://doi.org/10.1093/rheumatology/keab398","https://doi.org/10.3899/jrheum.201248","https://doi.org/10.1002/acr.24640","https://doi.org/10.1016/j.semarthrit.2021.06.002","https://doi.org/10.3390/jcm10163458","https://doi.org/10.1016/j.semarthrit.2021.08.006","https://doi.org/10.1007/s40744-021-00357-1","https://doi.org/10.1007/s40744-021-00365-1","https://doi.org/10.3390/ijms221910220","https://doi.org/10.1093/rheumatology/keab741","https://doi.org/10.1007/s10792-021-02058-8","https://doi.org/10.3390/ph15010011","https://doi.org/10.3389/fimmu.2021.755844","https://doi.org/10.1016/j.autrev.2022.103031","https://doi.org/10.1016/j.bcp.2022.114929","https://doi.org/10.1186/s13075-021-02671-z","https://doi.org/10.3390/life12010077","https://doi.org/10.3390/ijms23042366","https://doi.org/10.1093/rheumatology/keac114","https://doi.org/10.3389/fimmu.2022.829409","https://doi.org/10.3389/fmed.2022.837133","https://doi.org/10.1016/j.bone.2022.116468","https://doi.org/10.3389/fmed.2022.930071","https://doi.org/10.1016/j.rdc.2022.03.005","https://doi.org/10.1186/s13075-022-02858-y","https://doi.org/10.1136/ard-2022-223044","https://doi.org/10.1016/j.berh.2020.101528","https://doi.org/10.1080/14740338.2020.1779219","https://doi.org/10.1007/s00296-020-04660-y","https://doi.org/10.1080/14712598.2020.1802421","https://doi.org/10.1620/tjem.252.133","https://doi.org/10.1002/acr.24243","https://doi.org/10.1080/14712598.2021.1847268","https://doi.org/10.1080/14737159.2020.1857734","https://doi.org/10.1007/s40744-020-00270-z","https://doi.org/10.1186/s13075-020-02393-8","https://doi.org/10.1093/rap/rkaa077","https://doi.org/10.1007/s40744-020-00272-x","https://doi.org/10.1080/14397595.2021.1879362","https://doi.org/10.1111/1346-8138.15754","https://doi.org/10.1155/2021/6663708","https://doi.org/10.2147/ceor.s293698","https://doi.org/10.1093/rheumatology/keab148","https://doi.org/10.1371/journal.pone.0247709","https://doi.org/10.1007/s10067-021-05710-x","https://doi.org/10.1007/s40744-021-00284-1","https://doi.org/10.1080/1744666x.2021.1908887","https://doi.org/10.1007/s12325-021-01733-7","https://doi.org/10.1302/2046-3758.104.bjr-2020-0331.r1","https://doi.org/10.1177/1759720x211004326","https://doi.org/10.1093/rheumatology/keab330","https://doi.org/10.47360/1995-4484-2021-141-151","https://doi.org/10.1007/s40744-021-00310-2","https://doi.org/10.3389/fphar.2021.679588","https://doi.org/10.1093/rheumatology/keab464","https://doi.org/10.3389/fimmu.2021.701922","https://doi.org/10.3389/fimmu.2021.692041","https://doi.org/10.3390/jpm11060573","https://doi.org/10.1186/s42358-021-00186-4","https://doi.org/10.1007/s13346-021-01038-w","https://doi.org/10.2169/internalmedicine.8205-21","https://doi.org/10.1016/j.jbspin.2021.105285","https://doi.org/10.3390/molecules26216583","https://doi.org/10.1007/s40744-021-00401-0","https://doi.org/10.1080/1744666x.2022.2017773","https://doi.org/10.1016/j.berh.2021.101735","https://doi.org/10.1093/rheumatology/keab917","https://doi.org/10.1093/rheumatology/keac068","https://doi.org/10.1093/rheumatology/keab902","https://doi.org/10.1002/ptr.7444","https://doi.org/10.1093/rheumatology/keac213","https://doi.org/10.1136/annrheumdis-2022-222338","https://doi.org/10.1093/rheumatology/keac285","https://doi.org/10.1016/j.autrev.2022.103117","https://doi.org/10.2967/jnumed.121.263774","https://doi.org/10.1016/j.semarthrit.2022.152031","https://doi.org/10.3390/medicina58070931","https://doi.org/10.1007/s10067-022-06307-8","https://doi.org/10.1136/annrheumdis-2019-216821","https://doi.org/10.3390/jcm9051528","https://doi.org/10.14412/1996-7012-2020-2-27-34","https://doi.org/10.1080/14656566.2020.1779703","https://doi.org/10.1136/annrheumdis-2020-217207","https://doi.org/10.1111/eci.13363","https://doi.org/10.1136/rmdopen-2020-001398","https://doi.org/10.1007/s12325-020-01501-z","https://doi.org/10.1007/s10067-020-05458-w","https://doi.org/10.1002/acr.24524","https://doi.org/10.2147/jir.s282249","https://doi.org/10.3390/md19010010","https://doi.org/10.1016/j.intimp.2020.107273","https://doi.org/10.1080/14397595.2021.1879429","https://doi.org/10.1007/s00296-021-04800-y","https://doi.org/10.1093/rheumatology/keab151","https://doi.org/10.3899/jrheum.201135","https://doi.org/10.3899/jrheum.201467","https://doi.org/10.1007/s12325-021-01730-w","https://doi.org/10.1080/14397595.2021.1912922","https://doi.org/10.1136/annrheumdis-2021-220315","https://doi.org/10.1080/21678707.2021.1932458","https://doi.org/10.1093/rheumatology/keab429","https://doi.org/10.1136/annrheumdis-2021-220403","https://doi.org/10.1177/1759720x211011826","https://doi.org/10.1016/j.jns.2021.117530","https://doi.org/10.1111/eci.13635","https://doi.org/10.3390/jcm10132944","https://doi.org/10.1136/dtb.2020.000061","https://doi.org/10.3390/ijms22168662","https://doi.org/10.1016/j.lanwpc.2021.100240","https://doi.org/10.1007/s40744-021-00356-2","https://doi.org/10.1136/rmdopen-2021-001616","https://doi.org/10.1002/cpt.2415","https://doi.org/10.1136/rmdopen-2021-001653","https://doi.org/10.3390/ijms222111561","https://doi.org/10.1002/acr2.11334","https://doi.org/10.3389/fimmu.2021.776879","https://doi.org/10.3390/jcm10225259","https://doi.org/10.3390/pharmaceutics13121994","https://doi.org/10.1093/mr/roab126","https://doi.org/10.1007/s00296-021-05059-z","https://doi.org/10.1016/j.berh.2021.101737","https://doi.org/10.1093/rheumatology/keac024","https://doi.org/10.1007/s00108-021-01248-x","https://doi.org/10.3389/fmed.2021.764067","https://doi.org/10.1016/j.jid.2021.11.018","https://doi.org/10.1038/s41598-021-04075-0","https://doi.org/10.1007/s40744-022-00442-z","https://doi.org/10.1186/s13075-022-02751-8","https://doi.org/10.1186/s13075-022-02746-5","https://doi.org/10.1016/j.ejmech.2022.114382","https://doi.org/10.3390/ijms23084111","https://doi.org/10.3389/fimmu.2022.883287","https://doi.org/10.3390/jpm12030353","https://doi.org/10.1080/1744666x.2022.2064275","https://doi.org/10.1016/j.semarthrit.2020.03.022","https://doi.org/10.3389/fimmu.2022.901437","https://doi.org/10.1007/s12010-022-04011-6","https://doi.org/10.1155/2022/6379161","https://doi.org/10.1136/ard-2022-222784","https://doi.org/10.3389/fmed.2022.991677","https://doi.org/10.1001/jamadermatol.2022.3337","https://doi.org/10.1136/ard-2022-222835","https://doi.org/10.3389/fimmu.2022.998554","https://doi.org/10.3389/fimmu.2022.944387","https://doi.org/10.3389/fmicb.2022.931431","https://doi.org/10.1016/j.autrev.2022.103217","https://doi.org/10.1111/bcp.15579","https://doi.org/10.3390/jpm12111905","https://doi.org/10.1016/j.pharmthera.2022.108327","https://doi.org/10.1002/art.42463","https://doi.org/10.1016/s2665-9913(20)30175-2","https://doi.org/10.31138/mjr.31.1.120","https://doi.org/10.3390/jpm10040150","https://doi.org/10.1111/1756-185x.13996","https://doi.org/10.1007/s10067-020-05456-y","https://doi.org/10.17116/kurort20209705192","https://doi.org/10.3390/jcm9103319","https://doi.org/10.3390/jpm10040220","https://doi.org/10.1177/2040622320975241","https://doi.org/10.1007/s12325-020-01572-y","https://doi.org/10.1007/s40744-021-00322-y","https://doi.org/10.1016/j.intimp.2020.107260","https://doi.org/10.1177/1759720x20986734","https://doi.org/10.1016/j.jbspin.2021.105137","https://doi.org/10.1093/rheumatology/keab130","https://doi.org/10.2174/1874312902115010001","https://doi.org/10.1080/03009742.2020.1855365","https://doi.org/10.3803/enm.2021.970","https://doi.org/10.1016/j.reuma.2020.10.006","https://doi.org/10.1080/14397595.2021.1910615","https://doi.org/10.1093/rheumatology/keab313","https://doi.org/10.1109/lifetech52111.2021.9391953","https://doi.org/10.2147/jir.s284405","https://doi.org/10.1111/imj.15336","https://doi.org/10.1111/1756-185x.14127","https://doi.org/10.1093/rheumatology/keab496","https://doi.org/10.1007/s00296-021-04944-x","https://doi.org/10.1007/s10067-021-05853-x","https://doi.org/10.1093/rheumatology/keab631","https://doi.org/10.1080/14656566.2021.1967929","https://doi.org/10.1093/rheumatology/keab658","https://doi.org/10.3389/fimmu.2021.638814","https://doi.org/10.2217/bmm-2021-0070","https://doi.org/10.1007/s00296-021-04985-2","https://doi.org/10.1080/03009742.2021.1947005","https://doi.org/10.1136/rmdopen-2021-001795","https://doi.org/10.3899/jrheum.210984","https://doi.org/10.1136/rmdopen-2021-001804","https://doi.org/10.3389/fmed.2021.757102","https://doi.org/10.1371/journal.pone.0259389","https://doi.org/10.1093/rap/rkab052","https://doi.org/10.1186/s42358-021-00228-x","https://doi.org/10.1093/mr/roab108","https://doi.org/10.1186/s41927-021-00226-y","https://doi.org/10.1007/s40744-021-00404-x","https://doi.org/10.1016/j.jep.2021.114907","https://doi.org/10.1080/14712598.2022.2012146","https://doi.org/10.1093/rap/rkab099","https://doi.org/10.1007/s40744-021-00423-8","https://doi.org/10.1016/j.semarthrit.2022.151952","https://doi.org/10.1186/s13102-022-00408-2","https://doi.org/10.1016/j.amjmed.2022.01.017","https://doi.org/10.1093/rheumatology/keac075","https://doi.org/10.1093/rap/rkac002","https://doi.org/10.1093/ckj/sfac036","https://doi.org/10.1177/1759720x221074457","https://doi.org/10.1136/annrheumdis-2021-221323","https://doi.org/10.1016/s2665-9913(22)00008-x","https://doi.org/10.1371/journal.pone.0264628","https://doi.org/10.1093/rheumatology/keac136","https://doi.org/10.3390/jcm11071799","https://doi.org/10.1007/s00296-021-05086-w","https://doi.org/10.1007/s40744-022-00441-0","https://doi.org/10.1016/j.ymben.2022.03.006","https://doi.org/10.1016/s2665-9913(22)00092-3","https://doi.org/10.1007/s10067-022-06185-0","https://doi.org/10.46497/archrheumatol.2021.8524","https://doi.org/10.1097/ede.0000000000001422","https://doi.org/10.1371/journal.pone.0266816","https://doi.org/10.1016/j.phrs.2022.106246","https://doi.org/10.47360/1995-4484-2022-131-148","https://doi.org/10.1111/imj.15816","https://doi.org/10.1016/j.ejim.2022.05.014","https://doi.org/10.1186/s13075-022-02817-7","https://doi.org/10.1186/s13075-022-02807-9","https://doi.org/10.1080/17476348.2022.2089116","https://doi.org/10.1016/j.semarthrit.2022.152050","https://doi.org/10.3389/fimmu.2022.923582","https://doi.org/10.1136/annrheumdis-2022-222517","https://doi.org/10.1136/annrheumdis-2021-221807","https://doi.org/10.3389/fmed.2022.921675","https://doi.org/10.1097/mcp.0000000000000906","https://doi.org/10.1093/mr/roac085","https://doi.org/10.1111/1756-185x.14405","https://doi.org/10.1111/1756-185x.14414","https://doi.org/10.1007/s10067-022-06329-2","https://doi.org/10.3389/fmed.2022.689711","https://doi.org/10.3390/pharmaceutics14081648","https://doi.org/10.1186/s12916-022-02587-8","https://doi.org/10.1002/art.42347","https://doi.org/10.2147/oarrr.s285407","https://doi.org/10.3390/organoids1020011","https://doi.org/10.1016/j.jconrel.2022.11.018","https://doi.org/10.1021/acs.jmedchem.2c01082","https://doi.org/10.1016/j.intimp.2022.109484","https://doi.org/10.1186/s41232-022-00221-x","https://doi.org/10.3390/life13020361","https://doi.org/10.1038/s41584-020-0443-z","https://doi.org/10.2217/imt-2020-0086","https://doi.org/10.2217/imt-2020-0071","https://doi.org/10.1109/hsi49210.2020.9142640","https://doi.org/10.1007/s10067-020-05357-0","https://doi.org/10.1016/j.clim.2020.108592","https://doi.org/10.7326/m20-6010","https://doi.org/10.1155/2020/4873648","https://doi.org/10.3390/jcm9103219","https://doi.org/10.1080/14737167.2021.1834384","https://doi.org/10.1056/nejme2026142","https://doi.org/10.1093/rheumatology/keaa724","https://doi.org/10.5772/intechopen.92771","https://doi.org/10.3390/app10238600","https://doi.org/10.33667/2078-5631-2020-31-43-47","https://doi.org/10.1080/14397595.2021.1883251","https://doi.org/10.23736/s0026-4806.21.06902-0","https://doi.org/10.1093/rap/rkab004","https://doi.org/10.1186/s41927-020-00173-0","https://doi.org/10.1016/s2665-9913(21)00013-8","https://doi.org/10.5124/jkma.2021.64.2.105","https://doi.org/10.1007/s40259-021-00467-w","https://doi.org/10.1136/rmdopen-2020-001560","https://doi.org/10.3390/sym13040538","https://doi.org/10.1016/j.intimp.2021.107565","https://doi.org/10.1186/s12891-021-04192-x","https://doi.org/10.1093/rheumatology/keab274","https://doi.org/10.1111/1756-185x.14100","https://doi.org/10.1093/rheumatology/keab403","https://doi.org/10.1080/14740338.2021.1924146","https://doi.org/10.1136/rmdopen-2021-001601","https://doi.org/10.1007/s10396-021-01102-5","https://doi.org/10.1136/annrheumdis-2021-220265","https://doi.org/10.3390/ijerph18115679","https://doi.org/10.3389/fmed.2021.627004","https://doi.org/10.1093/rheumatology/keab472","https://doi.org/10.1007/s10067-021-05815-3","https://doi.org/10.2147/ppa.s316263","https://doi.org/10.3390/clinpract11030055","https://doi.org/10.1007/s10067-021-05802-8","https://doi.org/10.1186/s13018-021-02603-2","https://doi.org/10.1097/md.0000000000026592","https://doi.org/10.1038/s41584-021-00667-2","https://doi.org/10.1177/1759720x211033679","https://doi.org/10.1007/s10067-021-05744-1","https://doi.org/10.1007/s12325-021-01867-8","https://doi.org/10.1002/acr.24762","https://doi.org/10.1007/s10067-021-05876-4","https://doi.org/10.1093/rheumatology/keab676","https://doi.org/10.1080/03007995.2021.1981278","https://doi.org/10.1016/j.jtauto.2021.100122","https://doi.org/10.1002/rai2.12006","https://doi.org/10.18295/squmj.9.2021.128","https://doi.org/10.3389/fmed.2021.708168","https://doi.org/10.1007/s10067-021-05961-8","https://doi.org/10.3389/fimmu.2021.744022","https://doi.org/10.1080/14737159.2021.2000394","https://doi.org/10.3389/fcell.2021.728821","https://doi.org/10.1186/s41927-021-00215-1","https://doi.org/10.1002/14651858.cd014898","https://doi.org/10.2196/31570","https://doi.org/10.1016/j.amsu.2021.103085","https://doi.org/10.1007/s40744-021-00396-8","https://doi.org/10.1093/rap/rkab087","https://doi.org/10.1002/14651858.cd014899","https://doi.org/10.4078/jrd.2022.29.1.22","https://doi.org/10.1007/s40744-021-00412-x","https://doi.org/10.1016/j.berh.2021.101725","https://doi.org/10.1097/jcma.0000000000000673","https://doi.org/10.3390/healthcare9121726","https://doi.org/10.1080/14740338.2022.2020247","https://doi.org/10.1002/14651858.cd014897","https://doi.org/10.1016/j.cellimm.2021.104476","https://doi.org/10.1007/s10067-021-05908-z","https://doi.org/10.1016/j.berh.2021.101741","https://doi.org/10.1093/mr/roab091","https://doi.org/10.1155/2022/7442289","https://doi.org/10.1093/rheumatology/keac081","https://doi.org/10.1021/acsabm.1c01205","https://doi.org/10.2147/dddt.s332282","https://doi.org/10.1038/s41598-022-06584-y","https://doi.org/10.1016/j.semarthrit.2022.151988","https://doi.org/10.1007/s12016-021-08918-6","https://doi.org/10.1136/bcr-2021-247276","https://doi.org/10.1016/j.cyto.2022.155837","https://doi.org/10.1007/s00296-021-05072-2","https://doi.org/10.1093/rap/rkac021","https://doi.org/10.1093/mr/roac020","https://doi.org/10.1080/14712598.2022.2066972","https://doi.org/10.3390/medicina58050571","https://doi.org/10.1007/s10067-022-06162-7","https://doi.org/10.1080/08916934.2022.2067985","https://doi.org/10.17116/jnevro202212203138","https://doi.org/10.1002/jcla.24449","https://doi.org/10.1093/rheumatology/keac261","https://doi.org/10.2147/pgpm.s350417","https://doi.org/10.1097/bor.0000000000000870","https://doi.org/10.2147/dddt.s350387","https://doi.org/10.1097/rhu.0000000000001767","https://doi.org/10.1080/1744666x.2021.1982383","https://doi.org/10.1007/s10067-022-06176-1","https://doi.org/10.1007/s10067-022-06205-z","https://doi.org/10.3390/jcm11112955","https://doi.org/10.1038/s41598-022-14440-2","https://doi.org/10.1007/s00223-022-01001-y","https://doi.org/10.1136/ard-2022-222679","https://doi.org/10.3389/fphar.2022.821616","https://doi.org/10.3899/jrheum.220209","https://doi.org/10.1136/rmdopen-2022-002458","https://doi.org/10.1155/2022/8316106","https://doi.org/10.1177/10600280221113092","https://doi.org/10.1093/mr/roac089","https://doi.org/10.3389/fphar.2022.927179","https://doi.org/10.1136/rmdopen-2022-002442","https://doi.org/10.1515/dmpt-2021-0236","https://doi.org/10.1093/rheumatology/keac476","https://doi.org/10.1080/14737167.2022.2117690","https://doi.org/10.7759/cureus.28357","https://doi.org/10.1093/mr/roac106","https://doi.org/10.3390/pharmaceutics14091942","https://doi.org/10.47360/1995-4484-2022-427-437","https://doi.org/10.3389/fmed.2022.1017650","https://doi.org/10.1007/s40744-022-00500-6","https://doi.org/10.1186/s13075-022-02918-3","https://doi.org/10.1016/j.coph.2022.102308","https://doi.org/10.3389/fmed.2022.1049875","https://doi.org/10.1080/03009742.2022.2121081","https://doi.org/10.1038/s41598-022-23152-6","https://doi.org/10.1016/j.jaut.2022.102950","https://doi.org/10.3390/ijms232213913","https://doi.org/10.47360/1995-4484-2022-505-518","https://doi.org/10.1186/s41927-022-00303-w","https://doi.org/10.3390/jpm12121984","https://doi.org/10.1016/j.lfs.2022.121302","https://doi.org/10.3389/fphar.2022.1090361","https://doi.org/10.1007/s00417-022-05946-6","https://doi.org/10.1186/s41927-022-00317-4","https://doi.org/10.7759/cureus.33404","https://doi.org/10.1186/s12985-023-01967-7","https://doi.org/10.1093/rheumatology/keac693","https://doi.org/10.1007/s00296-022-05263-5","https://doi.org/10.3390/clinpract13010016","https://doi.org/10.1002/cpt.2866","https://doi.org/10.1111/pai.13911","https://doi.org/10.1007/s40744-022-00519-9","https://doi.org/10.3389/fimmu.2023.1150162","https://doi.org/10.1038/s41584-020-0385-5","https://doi.org/10.36469/jheor.2020.12273","https://doi.org/10.1093/rap/rkaa015","https://doi.org/10.1007/s40267-020-00739-5","https://doi.org/10.1007/s00296-020-04607-3","https://doi.org/10.1080/14656566.2020.1774555","https://doi.org/10.1007/s40620-020-00776-3","https://doi.org/10.1080/14397595.2020.1782565","https://doi.org/10.47360/1995-4484-2020-420-427","https://doi.org/10.47360/1995-4484-2020-447-450","https://doi.org/10.4078/jrd.2020.27.4.218","https://doi.org/10.1080/17425255.2020.1832082","https://doi.org/10.1007/s10067-020-05451-3","https://doi.org/10.1016/j.reumae.2021.03.002","https://doi.org/10.1021/acs.molpharmaceut.0c00740","https://doi.org/10.1016/j.jbspin.2020.105112","https://doi.org/10.1093/rheumatology/keaa803","https://doi.org/10.47360/1995-4484-2020-663-672","https://doi.org/10.1136/annrheumdis-2021-219891","https://doi.org/10.3390/ph14020106","https://doi.org/10.1007/s00296-021-04814-6","https://doi.org/10.1136/bcr-2020-239112","https://doi.org/10.1093/jpp/rgab025","https://doi.org/10.1093/rheumatology/keab306","https://doi.org/10.21518/2079-701x-2021-2-76-84","https://doi.org/10.1016/j.med.2021.03.028","https://doi.org/10.1016/s2665-9913(21)00069-2","https://doi.org/10.1097/01.jaa.0000742944.34230.87","https://doi.org/10.1080/17512433.2021.1913050","https://doi.org/10.7705/biomedica.5416","https://doi.org/10.2478/rir-2021-0007","https://doi.org/10.1093/rap/rkab032","https://doi.org/10.1038/s41598-021-89502-y","https://doi.org/10.3390/pharmaceutics13050736","https://doi.org/10.1002/acr.24645","https://doi.org/10.1136/annrheumdis-2021-220494","https://doi.org/10.1007/s00296-021-04893-5","https://doi.org/10.3389/fmed.2021.669688","https://doi.org/10.1080/14656566.2021.1940136","https://doi.org/10.1007/s10067-021-05811-7","https://doi.org/10.36290/vnl.2021.052","https://doi.org/10.3389/fmed.2021.692557","https://doi.org/10.1007/s40268-021-00355-2","https://doi.org/10.33393/grhta.2021.2267","https://doi.org/10.1007/s10067-021-05860-y","https://doi.org/10.1016/j.rcreu.2021.03.015","https://doi.org/10.1016/j.ultrasmedbio.2021.06.007","https://doi.org/10.1093/rheumatology/keab582","https://doi.org/10.47360/1995-4484-2021-269-274","https://doi.org/10.1016/s2665-9913(21)00224-1","https://doi.org/10.1111/jocn.16003","https://doi.org/10.2147/oarrr.s322833","https://doi.org/10.1038/s41598-021-97444-8","https://doi.org/10.3390/jcm10184070","https://doi.org/10.1007/s10067-021-05914-1","https://doi.org/10.1007/s00393-021-01086-0","https://doi.org/10.1055/a-1577-2719","https://doi.org/10.2169/internalmedicine.7674-21","https://doi.org/10.1007/s00296-021-05026-8","https://doi.org/10.1002/msc.1595","https://doi.org/10.1093/mr/roab037","https://doi.org/10.2147/btt.s322860","https://doi.org/10.1186/s42358-021-00227-y","https://doi.org/10.1080/14737159.2022.2020648","https://doi.org/10.3238/arztebl.m2022.0067","https://doi.org/10.1186/s41687-021-00400-3","https://doi.org/10.1093/rheumatology/keab945","https://doi.org/10.1007/s40744-021-00405-w","https://doi.org/10.1097/md.0000000000028285","https://doi.org/10.1093/mr/roab129","https://doi.org/10.1007/s10067-022-06062-w","https://doi.org/10.1111/1756-185x.14281","https://doi.org/10.1002/acr.24830","https://doi.org/10.1093/rap/rkab107","https://doi.org/10.1093/mr/roab003","https://doi.org/10.1007/s11010-022-04354-y","https://doi.org/10.1080/03009742.2021.2003033","https://doi.org/10.3390/diagnostics12010182","https://doi.org/10.3389/fmed.2021.785744","https://doi.org/10.1007/s40744-022-00426-z","https://doi.org/10.1093/rheumatology/keac040","https://doi.org/10.1007/s40744-021-00418-5","https://doi.org/10.1038/s41598-022-06194-8","https://doi.org/10.1111/pin.13212","https://doi.org/10.1007/s40744-022-00427-y","https://doi.org/10.1177/03000605221088560","https://doi.org/10.1080/03007995.2022.2050108","https://doi.org/10.4103/jmu.jmu_146_21","https://doi.org/10.1136/bmjopen-2021-056352","https://doi.org/10.1016/j.autrev.2022.103085","https://doi.org/10.1002/acr2.11422","https://doi.org/10.1136/bmjopen-2021-052021","https://doi.org/10.1101/2022.04.08.22273582","https://doi.org/10.1186/s41927-022-00252-4","https://doi.org/10.3390/jpm12040641","https://doi.org/10.1001/jama.2022.2938","https://doi.org/10.3390/pharmaceutics14040877","https://doi.org/10.3899/jrheum.211199","https://doi.org/10.5582/ddt.2022.01028","https://doi.org/10.1089/tmj.2022.0078","https://doi.org/10.1007/s00296-022-05090-8","https://doi.org/10.3389/fmed.2022.839206","https://doi.org/10.1186/s12962-022-00347-2","https://doi.org/10.15557/jou.2022.0004","https://doi.org/10.31138/mjr.33.1.14","https://doi.org/10.1080/1744666x.2021.2000390","https://doi.org/10.14412/1996-7012-2022-2-13-20","https://doi.org/10.1007/s10067-022-06187-y","https://doi.org/10.1038/s41598-022-12271-9","https://doi.org/10.1093/mr/roac042","https://doi.org/10.1038/s41598-022-11879-1","https://doi.org/10.1093/rap/rkac038","https://doi.org/10.1002/acr.24958","https://doi.org/10.1007/s10067-022-06221-z","https://doi.org/10.1136/bmjopen-2021-058303","https://doi.org/10.1002/ijc.34140","https://doi.org/10.1136/annrheumdis-2022-222253","https://doi.org/10.1002/art.42249","https://doi.org/10.26442/00403660.2022.05.201489","https://doi.org/10.1007/s40744-022-00467-4","https://doi.org/10.1002/iid3.630","https://doi.org/10.1007/s10067-022-06245-5","https://doi.org/10.1016/j.xkme.2022.100504","https://doi.org/10.1080/17460441.2022.2093852","https://doi.org/10.1093/mr/roac073","https://doi.org/10.3390/jcm11144178","https://doi.org/10.1111/1346-8138.16524","https://doi.org/10.1016/j.semarthrit.2022.152076","https://doi.org/10.1097/rhu.0000000000001883","https://doi.org/10.1016/j.bbrc.2022.07.111","https://doi.org/10.1186/s13075-022-02884-w","https://doi.org/10.1177/1759720x221114101","https://doi.org/10.1177/1759720x221114107","https://doi.org/10.1093/mr/roac090","https://doi.org/10.2147/ppa.s374445","https://doi.org/10.1111/1756-185x.14423","https://doi.org/10.3389/fcimb.2022.973563","https://doi.org/10.1016/s2665-9913(22)00186-2","https://doi.org/10.1093/rheumatology/keac458","https://doi.org/10.1007/s00393-022-01259-5","https://doi.org/10.26693/jmbs07.04.019","https://doi.org/10.1093/rap/rkac071","https://doi.org/10.1093/rap/rkac074","https://doi.org/10.3390/molecules27185973","https://doi.org/10.1371/journal.pone.0272235","https://doi.org/10.1186/s13020-022-00670-z","https://doi.org/10.1177/1759720x221114105","https://doi.org/10.1007/s40744-022-00490-5","https://doi.org/10.1007/s00296-022-05206-0","https://doi.org/10.3390/biomedicines10102409","https://doi.org/10.1186/s12913-022-08591-1","https://doi.org/10.3389/fphar.2022.980832","https://doi.org/10.1186/s43166-022-00153-x","https://doi.org/10.2147/jir.s380642","https://doi.org/10.3390/biom12101483","https://doi.org/10.2147/dddt.s330413","https://doi.org/10.5009/gnl210551","https://doi.org/10.1016/j.semarthrit.2022.152118","https://doi.org/10.3390/pharmaceutics14112328","https://doi.org/10.1016/j.bbrc.2022.10.106","https://doi.org/10.1097/rhu.0000000000001913","https://doi.org/10.1007/s10787-022-01088-7","https://doi.org/10.3389/fmed.2022.1011734","https://doi.org/10.1038/s41598-022-24027-6","https://doi.org/10.3389/fphar.2022.1075603","https://doi.org/10.2147/oarrr.s385423","https://doi.org/10.1093/rheumatology/keac645","https://doi.org/10.3390/jcm11236894","https://doi.org/10.1016/j.jbspin.2022.105496","https://doi.org/10.1016/j.molimm.2022.11.016","https://doi.org/10.3389/fmed.2022.1027347","https://doi.org/10.1016/j.ejim.2022.11.024","https://doi.org/10.1016/j.jocd.2022.12.003","https://doi.org/10.1016/j.bioactmat.2022.12.001","https://doi.org/10.1186/s41927-022-00304-9","https://doi.org/10.1002/advs.202204998","https://doi.org/10.3389/fimmu.2022.1074329","https://doi.org/10.1136/ard-2022-223443","https://doi.org/10.1186/s41927-022-00305-8","https://doi.org/10.1093/rheumatology/keac708","https://doi.org/10.1016/j.gene.2022.147123","https://doi.org/10.1093/rheumatology/keac709","https://doi.org/10.1186/s41927-022-00308-5","https://doi.org/10.1001/jamanetworkopen.2022.46299","https://doi.org/10.1093/rheumatology/keac721","https://doi.org/10.1186/s41927-022-00322-7","https://doi.org/10.1136/rmdopen-2022-002614","https://doi.org/10.1016/b978-0-323-95061-9.00049-7","https://doi.org/10.1093/rheumatology/keac710","https://doi.org/10.3390/jcm12010286","https://doi.org/10.1186/s41927-022-00324-5","https://doi.org/10.3390/ijms24021027","https://doi.org/10.3390/medicina59010167","https://doi.org/10.1093/rheumatology/kead021","https://doi.org/10.3390/jcm12020527","https://doi.org/10.1080/14740338.2023.2172157","https://doi.org/10.3390/life13020319","https://doi.org/10.1080/25785826.2023.2170384","https://doi.org/10.1186/s41927-022-00319-2","https://doi.org/10.1007/s40744-023-00534-4","https://doi.org/10.1111/iej.13902","https://doi.org/10.3389/fimmu.2023.1098977","https://doi.org/10.1136/rmdopen-2022-002722","https://doi.org/10.3390/nu15040963","https://doi.org/10.1093/rheumatology/kead079","https://doi.org/10.3389/fphar.2023.1089272","https://doi.org/10.1093/rheumatology/kead088","https://doi.org/10.3390/jcm12051734","https://doi.org/10.1080/14712598.2023.2185132","https://doi.org/10.1007/s00296-023-05289-3","https://doi.org/10.1148/radiol.222052","https://doi.org/10.22540/jfsf-08-044","https://doi.org/10.1016/j.jconrel.2023.02.035","https://doi.org/10.1177/1759720x231158618","https://doi.org/10.1016/s2665-9913(23)00070-x","https://doi.org/10.1093/rap/rkad015","https://doi.org/10.47360/1995-4484-2023-165-180","https://doi.org/10.1136/bmj-2022-074678","https://doi.org/10.1038/s41584-020-0411-7","https://doi.org/10.1002/art.41268","https://doi.org/10.5772/intechopen.91965","https://doi.org/10.1002/psb.1836","https://doi.org/10.1136/annrheumdis-2020-217705","https://doi.org/10.3390/jcm9062017","https://doi.org/10.1007/s00761-020-00801-x","https://doi.org/10.5772/intechopen.92989","https://doi.org/10.1136/annrheumdis-2020-218403","https://doi.org/10.1136/annrheumdis-2020-218731","https://doi.org/10.1093/rheumatology/keaa343","https://doi.org/10.1093/rheumatology/keaa488","https://doi.org/10.1101/804609",{"type":"number","value":"nan"},"https://doi.org/10.1093/rap/rkaa059","https://doi.org/10.3389/fphar.2020.572260","https://doi.org/10.1016/j.rhum.2020.10.075","https://doi.org/10.1080/14397595.2020.1864914","https://doi.org/10.1007/s00296-020-04762-7","https://doi.org/10.1136/bmjopen-2020-041420","https://doi.org/10.1016/j.rcreue.2020.06.009","https://doi.org/10.1007/s10067-021-05599-6","https://doi.org/10.1080/14397595.2021.1879367","https://doi.org/10.1055/a-1340-0000","https://doi.org/10.1080/14397595.2021.1883252","https://doi.org/10.5124/jkma.2021.64.2.95","https://doi.org/10.1186/s13075-021-02440-y","https://doi.org/10.5124/jkma.2021.64.2.90","https://doi.org/10.1093/rheumatology/keab195","https://doi.org/10.3899/jrheum.201430","https://doi.org/10.1007/s00393-021-00973-w","https://doi.org/10.1016/j.jbspin.2021.105172","https://doi.org/10.1007/s00393-021-00992-7","https://doi.org/10.1002/art.41746","https://doi.org/10.2147/oarrr.s300838","https://doi.org/10.1016/s1169-8330(21)00104-6","https://doi.org/10.1111/1756-185x.14108","https://doi.org/10.5124/jkma.2021.64.4.264","https://doi.org/10.1007/s12688-021-00427-w","https://doi.org/10.1007/s40744-021-00311-1","https://doi.org/10.1093/rheumatology/keaa864","https://doi.org/10.1016/j.rhum.2021.05.004","https://doi.org/10.1016/j.jbspin.2021.105174","https://doi.org/10.1093/rheumatology/keab425","https://doi.org/10.1097/md.0000000000025790","https://doi.org/10.1136/annrheumdis-2021-220477","https://doi.org/10.26442/00403660.2021.03.200656","https://doi.org/10.1016/j.rhum.2021.05.002","https://doi.org/10.1016/j.yacr.2021.04.001","https://doi.org/10.1016/b978-0-12-820472-6.00073-6","https://doi.org/10.3389/fphar.2021.707811","https://doi.org/10.1007/s00296-021-04939-8","https://doi.org/10.1002/acr2.11303","https://doi.org/10.1038/s41397-021-00238-4","https://doi.org/10.17826/cumj.914892","https://doi.org/10.32345/2664-4738.2.2021.09","https://doi.org/10.3899/jrheum.201688","https://doi.org/10.20492/aeahtd.894837","https://doi.org/10.21518/2079-701x-2021-10-112-121","https://doi.org/10.1136/bcr-2021-243889","https://doi.org/10.33667/2078-5631-2021-16-16-19","https://doi.org/10.3899/jrheum.210822","https://doi.org/10.1080/03009742.2021.1927389","https://doi.org/10.1136/jim-2021-001885","https://doi.org/10.1093/rheumatology/keab663","https://doi.org/10.31138/mjr.32.3.256","https://doi.org/10.1016/b978-0-12-820472-6.00122-5","https://doi.org/10.1088/1755-1315/852/1/012075","https://doi.org/10.2174/1573397117666211007091256","https://doi.org/10.1055/a-1275-2657","https://doi.org/10.1007/s00296-021-05020-0","https://doi.org/10.1093/mr/roab055","https://doi.org/10.1002/psb.1945","https://doi.org/10.18553/jmcp.2021.21120","https://doi.org/10.1016/j.reuma.2021.08.001","https://doi.org/10.1055/a-1578-5513","https://doi.org/10.1093/rheumatology/keab790","https://doi.org/10.1007/s10067-021-05985-0","https://doi.org/10.1093/mr/roab082","https://doi.org/10.2217/pgs-2020-0146","https://doi.org/10.1093/rap/rkab077","https://doi.org/10.1016/b978-0-12-820472-6.00127-4","https://doi.org/10.21518/2079-701x-2021-19-155-162","https://doi.org/10.1186/s41927-021-00221-3","https://doi.org/10.1016/j.rhum.2021.10.193","https://doi.org/10.1007/978-3-030-80699-6_3","https://doi.org/10.1080/14656566.2021.2016697","https://doi.org/10.47360/1995-4484-2021-693-699","https://doi.org/10.1016/j.jbspin.2021.105326","https://doi.org/10.1016/j.reuma.2021.09.008","https://doi.org/10.3904/kjim.2021.018","https://doi.org/10.1016/j.jbspin.2021.105322","https://doi.org/10.3389/fmed.2021.755147","https://doi.org/10.1007/s10067-021-06017-7","https://doi.org/10.1016/b978-0-12-824390-9.00002-5","https://doi.org/10.1007/s12688-021-00467-2","https://doi.org/10.26442/00403660.2021.12.201241","https://doi.org/10.1055/a-1469-2433","https://doi.org/10.1007/s00393-021-01144-7","https://doi.org/10.1007/s00393-022-01157-w","https://doi.org/10.1016/b978-0-12-824390-9.00012-8","https://doi.org/10.1016/j.berh.2021.101739","https://doi.org/10.5114/reum.2021.112237","https://doi.org/10.1093/jalm/jfab131","https://doi.org/10.1371/journal.pone.0261667","https://doi.org/10.5306/wjco.v13.i1.49","https://doi.org/10.3390/jcm11030832","https://doi.org/10.1136/rmdopen-2021-002068","https://doi.org/10.1016/j.msard.2022.103510","https://doi.org/10.1007/s00296-021-05073-1","https://doi.org/10.1186/s13075-022-02728-7","https://doi.org/10.1016/j.mpmed.2021.12.003","https://doi.org/10.1016/j.jbspin.2021.105221","https://doi.org/10.1093/mr/roac015","https://doi.org/10.21019/pharmacotherapyfirst.ra_overview","https://doi.org/10.1007/s40744-022-00429-w","https://doi.org/10.3389/fmed.2022.858817","https://doi.org/10.2139/ssrn.3907252","https://doi.org/10.3389/fphar.2022.793394","https://doi.org/10.2196/preprints.31570","https://doi.org/10.1136/annrheumdis-2021-221841","https://doi.org/10.1093/rheumatology/keac153","https://doi.org/10.7759/cureus.23078","https://doi.org/10.36290/far.2021.025","https://doi.org/10.1093/rheumatology/keac154","https://doi.org/10.36290/med.2022.001","https://doi.org/10.1080/14656566.2022.2049238","https://doi.org/10.1016/b978-0-12-821446-6.00012-2","https://doi.org/10.3389/fdsfr.2022.881556","https://doi.org/10.1101/2022.04.05.22273443","https://doi.org/10.1111/ggi.14375","https://doi.org/10.2478/rir-2022-0005","https://doi.org/10.1093/mr/roac018","https://doi.org/10.1016/s2665-9913(22)00108-4","https://doi.org/10.1093/rheumatology/keac255","https://doi.org/10.1093/rheumatology/keac257","https://doi.org/10.1111/jcpt.13675","https://doi.org/10.2147/oarrr.s361454","https://doi.org/10.1055/a-1785-3679","https://doi.org/10.1007/978-981-16-7200-2_2","https://doi.org/10.1007/978-981-16-7200-2_27","https://doi.org/10.1055/a-1670-5087","https://doi.org/10.1016/b978-0-323-91369-0.00006-6","https://doi.org/10.1097/md.0000000000028463","https://doi.org/10.1016/b978-0-323-85857-1.00003-1","https://doi.org/10.1136/rmdopen-2021-002040","https://doi.org/10.1016/j.rhum.2022.05.003","https://doi.org/10.1007/978-981-33-4885-1_6","https://doi.org/10.1038/s41584-022-00799-z","https://doi.org/10.1007/s40261-022-01162-6","https://doi.org/10.1016/j.rcreue.2021.03.003","https://doi.org/10.1186/s13075-022-02826-6","https://doi.org/10.1016/j.clinthera.2022.05.002","https://doi.org/10.1002/acr.24965","https://doi.org/10.1007/s00393-022-01222-4","https://doi.org/10.1002/acr.24966","https://doi.org/10.1186/s12874-022-01639-0","https://doi.org/10.1186/s12875-022-01744-5","https://doi.org/10.2147/jir.s240593","https://doi.org/10.2147/oarrr.s368190","https://doi.org/10.1016/j.monrhu.2022.05.006","https://doi.org/10.1038/s41598-022-14368-7","https://doi.org/10.1093/rheumatology/keac355","https://doi.org/10.26442/00403660.2022.05.201501","https://doi.org/10.3390/jpm12061003","https://doi.org/10.14412/1996-7012-2022-3-21-28","https://doi.org/10.14412/1996-7012-2022-3-29-36","https://doi.org/10.1136/bmjopen-2022-061917","https://doi.org/10.1371/journal.pone.0270391","https://doi.org/10.1186/s41927-022-00267-x","https://doi.org/10.1007/s00296-022-05163-8","https://doi.org/10.1111/1756-185x.14374","https://doi.org/10.25040/ntsh2022.01.16","https://doi.org/10.1302/2046-3758.117.bjr-2021-0481.r1","https://doi.org/10.1002/art.42300","https://doi.org/10.2340/actadv.v102.1986","https://doi.org/10.2147/btt.s361164","https://doi.org/10.14744/nci.2022.05863","https://doi.org/10.1177/1759720x221096363","https://doi.org/10.1007/978-3-031-00936-5_11","https://doi.org/10.2169/internalmedicine.8497-21","https://doi.org/10.23736/s1824-4785.22.03477-x","https://doi.org/10.1038/s41598-022-16622-4","https://doi.org/10.3389/fphar.2022.964559","https://doi.org/10.3390/diagnostics12071773","https://doi.org/10.2478/rir-2022-0010","https://doi.org/10.33667/2078-5631-2022-15-7-13","https://doi.org/10.21037/atm-22-3234","https://doi.org/10.3390/jcm11154459","https://doi.org/10.1016/j.mayocp.2022.02.018","https://doi.org/10.1371/journal.pone.0272327","https://doi.org/10.1101/2022.08.02.500956","https://doi.org/10.18621/eurj.1091860","https://doi.org/10.2139/ssrn.4176841","https://doi.org/10.1186/s13075-022-02873-z","https://doi.org/10.1007/s10067-022-06320-x","https://doi.org/10.1097/md.0000000000029838","https://doi.org/10.1097/md.0000000000029974","https://doi.org/10.3389/fimmu.2022.858069","https://doi.org/10.1093/mr/roac092","https://doi.org/10.1186/s13075-022-02886-8","https://doi.org/10.1093/mrcr/rxac063","https://doi.org/10.1093/mr/roac093","https://doi.org/10.3899/jrheum.220152","https://doi.org/10.1007/s00296-022-05185-2","https://doi.org/10.1007/s10067-022-06259-z","https://doi.org/10.1111/1756-185x.14419","https://doi.org/10.21203/rs.3.rs-1933280/v1","https://doi.org/10.2174/1573397118666220819154605","https://doi.org/10.1016/j.jse.2022.07.011","https://doi.org/10.1101/2022.08.24.22279163","https://doi.org/10.1016/j.rhum.2022.03.004","https://doi.org/10.1155/2022/3406783","https://doi.org/10.1002/msc.1684","https://doi.org/10.1186/s41927-022-00280-0","https://doi.org/10.4274/raed.galenos.2022.54264","https://doi.org/10.1007/s00508-022-02062-7","https://doi.org/10.1111/ggi.14475","https://doi.org/10.4078/jrd.22.0024","https://doi.org/10.1093/rheumatology/keac518","https://doi.org/10.1093/mr/roac108","https://doi.org/10.3390/jcm11175207","https://doi.org/10.1016/j.jbspin.2022.105460","https://doi.org/10.1093/rheumatology/keac533","https://doi.org/10.1186/s13075-022-02903-w","https://doi.org/10.1136/ard-2022-222585","https://doi.org/10.1007/s40266-022-00976-5","https://doi.org/10.31832/smj.1035088","https://doi.org/10.47360/1995-4484-2022-473-480","https://doi.org/10.1016/j.pbiomolbio.2022.09.007","https://doi.org/10.1093/rheumatology/keac515","https://doi.org/10.1002/cdt3.43","https://doi.org/10.3389/fmed.2022.990317","https://doi.org/10.3390/jcm11195674","https://doi.org/10.1093/rheumatology/keac456","https://doi.org/10.1007/s40744-022-00483-4","https://doi.org/10.3389/fimmu.2022.977265","https://doi.org/10.1136/rmdopen-2022-002212","https://doi.org/10.1101/2022.09.30.22280396","https://doi.org/10.1166/jbt.2022.3130","https://doi.org/10.1080/17460441.2022.2131765","https://doi.org/10.1038/s41598-022-21160-0","https://doi.org/10.3389/fcell.2022.1011371","https://doi.org/10.51987/revhospitalbaires.v42i3.206","https://doi.org/10.3389/fmed.2022.989514","https://doi.org/10.1093/rheumatology/keac579","https://doi.org/10.1016/j.rhum.2022.10.003","https://doi.org/10.3390/jpm12101618","https://doi.org/10.1007/s40744-022-00498-x","https://doi.org/10.3389/fimmu.2022.943293","https://doi.org/10.21203/rs.3.rs-2076805/v1","https://doi.org/10.1177/1759720x221124028","https://doi.org/10.1186/s41927-022-00290-y","https://doi.org/10.1016/j.rhum.2022.10.006","https://doi.org/10.1038/s41598-022-22152-w","https://doi.org/10.1016/j.reuma.2022.08.005","https://doi.org/10.1002/acr2.11503","https://doi.org/10.3389/fphar.2022.1000865","https://doi.org/10.21203/rs.3.rs-1994034/v1","https://doi.org/10.2174/1381612829666221025154714","https://doi.org/10.3389/fimmu.2022.1040725","https://doi.org/10.3389/fphar.2022.967787","https://doi.org/10.1093/mr/roac129","https://doi.org/10.1080/14737159.2022.2140586","https://doi.org/10.3390/jcm11216313","https://doi.org/10.1016/j.reumae.2021.08.004","https://doi.org/10.1007/s40744-022-00503-3","https://doi.org/10.1007/s40801-022-00338-y","https://doi.org/10.1007/s00393-022-01274-6","https://doi.org/10.3390/ijerph192114616","https://doi.org/10.1177/20499361221135155","https://doi.org/10.1093/rheumatology/keac629","https://doi.org/10.1007/s10067-022-06432-4","https://doi.org/10.1080/1744666x.2023.2149495","https://doi.org/10.3389/fchem.2022.1023779","https://doi.org/10.1093/mr/roac136","https://doi.org/10.1186/s13075-022-02941-4","https://doi.org/10.1016/j.jbspin.2022.105491","https://doi.org/10.1016/j.rdc.2022.08.005","https://doi.org/10.1186/s41927-022-00301-y","https://doi.org/10.1136/rmdopen-2022-002615","https://doi.org/10.21518/2079-701x-2022-16-21-139-145","https://doi.org/10.1136/rmdopen-2022-002549","https://doi.org/10.1016/j.reumae.2021.09.009","https://doi.org/10.3889/oamjms.2022.10337","https://doi.org/10.1093/rheumatology/keac665","https://doi.org/10.21203/rs.3.rs-2318291/v1","https://doi.org/10.1186/s12969-022-00769-5","https://doi.org/10.1136/rmdopen-2022-002570","https://doi.org/10.1093/mr/roac152","https://doi.org/10.1093/mr/roac153","https://doi.org/10.1007/978-90-368-2888-8_5","https://doi.org/10.1186/s43166-022-00162-w","https://doi.org/10.1186/s41927-022-00314-7","https://doi.org/10.1136/rmdopen-2022-002593","https://doi.org/10.29169/1927-5951.2022.12.06","https://doi.org/10.1080/1744666x.2023.2157814","https://doi.org/10.1136/rmdopen-2022-002636","https://doi.org/10.7759/cureus.32240","https://doi.org/10.21203/rs.3.rs-2378275/v1","https://doi.org/10.1002/9781119833413.ch13","https://doi.org/10.1093/mr/roac156","https://doi.org/10.1007/s40744-022-00511-3","https://doi.org/10.1007/s10067-022-06478-4","https://doi.org/10.1016/j.rhum.2022.10.252","https://doi.org/10.1136/rmdopen-2022-002700","https://doi.org/10.1136/bmjopen-2021-051936","https://doi.org/10.1038/s41598-022-26728-4","https://doi.org/10.1136/rmdopen-2022-002796","https://doi.org/10.1136/rmdopen-2022-002658","https://doi.org/10.3390/medicina58121851","https://doi.org/10.1111/1756-185x.14550","https://doi.org/10.12998/wjcc.v10.i36.13467","https://doi.org/10.1093/rheumatology/keac715","https://doi.org/10.3390/ecsoc-25-11650","https://doi.org/10.4103/ijo.ijo_1776_22","https://doi.org/10.1590/1678-4324-2022220151","https://doi.org/10.4103/jcrsm.jcrsm_26_22","https://doi.org/10.1007/978-3-662-61937-7_73-1","https://doi.org/10.1371/journal.pone.0279632","https://doi.org/10.3389/fphar.2022.1031910","https://doi.org/10.4081/reumatismo.2022.1511","https://doi.org/10.15656/kjcg.2022.23.2.96","https://doi.org/10.14412/1996-7012-2022-6-73-79","https://doi.org/10.3390/jpm13010061","https://doi.org/10.3390/genes14010089","https://doi.org/10.3390/jcm12010207","https://doi.org/10.3390/diagnostics13010148","https://doi.org/10.1136/rmdopen-2022-002792","https://doi.org/10.1007/s12325-022-02413-w","https://doi.org/10.1016/j.semarthrit.2022.152160","https://doi.org/10.1007/s40744-022-00527-9","https://doi.org/10.1007/s40261-022-01238-3","https://doi.org/10.1371/journal.pone.0280234","https://doi.org/10.1007/s40744-022-00526-w","https://doi.org/10.12688/f1000research.112921.2","https://doi.org/10.3390/ijms24031958","https://doi.org/10.1007/s40744-022-00529-7","https://doi.org/10.3389/jpps.2023.11135","https://doi.org/10.31138/mjr.33.4.471","https://doi.org/10.1101/2023.01.20.23284852","https://doi.org/10.2147/ijgm.s393273","https://doi.org/10.1093/mr/road013","https://doi.org/10.1016/j.jep.2023.116175","https://doi.org/10.1093/omcr/omac155","https://doi.org/10.3389/fimmu.2023.1087986","https://doi.org/10.2147/oarrr.s282622","https://doi.org/10.1007/s40744-022-00521-1","https://doi.org/10.1016/j.rhum.2022.12.016","https://doi.org/10.1097/crd.0000000000000486","https://doi.org/10.1371/journal.pone.0281213","https://doi.org/10.1186/s13075-022-02985-6","https://doi.org/10.1080/03009742.2023.2164979","https://doi.org/10.1007/s40744-022-00523-z","https://doi.org/10.21203/rs.3.rs-2318291/v2","https://doi.org/10.1016/b978-2-294-77859-9.00021-9","https://doi.org/10.3390/diagnostics13040609","https://doi.org/10.3390/v15020468","https://doi.org/10.1007/s00393-023-01323-8","https://doi.org/10.1016/j.ejr.2023.01.002","https://doi.org/10.3389/fphar.2023.1135803","https://doi.org/10.1371/journal.pone.0281155","https://doi.org/10.1016/j.reuma.2022.12.003","https://doi.org/10.1186/s12916-023-02746-5","https://doi.org/10.1093/rheumatology/kead075","https://doi.org/10.7759/cureus.34952","https://doi.org/10.1007/s10067-023-06519-6","https://doi.org/10.1080/14740338.2023.2181340","https://doi.org/10.1080/1744666x.2023.2181790","https://doi.org/10.1007/s10067-023-06548-1","https://doi.org/10.1186/s13075-023-03007-9","https://doi.org/10.1093/mr/road021","https://doi.org/10.1002/acr.25106","https://doi.org/10.1021/acsami.3c00131","https://doi.org/10.1007/s00403-023-02566-w","https://doi.org/10.1093/rheumatology/kead083","https://doi.org/10.1007/s11845-023-03323-8","https://doi.org/10.1016/j.heliyon.2023.e14008","https://doi.org/10.21203/rs.3.rs-2624931/v1","https://doi.org/10.1007/s40744-023-00541-5","https://doi.org/10.1016/j.rcreu.2023.02.001","https://doi.org/10.1136/rmdopen-2022-002924","https://doi.org/10.23736/s2724-5895.20.02805-6","https://doi.org/10.1016/j.ebiom.2023.104501","https://doi.org/10.1136/rmdopen-2022-002898","https://doi.org/10.1007/s11926-023-01098-6","https://doi.org/10.1186/s13063-023-07176-5","https://doi.org/10.1016/b978-0-323-85831-1.00010-3","https://doi.org/10.2478/afpuc-2022-0016","https://doi.org/10.1097/rhu.0000000000001945","https://doi.org/10.1371/journal.pone.0282564","https://doi.org/10.1007/s00108-023-01484-3","https://doi.org/10.3390/jcm12051901","https://doi.org/10.1097/rhu.0000000000001952","https://doi.org/10.1136/rmdopen-2022-002842","https://doi.org/10.3389/fphys.2023.1138947","https://doi.org/10.2147/cia.s398386","https://doi.org/10.7759/cureus.35916","https://doi.org/10.1016/j.semarthrit.2023.152190","https://doi.org/10.3389/fmed.2023.1129939","https://doi.org/10.1080/03009742.2023.2182449","https://doi.org/10.3390/ph16030465","https://doi.org/10.47360/1995-4484-2023-87-99","https://doi.org/10.1186/s12951-023-01857-8","https://doi.org/10.1186/s41927-023-00329-8","https://doi.org/10.2196/43230","https://doi.org/10.3390/jpm13040607","https://doi.org/10.1016/j.tmaid.2023.102570","https://doi.org/10.1007/s10067-023-06587-8","https://doi.org/10.5387/fms.2022-06","https://doi.org/10.1007/978-3-031-23488-0_1","https://doi.org/10.1097/rhu.0000000000001956","https://doi.org/10.4274/raed.galenos.2023.46036","https://doi.org/10.1016/j.pharmthera.2023.108402","https://doi.org/10.1172/jci.insight.165024","https://doi.org/10.1016/j.jep.2023.116350","https://doi.org/10.12998/wjcc.v11.i11.2474","https://doi.org/10.1186/s43166-023-00187-9","https://doi.org/10.21203/rs.3.rs-2728661/v1","https://doi.org/10.1093/mr/road033","https://doi.org/10.3390/osteology3020006","https://doi.org/10.1007/s12325-023-02479-0","https://doi.org/10.1097/cm9.0000000000002564","https://doi.org/10.26641/2307-0404.2023.1.276049","https://doi.org/10.3390/jcm12082781","https://doi.org/10.3390/diagnostics13081385","https://doi.org/10.1007/s10654-023-01000-9","https://doi.org/10.1111/1756-185x.14695","https://doi.org/10.1007/s10067-023-06588-7","https://doi.org/10.1016/j.jos.2023.03.020","https://doi.org/10.2147/por.s399221","https://doi.org/10.1089/tmj.2023.0074","https://doi.org/10.3389/fphar.2023.1132602","https://doi.org/10.1016/j.reumae.2022.08.006","https://doi.org/10.14412/1996-7012-2023-2-23-36","https://doi.org/10.3390/ijms24097692","https://doi.org/10.1186/s42358-023-00301-7","https://doi.org/10.1016/j.intimp.2023.110203","https://doi.org/10.1016/j.intimp.2023.110227","https://doi.org/10.1136/rmdopen-2023-003196","https://doi.org/10.1016/j.heliyon.2023.e15839","https://doi.org/10.54707/meric.1254567","https://doi.org/10.1002/acr.25141","https://doi.org/10.1093/rheumatology/kead198","https://doi.org/10.1007/s12688-023-00615-w","https://doi.org/10.1016/j.autrev.2023.103357","https://doi.org/10.1080/09593985.2023.2209891","https://doi.org/10.1136/bmjopen-2022-068600","https://doi.org/10.1007/s40744-023-00551-3","https://doi.org/10.1007/978-3-662-63844-6_5","https://doi.org/10.2147/oarrr.s408894","https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.183","https://doi.org/10.1186/s41927-023-00331-0","https://doi.org/10.1007/s40744-023-00557-x","https://doi.org/10.1007/s40744-023-00560-2","https://doi.org/10.1136/rmdopen-2022-002894","https://doi.org/10.1007/s10067-023-06623-7","https://doi.org/10.1172/jci.insight.164778","https://doi.org/10.1007/s10067-023-06639-z","https://doi.org/10.1186/s13075-023-03045-3","https://doi.org/10.1007/s10067-023-06620-w","https://doi.org/10.3390/healthcare11111526","https://doi.org/10.1038/s41584-023-00969-7","https://doi.org/10.4103/injr.injr_13_23","https://doi.org/10.1093/mr/road045","https://doi.org/10.1093/rheumatology/kead257","https://doi.org/10.1111/imj.16144","https://doi.org/10.1371/journal.pcbi.1011073","https://doi.org/10.1093/mr/road041","https://doi.org/10.3390/ijms24119761","https://doi.org/10.1111/joim.13681","https://doi.org/10.3389/fphar.2023.1189389","https://doi.org/10.1186/s42358-023-00296-1","https://doi.org/10.1007/s10067-023-06653-1","https://doi.org/10.1007/s10067-023-06654-0","https://doi.org/10.1136/ard-2023-224148","https://doi.org/10.1016/j.arr.2023.101981","https://doi.org/10.1186/s12014-023-09411-2","https://doi.org/10.1002/acr2.11573","https://doi.org/10.1007/s10067-023-06649-x","https://doi.org/10.17116/jnevro202312305120","https://doi.org/10.1186/s12916-023-02868-w","https://doi.org/10.3389/fmed.2023.1179240","https://doi.org/10.1136/bmjopen-2022-069014","https://doi.org/10.1016/j.reuma.2023.05.002","https://doi.org/10.1016/j.rcsop.2023.100296","https://doi.org/10.3389/fmed.2023.1185300","https://doi.org/10.1177/20406223231178273","https://doi.org/10.18332/pne/161867","https://doi.org/10.1007/s40259-023-00612-7","https://doi.org/10.1007/s00394-023-03196-8","https://doi.org/10.1111/1756-185x.14778","https://doi.org/10.47360/1995-4484-2023-307-319","https://doi.org/10.1001/jamanetworkopen.2023.21398","https://doi.org/10.3390/molecules28135053","https://doi.org/10.3390/jpm13071087","https://doi.org/10.1186/s41927-023-00341-y"],"shape":[1424],"dtype":"object","order":"little"}],["pmid",{"type":"ndarray","array":{"type":"bytes","data":"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"},"shape":[1424],"dtype":"float64","order":"little"}],["is_trial",[false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false,false]]]}}},"cell_styles":{"type":"map","entries":[["id","8306b765fbb7423e802187737a4e90e2"],["data",{"type":"map"}]]},"pagination":"local","page":1,"page_size":20,"max_page":72,"select_mode":true,"selectable_rows":null,"theme_classes":["table-sm"]}}]}}]}}],"defs":[{"type":"model","name":"ReactiveHTML1"},{"type":"model","name":"FlexBox1","properties":[{"name":"align_content","kind":"Any","default":"flex-start"},{"name":"align_items","kind":"Any","default":"flex-start"},{"name":"flex_direction","kind":"Any","default":"row"},{"name":"flex_wrap","kind":"Any","default":"wrap"},{"name":"justify_content","kind":"Any","default":"flex-start"}]},{"type":"model","name":"FloatPanel1","properties":[{"name":"config","kind":"Any","default":{"type":"map"}},{"name":"contained","kind":"Any","default":true},{"name":"position","kind":"Any","default":"right-top"},{"name":"offsetx","kind":"Any","default":null},{"name":"offsety","kind":"Any","default":null},{"name":"theme","kind":"Any","default":"primary"},{"name":"status","kind":"Any","default":"normalized"}]},{"type":"model","name":"GridStack1","properties":[{"name":"mode","kind":"Any","default":"warn"},{"name":"ncols","kind":"Any","default":null},{"name":"nrows","kind":"Any","default":null},{"name":"allow_resize","kind":"Any","default":true},{"name":"allow_drag","kind":"Any","default":true},{"name":"state","kind":"Any","default":[]}]},{"type":"model","name":"drag1","properties":[{"name":"slider_width","kind":"Any","default":5},{"name":"slider_color","kind":"Any","default":"black"},{"name":"value","kind":"Any","default":50}]},{"type":"model","name":"click1","properties":[{"name":"terminal_output","kind":"Any","default":""},{"name":"debug_name","kind":"Any","default":""},{"name":"clears","kind":"Any","default":0}]},{"type":"model","name":"FastWrapper1","properties":[{"name":"object","kind":"Any","default":null},{"name":"style","kind":"Any","default":null}]},{"type":"model","name":"NotificationAreaBase1","properties":[{"name":"js_events","kind":"Any","default":{"type":"map"}},{"name":"position","kind":"Any","default":"bottom-right"},{"name":"_clear","kind":"Any","default":0}]},{"type":"model","name":"NotificationArea1","properties":[{"name":"js_events","kind":"Any","default":{"type":"map"}},{"name":"notifications","kind":"Any","default":[]},{"name":"position","kind":"Any","default":"bottom-right"},{"name":"_clear","kind":"Any","default":0},{"name":"types","kind":"Any","default":[{"type":"map","entries":[["type","warning"],["background","#ffc107"],["icon",{"type":"map","entries":[["className","fas fa-exclamation-triangle"],["tagName","i"],["color","white"]]}]]},{"type":"map","entries":[["type","info"],["background","#007bff"],["icon",{"type":"map","entries":[["className","fas fa-info-circle"],["tagName","i"],["color","white"]]}]]}]}]},{"type":"model","name":"Notification","properties":[{"name":"background","kind":"Any","default":null},{"name":"duration","kind":"Any","default":3000},{"name":"icon","kind":"Any","default":null},{"name":"message","kind":"Any","default":""},{"name":"notification_type","kind":"Any","default":null},{"name":"_destroyed","kind":"Any","default":false}]},{"type":"model","name":"TemplateActions1","properties":[{"name":"open_modal","kind":"Any","default":0},{"name":"close_modal","kind":"Any","default":0}]},{"type":"model","name":"BootstrapTemplateActions1","properties":[{"name":"open_modal","kind":"Any","default":0},{"name":"close_modal","kind":"Any","default":0}]},{"type":"model","name":"MaterialTemplateActions1","properties":[{"name":"open_modal","kind":"Any","default":0},{"name":"close_modal","kind":"Any","default":0}]}]}}
    </script>
    <script type="text/javascript">
      (function() {
        const fn = function() {
          Bokeh.safely(function() {
            (function(root) {
              function embed_document(root) {
              const docs_json = document.getElementById('p1140').textContent;
              const render_items = [{"docid":"9930c1ed-40c2-480b-9332-9bc6908ca5e2","roots":{"p1002":"bc0230a8-c341-4a63-822a-b9b80bcf8293","p1009":"ae9ac02f-829b-46f5-b297-a9a2f69216ac","p1012":"ad97d1a7-5ce5-42e5-a72e-410f525ce77c","p1013":"e4cedbbf-56e6-4fee-ad91-ee5d4ee3e1d1","p1016":"be336cf6-2e6f-4419-a775-f281022e6947","p1017":"e3b3b04b-40e1-4765-97a4-d13e7e23f472"},"root_ids":["p1002","p1009","p1012","p1013","p1016","p1017"]}];
              root.Bokeh.embed.embed_items(docs_json, render_items);
              }
              if (root.Bokeh !== undefined) {
                embed_document(root);
              } else {
                let attempts = 0;
                const timer = setInterval(function(root) {
                  if (root.Bokeh !== undefined) {
                    clearInterval(timer);
                    embed_document(root);
                  } else {
                    attempts++;
                    if (attempts > 100) {
                      clearInterval(timer);
                      console.log("Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing");
                    }
                  }
                }, 10, root)
              }
            })(window);
          });
        };
        if (document.readyState != "loading") fn();
        else document.addEventListener("DOMContentLoaded", fn);
      })();
    </script>
  </body>
</html>